{
      "FullStudiesResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:09:28 23:22:14.126",
            "Expression": "mesenchymal stem",
            "NStudiesAvail": 429205,
            "NStudiesFound": 1410,
            "MinRank": 1,
            "MaxRank": 50,
            "NStudiesReturned": 50,
            "FullStudies": [
                  {
                        "Rank": 1,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04125329",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "43136152-9"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Yan'an Affiliated Hospital of Kunming Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy",
                                          "OfficialTitle": "Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2021",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 1, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 1, 2024",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 1, 2024",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 16, 2019",
                                          "StudyFirstSubmitQCDate": "October 10, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 14, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "April 19, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 21, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Yan'an Affiliated Hospital of Kunming Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This clinical trial assessed the safety of human umbilical cord mesenchymal stem cell therapy in 15 patients with diabetic nephropathy. Fifteen subjects received umbilical cord mesenchymal stem cell therapy 3 times. Approximately 1 \u00d7 106/kg of human umbilical cord mesenchymal stem cells were administered by peripheral intravenous infusion once a month .Endpoints:Primary endpoint: Safety and adverse events (safety and tolerability of umbilical cord mesenchymal stem cell therapy within 60 weeks).Secondary endpoint indicators:Efficacy measures: eGFR, urinary albumin-to-creatinine ratio, and percentage changes of 24-h urinary protein quantities from baseline to 60 weeks.",
                                          "DetailedDescription": "Dosage and administration method: Fifteen subjects received umbilical cord mesenchymal stem cell therapy 3 times. Approximately 1 \u00d7 106/kg of human umbilical cord mesenchymal stem cells were administered by peripheral intravenous infusion once a month at 0, 4, and 8 weeks. Routine medications were used.\n\nFollow-up: Patient follow-up was performed 7 times at 0, 4, 8, 20, 32, 48, and 60 weeks. Blood and urine were collected for determination of urinary albumin-to-creatinine ratio, 24-h urine protein ratio, liver and kidney function, fasting blood glucose, 2-h postprandial blood glucose, glycosylated hemoglobin, eGFR, blood lipids, and blood electrolytes at each follow-up visit. The daily dose of insulin was recorded. Blood samples were taken after each infusion of stem cells for flow cytometry and for the detection of CD3, CD4, CD8, CD28+, Treg, CD80, CD86, HLA-DR, CD83, and CD1a cells. Plasma levels of the cytokines IFN-gamma, TNF, IL-2, IL-4, IL-10, IL-6, IL-12P70, IL-8, and IL-1 beta were also determined.\n\nEndpoints:\n\nPrimary endpoint: Safety and adverse events (safety and tolerability of umbilical cord mesenchymal stem cell therapy within 60 weeks): The number and severity of adverse events, an evaluation of their association with the umbilical cord mesenchymal stem cell treatment, and the outcome of the adverse events.\n\nThe patients' discomfort and clinical symptoms during the study period were recorded.\n\nThe subjects' relevant laboratory test indices, 12-lead electrocardiogram, vital signs, and physical examination results were recorded during the study.\n\nSecondary endpoint indicators:\n\nEfficacy measures: eGFR, urinary albumin-to-creatinine ratio, and percentage changes of 24-h urinary protein quantities from baseline to 60 weeks.\n\nData analysis:\n\nThe number of adverse events and the number of severity adverse events were determined based on the changes in the data summary (i.e., descriptive statistics).\n\nA multilevel statistical analysis model (mixed effects model) was used to infer the relationship between treatment factors and key indicators, reflect the changing trend of key indicators in different time periods, and draw statistical analysis conclusions."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Mesenchymal Stem Cells",
                                                      "Diabetic Nephropathy"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Human umbilical cord mesenchymal stem cells",
                                                      "Diabetic nephropathy"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Early Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "15",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Human umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Human umbilical cord mesenchymal stem cells were given to each diabetic nephropathy subject once a month, peripheral intravenous injection, a total of three times",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Human umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Human umbilical cord mesenchymal stem cells",
                                                            "InterventionDescription": "Human umbilical cord mesenchymal stem cells were given to each diabetic nephropathy subject once a month, peripheral intravenous injection, a total of three times",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Human umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Incidence of Treatment-Emergent and Treatment-Chronic Adverse Events of human umbilical cord mesenchymal stem cells for diabetic nephropathy patient",
                                                            "PrimaryOutcomeDescription": "The patient's discomfort and clinical symptoms during the study were recorded, as well as the related laboratory test indicators and physical examination abnormalities of the subjects during the study.Describe the association with umbilical cord mesenchymal stem cell therapy and calculate the incidence of treatment-related acute and chronic adverse events.",
                                                            "PrimaryOutcomeTimeFrame": "60 weeks"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in eGFR before and after treatment; Changes in 24h urine protein quantification before and after treatment",
                                                            "SecondaryOutcomeDescription": "Main evaluation index of curative effect:percentage changes in estimated glomerular filtration rate (eGFR), urinary albumin creatinine ratio, and 24-hour urinary protein quantification from baseline to 60 weeks of treatment. Other efficacy indicators included fasting blood glucose, blood glucose 2 hours after breakfast, HbA1c, blood and urine routine, liver and renal function, blood lipid, blood electrolyte, and daily insulin dosage.",
                                                            "SecondaryOutcomeTimeFrame": "60Weeks,but the major evaluated time is 12 weeks after the last treatment, compared with baseline (0W)"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Enrollment criteria:\n\nAdult patients (age 18-60 years) who met the WHO 1999 diagnostic criteria for type 2 diabetes, regardless of gender;\nConcomitant proteinuria ,3500 mg/day\u226524h urinary protein excretion \u2265500 mg/day, and uncontrolled disease course;\nPathological examination of puncture biopsy resulting in diagnosis of type IIa, IIb, III, or IV diabetic nephropathy. (In 2010, an international expert group led by Bruijn of Leiden University in the Netherlands published a pathological classification system for diabetic nephropathy);\neGFR between 30 ml/min/1.732 m2 and 60 ml/min/1.732 m2;\nDiabetes treatment according to guidelines and norms before the umbilical cord mesenchymal stem cell therapy;\nIf there is a possibility of pregnancy in female, must be negative pregnancy test, not in lactation, and confirm that is receiving the method of contraception recognized by the researchers, and agree to maintain the method of contraception throughout the study. Sexually active male patients must agree to the use of an appropriate contraceptive method for birth control from the first administration of the study treatment until 24 weeks after the last administration.\nparticipate in all visits, examinations, and treatments as required by the experimental protocol.\n\nExclusion criteria:\n\nPatients with kidney biopsy diagnosis of type I diabetic nephropathy or a diagnosis of another glomerular disease;\nPatients with abnormal renal function (serum creatinine \u2265 the upper limit of normal);\nPatients with HbA1c \u226510%;\nPatients with active liver disease or abnormal liver function test results (ALT or AST \u22652 times the upper limit of normal);\nPatients with blood leukocyte count <3.0 \u00d7 109/L, hemoglobin <90 g/L, platelet count <100 \u00d7 109/L, or those who have other hematologic diseases (severe anemia, idiopathic thrombocytopenic purpura, splenomegaly, coagulation dysfunction, etc.);\nPatients with serious and unstable cardiovascular or cerebrovascular diseases (unstable angina pectoris, coronary artery disease, cerebrovascular disease, transient ischemic attack, congestive heart failure, etc.), acute and difficult to control the disease, after treatment has not been effectively controlled severe hypertension (blood pressure >160/100 mm Hg), or organ transplantation;\nPatients with increased use of hypotensive drugs in the past 3 months;\nPatients with uncontrolled infection;\nPatients with tumors or abnormal tumor marker levels;\nPatients with blood-borne diseases (i.e., HIV, syphilis, hepatitis B, and hepatitis C);\nPregnancy, the potential for pregnancy, or lactation;\nPatients receiving immunosuppressive therapy;\nPatients with a history of allergy, especially patients allergic to human blood albumin;\nPatients with mental illness affecting their voluntarism, ability to make decisions, and ability to communicate\uff1b\nA history of alcoholism or known drug addiction in the last 2 years;\nParticipation in another clinical trial within the last 3 months;\nPatients judged inappropriate for this study by the physicians.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "wang xiaodan",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "0871-63211326",
                                                            "CentralContactEMail": "52830538@qq.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Tang zhe",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "0871-63211272"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Yan'an Hospital of Kunming City",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Kunming",
                                                            "LocationZip": "650051",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Zhouliu Hou",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "0871-63211326",
                                                                              "LocationContactEMail": "hzl579@163.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007674",
                                                            "ConditionMeshTerm": "Kidney Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003928",
                                                            "ConditionMeshTerm": "Diabetic Nephropathies"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000014570",
                                                            "ConditionAncestorTerm": "Urologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000048909",
                                                            "ConditionAncestorTerm": "Diabetes Complications"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003920",
                                                            "ConditionAncestorTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9850",
                                                            "ConditionBrowseLeafName": "Kidney Diseases",
                                                            "ConditionBrowseLeafAsFound": "Nephropathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6275",
                                                            "ConditionBrowseLeafName": "Diabetic Nephropathies",
                                                            "ConditionBrowseLeafAsFound": "Diabetic Nephropathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16471",
                                                            "ConditionBrowseLeafName": "Urologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25157",
                                                            "ConditionBrowseLeafName": "Diabetes Complications",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 2,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01221428",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSCKJ004"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Qingdao University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis",
                                          "OfficialTitle": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2010",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2012",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2012",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "October 14, 2010",
                                          "StudyFirstSubmitQCDate": "October 14, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 15, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 14, 2010",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 15, 2010",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyOldNameTitle": "Wang, Yangang MD",
                                                "ResponsiblePartyOldOrganization": "Stem Cell Research Center of Medical School Hospital of Qingdao University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Qingdao University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for ulcerative colitis is safe and effective.",
                                          "DetailedDescription": "Ulcerative colitis is characterized as chronic and nonspecific inflammation of gastroenteritis tract\uff0eNowadays\uff0cetiology and pathogenesis of UC have been unclear\uff0eRecent basic research has been revealed that stem cell can settle down in epithelium of gastroenteritis tract\uff0cwhich provide a hope for treating the disease.We hope umbilical cord Mesenchymal Stem Cells could not only address the need for epithelial cell replacement but also control of the autoimmune response to mocous membrane of colon."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Ulcerative Colitis",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Ulcerative colitis",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "50",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous infusion of ex vivo cultured umbilical cord mesenchymal stem cells,one week later,conduct intervention operation to inject mesenchymal stem cells to mesenteric artery.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Umbilical Cord Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Umbilical Cord Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Intravenous infusion of ex vivo cultured umbilical cord mesenchymal stem cells(2*10/7),one week later,conduct intervention operation to inject mesenchymal stem cells to mesenteric artery(1*10/7).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "the result of enteroscopy and pathological report",
                                                            "PrimaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "the clinical symptom (including stomachache,abdominal distention,bloody purulent stool)",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female, 18 years of age or older.\nUlcerative colitis described according to usual criteria.\nRefractoriness Ulcerative colitis or unefficient by using other therapy\nSigned informed consent form.\n\nExclusion Criteria:\n\nHistory of neoplasm or hematological disease\nUncontrolled high blood pressure (>180/110)\nSevere cardiac insufficiency (New York Heart Association [NYHA] IV) or ejection fraction<30%\nMalignant ventricular arrythmia\nDeep venous thrombosis during the last 3 months\nActive bacterial infection\nBody mass index > 35 Kg/m2\nStroke or myocardial infarction during the last 3 months",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Gang Zhao, MD",
                                                            "OverallOfficialAffiliation": "The Affiliated Hospital of Qingdao University",
                                                            "OverallOfficialRole": "Study Director"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Stem Cell Research Center of Medical School Hospital of Qingdao University",
                                                            "LocationCity": "Qingdao",
                                                            "LocationState": "Shandong",
                                                            "LocationZip": "266003",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003092",
                                                            "ConditionMeshTerm": "Colitis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003093",
                                                            "ConditionMeshTerm": "Colitis, Ulcerative"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000014456",
                                                            "ConditionMeshTerm": "Ulcer"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000005759",
                                                            "ConditionAncestorTerm": "Gastroenteritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005767",
                                                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003108",
                                                            "ConditionAncestorTerm": "Colonic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007410",
                                                            "ConditionAncestorTerm": "Intestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000015212",
                                                            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M5472",
                                                            "ConditionBrowseLeafName": "Colitis",
                                                            "ConditionBrowseLeafAsFound": "Colitis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5473",
                                                            "ConditionBrowseLeafName": "Colitis, Ulcerative",
                                                            "ConditionBrowseLeafAsFound": "Ulcerative Colitis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16358",
                                                            "ConditionBrowseLeafName": "Ulcer",
                                                            "ConditionBrowseLeafAsFound": "Ulcerative",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8027",
                                                            "ConditionBrowseLeafName": "Gastroenteritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5488",
                                                            "ConditionBrowseLeafName": "Colonic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9596",
                                                            "ConditionBrowseLeafName": "Intestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17069",
                                                            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 3,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03558334",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "XYunqiu"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Children's Hospital of Chongqing Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia",
                                          "OfficialTitle": "Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia in Premature Infants"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2019",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 28, 2018",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 31, 2021",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 30, 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 4, 2018",
                                          "StudyFirstSubmitQCDate": "June 14, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 15, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "May 19, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "May 21, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Xia Yunqiu",
                                                "ResponsiblePartyInvestigatorTitle": "doctor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Children's Hospital of Chongqing Medical University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Children's Hospital of Chongqing Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study is an open-label, single-center, dose escalation study to evaluate of safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs) in premature infants for moderate and severe Bronchopulmonary Dysplasia\uff08BPD\uff09.",
                                          "DetailedDescription": "BPD is a chronic lung disease that occur in premature infants receiving prolonged oxygen pulmonary and ventilator therapy. It remains a main complication of extreme prematurity and currently lacks efficient treatment.The mortality rate of one year after birth is still high and the quality of life is not optimistic.\n\nhUC-MSCs are widely used in clinic due to their low immunogenicity and convenient to get.Many animal study had shown that hUC-MSCs had therapeutic effects on a variety of animal models of lung disease.Furthermore,there are a large number of clinical trials of MSCs applied to various system diseases and the safety was verified.So,the main purpose of this study is to evaluate the safety and efficacy of hUC-MSCs in participants with moderate and severe BPD."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Bronchopulmonary Dysplasia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Bronchopulmonary Dysplasia",
                                                      "human umbilical cord -derived mesenchymal stem cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "12",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Transplantation of Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stem cell will be given to preterm infants with BPD.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Transplantation of mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "No Transplantation of Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Mesenchymal stem cell will be not given to preterm infants with BPD.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: No transplantation of mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Transplantation of mesenchymal stem cell",
                                                            "InterventionDescription": "Human umbilical cord-derived mesenchymal stem cell will be given to preterm infants through intravenous infusion.\n\nDose A - 1 million cells per kg Dose B - 5 million cells per kg",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Transplantation of Mesenchymal Stem Cell"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Intravenous infusion of mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "No transplantation of mesenchymal stem cell",
                                                            "InterventionDescription": "Human umbilical cord-derived mesenchymal stem cell will be not given to preterm infants through intravenous infusion.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "No Transplantation of Mesenchymal Stem Cell"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "No intravenous infusion of mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of participants with adverse reactions related to infusion after treatment",
                                                            "PrimaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "PrimaryOutcomeTimeFrame": "24 hours after administration"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of high-resolution chest CT in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety and efficacy of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "SecondaryOutcomeTimeFrame": "within 2 years after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of temperature in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "SecondaryOutcomeTimeFrame": "3 days after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of blood pressure in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD. Blood pressure is measured by electronic sphygmomanometer .",
                                                            "SecondaryOutcomeTimeFrame": "3 days after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of heart rate in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "SecondaryOutcomeTimeFrame": "3 days after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of respiratory rate in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "SecondaryOutcomeTimeFrame": "3 days after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of oxygen saturation in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "SecondaryOutcomeTimeFrame": "3 days after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Growth velocity (Z-score) in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety and efficacy of human umbilical cord -derived mesenchymal stem cells for BPD.",
                                                            "SecondaryOutcomeTimeFrame": "within 2 years after administration"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nThe participants meet the diagnostic criteria for moderate and severe BPD established by the National Institutes of Child Health and Human Development (NICHD) workshop.\nThe participants have abnormal respiratory manifestations.\nWritten consent form signed by a legal representative or a parent.\n\nExclusion Criteria:\n\nAlthough mechanical ventilation or oxygen is required in participants, there are no signs of dyspnea or BPD-related changes in lung imaging, such as central apnea or diaphragm paralysis.\nThe participants who have complex congenital heart disease.\nThe participants who have severe pulmonary hypertension(cardiac ultrasound confirmed) at the time of assessment.\nThe participants who have severe respiratory tract malformation: pierre-robin syndrome, tracheobronchomalacia, vascular ring syndrome, congenital tracheal stenosis, tracheo-esophageal fistula, pulmonary emphysema, pulmonary sequestration, congenital pulmonary dysplasia, congenital pulmonary cyst, congenital spasm, etc.\nThe participants who have severe chromosome anomalies :Edward syndrome, Patau syndrome, Down syndrome, etc) or severe congenital malformation (Hydrocephalus, Encephalocele, etc).\nThe participants who have severe congenital infection(Herpes, Toxoplasmosis, Rubella, Syphilis, AIDS, etc).\nThe participants who have severe sepsis or shock.\nThe participants who is going to have surgery 72 hours before/after this study drug administration.\nThe participants who have surfactant administration within 24 hours before this study drug administration.\nThe participants who have severe intracranial hemorrhage \u2265 grade 3 or 4.\nThe participants who have active pulmonary hemorrhage or active air leak syndrome at the time of assessment.\nThe participants who have the history of other clinical studies as a participant.\nThe participants who is considered inappropriate by the investigators.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "28 Days",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Yunqiu Xia",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "13637719980",
                                                            "CentralContactEMail": "sunny_199001@foxmail.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Lin Zou",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "18623121280"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Zhou Fu",
                                                            "OverallOfficialAffiliation": "Children's Hospital of Chongqing Medical University",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Children's Hospital of Chongqing Medical University",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Chongqing",
                                                            "LocationState": "Chongqing",
                                                            "LocationZip": "400014",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Yunqiu Xia",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "13637719980",
                                                                              "LocationContactEMail": "sunny_199001@foxmail.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "24508444",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Chang YS, Ahn SY, Yoo HS, Sung SI, Choi SJ, Oh WI, Park WS. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014 May;164(5):966-972.e6. doi: 10.1016/j.jpeds.2013.12.011. Epub 2014 Feb 6."
                                                      },
                                                      {
                                                            "ReferencePMID": "21336467",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Hayes D Jr, Meadows JT Jr, Murphy BS, Feola DJ, Shook LA, Ballard HO. Pulmonary function outcomes in bronchopulmonary dysplasia through childhood and into adulthood: implications for primary care. Prim Care Respir J. 2011 Jun;20(2):128-33. doi: 10.4104/pcrj.2011.00002. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "28341525",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ahn SY, Chang YS, Kim JH, Sung SI, Park WS. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. J Pediatr. 2017 Jun;185:49-54.e2. doi: 10.1016/j.jpeds.2017.02.061. Epub 2017 Mar 21."
                                                      },
                                                      {
                                                            "ReferencePMID": "25529339",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS, Lee JW, Rogers AJ, Levitt J, Wiener-Kronish J, Bajwa EK, Leavitt A, McKenna D, Thompson BT, Matthay MA. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015 Jan;3(1):24-32. doi: 10.1016/S2213-2600(14)70291-7. Epub 2014 Dec 17."
                                                      },
                                                      {
                                                            "ReferencePMID": "26928452",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Laube M, Stolzing A, Thome UH, Fabian C. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth. Int J Biochem Cell Biol. 2016 May;74:18-32. doi: 10.1016/j.biocel.2016.02.023. Epub 2016 Feb 27. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "23212278",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G, Emery D, Bodiga S, Eaton F, P\u00e9ault B, Mosca F, Lazzari L, Th\u00e9baud B. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax. 2013 May;68(5):475-84. doi: 10.1136/thoraxjnl-2012-202323. Epub 2012 Dec 4."
                                                      },
                                                      {
                                                            "ReferencePMID": "22837858",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Hansmann G, Fernandez-Gonzalez A, Aslam M, Vitali SH, Martin T, Mitsialis SA, Kourembanas S. Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ. 2012 Apr-Jun;2(2):170-81. doi: 10.4103/2045-8932.97603."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000001997",
                                                            "ConditionMeshTerm": "Bronchopulmonary Dysplasia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000006965",
                                                            "ConditionMeshTerm": "Hyperplasia"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055397",
                                                            "ConditionAncestorTerm": "Ventilator-Induced Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4425",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9168",
                                                            "ConditionBrowseLeafName": "Hyperplasia",
                                                            "ConditionBrowseLeafAsFound": "Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27305",
                                                            "ConditionBrowseLeafName": "Ventilator-Induced Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T874",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 4,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03765957",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2018-MSC/CSU/PS"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Central South University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells",
                                          "OfficialTitle": "Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2020",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 20, 2019",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 31, 2020",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 1, 2021",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "August 28, 2018",
                                          "StudyFirstSubmitQCDate": "December 4, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "December 5, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 22, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 23, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Yijing He",
                                                "ResponsiblePartyInvestigatorTitle": "Associate professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Central South University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Central South University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "To evaluate the effect and safety of treatment of psoriasis by human umbilical cord-derived mesenchymal stem cel",
                                          "DetailedDescription": "Psoriasis is a chronic and recurrent inflammatory skin disease and its histological features are characterized by epidermal hyperplasia, increased angiogenesis and immune cell infiltration. Psoriasis prevalence is about 0.1%-3%, affecting approximately 125 million people worldwide. In China, there are about 10 million psoriasis patients.\n\nHuman umbilical cord-derived MSC (huc-MSC) has many advantages for the treatment of immune disease. Because it was demonstrated that huc-MSCs are effective in modulating immune cells and treating diseases and it has low immunogenicity. Furthermore, huc-MSCs do not raise ethical issue for clinical applications.\n\nSome experimental results and cases has showed that mesenchymal stem cell (MSC) can prevent or treat psoriasis. This clinical study is conducted to provide more data to evaluate the effect and safety of treatment of psoriasis by human umbilical cord-derived mesenchymal stem cell."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Psoriasis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Early Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "12",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "The mesenchymal stem cells will be derived from human umbilical cord. After the subjects are screened and qualified, random number envelopes will be selected to group 12 subjects into group A, group B, group C and group D at a ratio of 1:1:1:1. The subjects of group A and B will be injected intravenously with 1.5x10E6/kg and 2.0x10E6/kg\uff08according to the weight of subject\uff09mesenchymal stem cells respectively at baseline and every 2 weeks, 4 times is a course of treatment. Subjects will be followed up for evaluation on 15 days, 30 days, 45 days, month 2, month 3 and month 6 after treatment. The subjetcts of group C and D will be injected intravenously with 2.5x10E6/kg and 3.0x10E6/kg \uff08according to the weight of subject\uff09mesenchymal stem cells respectively at baseline and every 4 weeks, 2 times is a course of treatment. Subjects will be followed up for evaluation on 15 days, 30 days, 45 days, month 2, month 3 and month 6 after treatment.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cells",
                                                            "InterventionDescription": "After the subjects are screened and qualified, random number envelopes will be selected to group 12 subjects into group A, group B, group C and group D at a ratio of 1:1:1:1. The subjetcts of group A and B will be injected intravenously with 1.5x10E6/kg and 2.0x10E6/kg\uff08according to the weight of subject\uff09mesenchymal stem cells respectively at baseline and every 2 weeks, 4 times is a course of treatment. Subjects will be followed up for evaluation on 15 days, 30 days, 45 days, month 2, month 3 and month 6 after treatment. The subjetcts of group C and D will be injected intravenously with 2.5x10E6/kg and 3.0x10E6/kg \uff08according to the weight of subject\uff09mesenchymal stem cells respectively at baseline and every 4 weeks, 2 times is a course of treatment. Subjects will be followed up for evaluation on 15 days, 30 days, 45 days, month 2, month 3 and month 6 after treatment. Besides MSCs, moisturizers such as boric acid ointment will be given to all subjects.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Human Umbilical Cord-derived Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of Participants Achieving Psoriasis Area and Severity Index \u226575% (PASI 75) Improvement",
                                                            "PrimaryOutcomeDescription": "The PASI combines assessments of the extent of body-surface involvement in 4 anatomical regions (head, trunk, arms, and legs) and the severity of desquamation (scaling), erythema, and plaque induration/infiltration (thickness) in each region, yielding an overall score of 0 for no psoriasis to 72 for the most severe disease. Participants achieving PASI 75 was defined as having an improvement of at least 75% in the PASI scores compared to baseline.",
                                                            "PrimaryOutcomeTimeFrame": "Month 6"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of Participants Achieving a Physician Global Assessment (PGA) of (0, 1)",
                                                            "PrimaryOutcomeDescription": "The PGA is a physician's determination of the participant's psoriasis lesions overall categorized by descriptions for induration, erythema, and scaling.",
                                                            "PrimaryOutcomeTimeFrame": "Month 6"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change From Baseline in Dermatology Life Quality Index (DLQI) Total Score",
                                                            "SecondaryOutcomeDescription": "The DLQI is a simple, participant-administered, 10 question, validated, quality-of-life questionnaire that covers 6 domains: symptoms and feelings, daily activities, leisure, work and school, personal relationships, and treatment. Response categories include \"not at all,\" \"a lot,\" and \"very much,\" with corresponding scores of 1, 2, and 3, respectively, and unanswered (\"not relevant\") responses scored as \"0.\" Totals range from 0 to 30 (less to more impairment), and a 5 point change from baseline is considered clinically relevant. Least Square (LS) Means in total DLQI score were calculated using Mixed Model Repeated Measures (MMRM) with baseline score as covariate, treatment, pooled center, visit and treatment-by-visit interaction as fixed effects.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, Month 6"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Adverse event",
                                                            "SecondaryOutcomeDescription": "An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, Month 6"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\n1.Understanding the whole process of the study, voluntary participation and signed the informed consent; 2.18 Years to 65 Years old, Body Mass Index (BMI) between 18.5-35; 3.Diagnosed according to biopsy for Psoriasis vulgaris for more than 6 months and resistance to phototherapy, systemic therapy, or a combination of these therapies,BSA(body surface area)>10%, PGA\u22653 and PASI>10 at baseline; 4. Patients participated in any stem cell therapy within 6 months;\n\nExclusion Criteria:\n\nWBC(white blood cell count ) <3.5x109/L, blood platelet count<100x109/L, hemoglobin<100g/L serum creatinine>1.5 x ULN(upper limit of normal), bilirubin > 1.5 x ULN(upper limit of normal), AST(SGOT,glutamic-oxalacetic transaminase)/ALT(SGPT,glutamic-pyruvic transaminase) >2.0 x ULN(upper limit of normal);Either HIV-antibody(human immunodeficiency virus-antibody), HBV-antibody (hepatitis B virus-antibody ) or syphilis antibody is positive;\nHave a serious heart, lung, kidney and other vital organs and endocrine system lesions and the history,Patients suffering from any acute or chronic infectious diseases, patients suffering from malignant tumor; Mental disorders, history of alcohol abuse, drug or other substance abuse;\nPatients who have received systemic therapy within recent one month or topical therapy in two weeks;\nHaving a serious allergic history or being allergic to two or more than 2 kinds of food or drugs;\nPregnant women, or women who ready for pregnancy or lactating; Patients participated in any clinical trials within 3 months; Other cases which researchers believe that can not enroll.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Mi Zhang, M.D. Ph.D",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "08615116331788",
                                                            "CentralContactPhoneExt": "08615116331788",
                                                            "CentralContactEMail": "648979182@qq.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Yehong Kuang, M.D. Ph.D",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "08613574171102",
                                                            "CentralContactPhoneExt": "08613574171102",
                                                            "CentralContactEMail": "yh_927@126.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Xiang Chen, M.D. Ph.D",
                                                            "OverallOfficialAffiliation": "Xiangya Hospital of Central South University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Xiangya Hospital, Central South University",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Changsha",
                                                            "LocationState": "Hunan",
                                                            "LocationZip": "410000",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Mi Zhang, M.D. Ph.D",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "08615116331788",
                                                                              "LocationContactPhoneExt": "08615116331788",
                                                                              "LocationContactEMail": "648979182@qq.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Yehong Kuang, M.D. Ph.D",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "08613574171102",
                                                                              "LocationContactPhoneExt": "08613574171102",
                                                                              "LocationContactEMail": "yh_927@126.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Xiang Chen, M.D. Ph.D",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Mi Zhang, M.D. Ph.D",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Yehong Kuang, M.D. Ph.D",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "29606893",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Comella K, Parlo M, Daly R, Dominessy K. First-in-man intravenous implantation of stromal vascular fraction in psoriasis: a case study. Int Med Case Rep J. 2018 Mar 21;11:59-64. doi: 10.2147/IMCRJ.S163612. eCollection 2018."
                                                      },
                                                      {
                                                            "ReferencePMID": "28956015",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Lee YS, Sah SK, Lee JH, Seo KW, Kang KS, Kim TY. Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice. Biochem Biophys Rep. 2016 Oct 8;9:281-288. doi: 10.1016/j.bbrep.2016.10.002. eCollection 2017 Mar."
                                                      },
                                                      {
                                                            "ReferencePMID": "26025581",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Boehncke WH, Sch\u00f6n MP. Psoriasis. Lancet. 2015 Sep 5;386(9997):983-94. doi: 10.1016/S0140-6736(14)61909-7. Epub 2015 May 27. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "29053579",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Owczarczyk-Saczonek A, Krajewska-W\u0142odarczyk M, Kruszewska A, Placek W, Maksymowicz W, Wojtkiewicz J. Stem Cells as Potential Candidates for Psoriasis Cell-Replacement Therapy. Int J Mol Sci. 2017 Oct 20;18(10). pii: E2182. doi: 10.3390/ijms18102182. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "26136869",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Guan LX, Guan H, Li HB, Ren CA, Liu L, Chu JJ, Dai LJ. Therapeutic efficacy of umbilical cord-derived mesenchymal stem cells in patients with type 2 diabetes. Exp Ther Med. 2015 May;9(5):1623-1630. Epub 2015 Mar 9."
                                                      },
                                                      {
                                                            "ReferencePMID": "22017805",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang BC, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A. Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med. 2011 Oct 21;9:181. doi: 10.1186/1479-5876-9-181."
                                                      },
                                                      {
                                                            "ReferencePMID": "28961381",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Dahbour S, Jamali F, Alhattab D, Al-Radaideh A, Ababneh O, Al-Ryalat N, Al-Bdour M, Hourani B, Msallam M, Rasheed M, Huneiti A, Bahou Y, Tarawneh E, Awidi A. Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy. CNS Neurosci Ther. 2017 Nov;23(11):866-874. doi: 10.1111/cns.12759. Epub 2017 Sep 29."
                                                      },
                                                      {
                                                            "ReferencePMID": "27882169",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cui GH, Wang YY, Li CJ, Shi CH, Wang WS. Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: A meta-analysis. Exp Ther Med. 2016 Nov;12(5):3390-3400. Epub 2016 Oct 11."
                                                      },
                                                      {
                                                            "ReferencePMID": "35927231",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Cheng L, Wang S, Peng C, Zou X, Yang C, Mei H, Li C, Su X, Xiao N, Ouyang Q, Zhang M, Wang Q, Luo Y, Shen M, Qin Q, Wang H, Zhu W, Lu G, Lin G, Kuang Y, Chen X. Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1/2a, single-arm study. Signal Transduct Target Ther. 2022 Aug 5;7(1):263. doi: 10.1038/s41392-022-01059-y."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000011565",
                                                            "ConditionMeshTerm": "Psoriasis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000017444",
                                                            "ConditionAncestorTerm": "Skin Diseases, Papulosquamous"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012871",
                                                            "ConditionAncestorTerm": "Skin Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M13574",
                                                            "ConditionBrowseLeafName": "Psoriasis",
                                                            "ConditionBrowseLeafAsFound": "Psoriasis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18865",
                                                            "ConditionBrowseLeafName": "Skin Diseases, Papulosquamous",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 5,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01219465",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSCT1DM003"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Qingdao University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus",
                                          "OfficialTitle": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2010",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2012",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2012",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "October 12, 2010",
                                          "StudyFirstSubmitQCDate": "October 12, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 13, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 12, 2010",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 13, 2010",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyOldNameTitle": "Wang, Yangang MD",
                                                "ResponsiblePartyOldOrganization": "Stem Cell Research Center of Medical School Hospital of Qingdao University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Qingdao University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for initial type 1 diabetes is safe and effective.",
                                          "DetailedDescription": "Type 1 diabetes mellitus (T1DM)is characterized by the autoimmune destruction of the pancreatic \u03b2 cells.Patients require multiple daily insulin injections throughout their lives as well as close monitoring of their diet and blood sugar levels to prevent complications. The investigators hope umbilical cord Mesenchymal Stem Cells could not only address the need for \u03b2-cell replacement but also control of the autoimmune response to \u03b2 cells."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Diabetes Mellitus",
                                                      "Diabetes Mellitus, Type 1",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Diabetes Mellitus",
                                                      "Diabetes Mellitus, Type 1",
                                                      "mesenchymal stem cells",
                                                      "Umbilical cord"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "50",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous infusion of ex vivo cultured umbilical cord mesenchymal stem cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "umbilical cord mesenchymal stem cells",
                                                            "InterventionDescription": "Transfusion of the umbilical cord mesenchymal stem cells (2 x 107 cells) intravenously.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "C peptide release test",
                                                            "PrimaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Exogenous insulin dose",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "blood glucose",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "glycosylated Hemoglobin A1c",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of severe and documented hypoglycemic events",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Immunologic reconstitution parameters",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nConfirmed diagnosis of type 1 diabetes by ADA criteria less than 9 weeks.\nAbility to provide written informed consent from patients or Child guardian.\n\nExclusion Criteria:\n\ndiabetic ketoacidosis.\nevidence of retinopathy at baseline.\nBody Mass Index >30.\nSevere or acute organ damage.\nInfectious diseases, e.g. HIV infection, or hepatitis B or C infection.\nSevere psychiatric disorder.\nPresence of malignancy.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "3 Years",
                                          "MaximumAge": "35 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Yangang Wang, MD Phd",
                                                            "OverallOfficialAffiliation": "The Affiliated Hospital of Qingdao University",
                                                            "OverallOfficialRole": "Study Director"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Stem Cell Research Center of Medical School Hospital of Qingdao University",
                                                            "LocationCity": "Qingdao",
                                                            "LocationState": "Shandong",
                                                            "LocationZip": "266003",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003922",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6269",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafAsFound": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 6,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02824393",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "TUBITAK-1001-215S612"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Celal Bayar University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria",
                                          "OfficialTitle": "Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune Urticaria"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2018",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 3, 2017",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "May 15, 2018",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 15, 2018",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 29, 2016",
                                          "StudyFirstSubmitQCDate": "July 1, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 6, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "July 17, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 18, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Cengiz K\u0131rmaz",
                                                "ResponsiblePartyInvestigatorTitle": "Professor Doctor (MD)",
                                                "ResponsiblePartyInvestigatorAffiliation": "Celal Bayar University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Celal Bayar University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "The Scientific and Technological Research Council of Turkey",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Ac\u0131badem Labcell",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The aim of this study is to determine whether autologous adipose tissue derived Mesenchymal Stem Cells of treatment for chronic autoimmune urticaria is safe and effective.",
                                          "DetailedDescription": "Chronic urticaria is a distressful disease, which negatively affects the quality of life. Pathogenesis isn't exactly clear, treatment is relatively palliative and results are usually suboptimal. 30-40% of the patients have autoimmune origin. Patients are forced to use immunosuppressive treatments which have systemic effects. Some of the treatments have effects as severe as the disease itself.\n\nMesenchymal stem cells (MSCs) are the most common used cells in clinical trials. These cells can provide efficient immunosuppression in severe conditions like immunosuppressive resistant Graft versus Host Disease. With this study at the first time and quite a different approach from conventional treatment, it will be tried an experimental treatment that used in the MSCs for the chronic autoimmune urticaria patients without of definitive treatment."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Urticaria",
                                                      "Autoimmune Diseases",
                                                      "Immune System Diseases",
                                                      "Skin Diseases"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stem cell",
                                                      "Chronic autoimmune urticaria"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Early Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Factorial Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous infusion of ex vivo cultured adipose tissue derived autologous mesenchymal stem cells, twice at two week intervals in total 1x10/6 cells/kg.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Autologous mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control patients",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "The patients who treated with the conventional therapy for urticaria, but not treat with mesenchymal stem cell."
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Autologous mesenchymal stem cell",
                                                            "InterventionDescription": "Intravenous infusion of ex vivo cultured adipose tissue derived autologous mesenchymal stem cells, twice at two week intervals in total 1x10/6 cells/kg.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cell"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Autologous adipose tissue derived mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change from baseline in weekly urticaria activity scores.",
                                                            "PrimaryOutcomeDescription": "The weekly urticaria activity scores will be assessed according to European Academy of Allergy and Clinical Immunology (EAACI) / Global Allergy and Asthma European Network (GALEN) guidelines.",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Follow-up of the mesenchymal stem cell treatment-related side effects according to World Health Organisation (WHO) Toxicity Grading Scale for Determining The Severity of Adverse Events.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The changes in the ratios of peripheral blood cluster of differentiation 4 (CD4) T cell subsets.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The changes in ratios of peripheral blood inflammatory and anti-inflammatory cytokines.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The changes in the levels of peripheral blood anti-Fc\u03b5RI autoantibody",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients diagnosed with chronic autoimmune urticaria (at least six months before)\nPatients who have >20 and over of urticaria activity score [according to European Academy of Allergy and Clinical Immunology (EAACI) / Global Allergy and Asthma European Network (GALEN) guidelines].\nPatients who capable of own daily findings record.\nPatients who could not be controlled despite the use of a treatment agent in the fourth step for 3 months (according to EAACI / GALEN guidelines).\n\nExclusion Criteria:\n\nPatients who have heart, liver or renal failure.\nPatients who have epilepsy, cerebrovascular or ischemic attack.\nPatients who have atopic dermatitis or another underlying itchy skin disease.\nPatients who have parasitic infection.\nPatients who have antibiotic allergy.\nHistory of malignancy.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Alper Tunga \u00d6zdemir, PhD",
                                                            "OverallOfficialAffiliation": "Ege University, Institute of Health Sciences, Department of Stem Cell, Izmir/TURKEY",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Erc\u00fcment Oval\u0131, Prof. Dr.",
                                                            "OverallOfficialAffiliation": "Ac\u0131badem Labcell, Istanbul/TURKEY",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Celal Bayar University, Medical School",
                                                            "LocationCity": "Manisa",
                                                            "LocationCountry": "Turkey"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Yes"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000014581",
                                                            "ConditionMeshTerm": "Urticaria"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012871",
                                                            "ConditionMeshTerm": "Skin Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000080223",
                                                            "ConditionMeshTerm": "Chronic Urticaria"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000001327",
                                                            "ConditionMeshTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000007154",
                                                            "ConditionMeshTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000017445",
                                                            "ConditionAncestorTerm": "Skin Diseases, Vascular"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006969",
                                                            "ConditionAncestorTerm": "Hypersensitivity, Immediate"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006967",
                                                            "ConditionAncestorTerm": "Hypersensitivity"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafAsFound": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafAsFound": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16482",
                                                            "ConditionBrowseLeafName": "Urticaria",
                                                            "ConditionBrowseLeafAsFound": "Urticaria",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafAsFound": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2129",
                                                            "ConditionBrowseLeafName": "Chronic Urticaria",
                                                            "ConditionBrowseLeafAsFound": "Chronic Autoimmune Urticaria",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9170",
                                                            "ConditionBrowseLeafName": "Hypersensitivity",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9172",
                                                            "ConditionBrowseLeafName": "Hypersensitivity, Immediate",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 7,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02118519",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "KneeUJCTC"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Jordan",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells in Knee Cartilage Injuries",
                                          "OfficialTitle": "Use of Mesenchymal Stem Cells for the Repair of Articular Cartilage Disorder of Knee Using Intra-articular Injection of Mesenchymal Cells Alone or Mesenchymal Cells With Platelet Lysate"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "February 2016",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "August 2015",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "August 2015",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "January 24, 2014",
                                          "StudyFirstSubmitQCDate": "April 16, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 21, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "February 23, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "February 24, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Fatima Jamali",
                                                "ResponsiblePartyInvestigatorTitle": "Researcher",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Jordan"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Jordan",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Induction of autologous repair chondrogenesis to regenerate injured articular cartilage using bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted culturing conditions.",
                                          "DetailedDescription": "Fourteen patients from both genders, age range 40-68, will be enrolled according to strict inclusion and exclusion criteria, divided into two equal groups based upon receiving autologous MSCs alone, or MSCs supported by platelet lysate through percutaneous injection.\n\nThe patients are followed by clinical assessment, laboratory investigations as well as magnetic resonance imaging (MRI) of the injected knee.\n\nThe investigators hypothesize that the two groups will give satisfactory clinical outcomes, but the investigators are looking forward to assessing the best product that will activate chondrogenesis and heal cartilaginous injury."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Articular Cartilage Disorder of Knee",
                                                      "Osteoarthritis, Knee"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Bone marrow derived Mesenchymal Stem Cells",
                                                      "Knee articular cartilage injury",
                                                      "Chondrogenesis",
                                                      "orthopedics"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Double",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "13",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cells",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Autologous Mesenchymal Stem Cells primed prior to intra articular injection into knees of patients with advanced articular cartilage injury",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Autologous Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "mesenchymal cells&platelet lysate",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Autologous Mesenchymal Stem Cells primed prior to intra articular injection with platelet lysate into knees of patients with advanced articular cartilage injury",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Autologous Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Autologous Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Comparison of clinical outcomes of patients injected by mesenchymal stem cells only with patients injected with mesenchymal stem cells supported by platelet lysate",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal cells&platelet lysate",
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells.",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Assessment of the articular cartilage healing in osteoarthritic patients through intra articular injection of Autologus Mesenchymal stem cell with/or without supported product.",
                                                            "SecondaryOutcomeDescription": "For every patient tests would be performed repeated at 6, and 12 months post-injection.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMRI must show moderate/severe articular injury\nSerum collagen II must be above the normal value.\nLesion site: Femoral and Tibial condyles or patella\nAdmission of steroid , NSAID, pain killers must be stopped before 1 month\n\nExclusion Criteria:\n\nLesion size\nPT and PTT not within normal value\nComplete blood count ( Hb, PCV, and RBC) not within the normal value\nHIV and Hepatitis Antigens (B and C) detection",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "40 Years",
                                          "MaximumAge": "68 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Abdallah Awidi, MD",
                                                            "OverallOfficialAffiliation": "Cell Therapy Center",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Mahasen S Najjar, MD",
                                                            "OverallOfficialAffiliation": "Jordan University Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Hiba Khalil, PhD",
                                                            "OverallOfficialAffiliation": "Al-Neelain University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Cell Therapy Center, Jordan University Hospital",
                                                            "LocationCity": "Amman",
                                                            "LocationZip": "11942",
                                                            "LocationCountry": "Jordan"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "29233163",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Al-Najar M, Khalil H, Al-Ajlouni J, Al-Antary E, Hamdan M, Rahmeh R, Alhattab D, Samara O, Yasin M, Abdullah AA, Al-Jabbari E, Hmaid D, Jafar H, Awidi A. Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study. J Orthop Surg Res. 2017 Dec 12;12(1):190. doi: 10.1186/s13018-017-0689-6."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000020370",
                                                            "ConditionMeshTerm": "Osteoarthritis, Knee"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000002357",
                                                            "ConditionMeshTerm": "Cartilage Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010003",
                                                            "ConditionAncestorTerm": "Osteoarthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001168",
                                                            "ConditionAncestorTerm": "Arthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007592",
                                                            "ConditionAncestorTerm": "Joint Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012216",
                                                            "ConditionAncestorTerm": "Rheumatic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M21321",
                                                            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
                                                            "ConditionBrowseLeafAsFound": "Osteoarthritis, Knee",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12078",
                                                            "ConditionBrowseLeafName": "Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4763",
                                                            "ConditionBrowseLeafName": "Cartilage Diseases",
                                                            "ConditionBrowseLeafAsFound": "Cartilage Disorder",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3628",
                                                            "ConditionBrowseLeafName": "Arthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9773",
                                                            "ConditionBrowseLeafName": "Joint Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 8,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04073472",
                                          "Organization": {
                                                "OrgFullName": "The Cleveland Clinic",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's",
                                          "OfficialTitle": "A Phase I Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Ileal Anal Anastomosis and Ileal Pouch Fistulas in the Setting of Crohn's Disease of the Pouch",
                                          "Acronym": "IPAAF"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2022",
                                          "OverallStatus": "Withdrawn",
                                          "WhyStopped": "This clinical trial was entered in error. Please refer to the correct entry of this study using the following link: https://clinicaltrials.gov/ct2/show/NCT04519684",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 1, 2021",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "June 1, 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 1, 2023",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "August 23, 2019",
                                          "StudyFirstSubmitQCDate": "August 27, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 29, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "April 1, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 5, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Amy Lightner",
                                                "ResponsiblePartyInvestigatorTitle": "Staff Surgeon",
                                                "ResponsiblePartyInvestigatorAffiliation": "The Cleveland Clinic"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "The Cleveland Clinic",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine the safety and feasibility of using allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat people with an ileal pouch anal anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch.",
                                          "DetailedDescription": "Proctocolectomy with ileal pouch anal anastomosis (IPAA) remains the procedure of choice for patients with ulcerative colitis (UC). IPAA allows at risk tissue to be removed with restoration of intestinal continuity while maintaining favorable long-term functional outcomes and quality of life. While less than 30% of patients experience short-term postoperative morbidity following IPAA, up to 15% of pouches will ultimately fail due to technical or inflammatory complications, the majority of which manifest as a fistula from the pouch to the perianal or vaginal locations. Pouch failure due to a fistula tract is notoriously difficult to treat. Despite immunosuppressive medications and attempts at local repair, most patients will end up with a pouch excision and permanent ostomy. This can be a devastating outcome in some patients as it impacts body image and quality of life.\n\nPelvic sepsis following original IPAA has been reported in 5% to 25% of patients, and is the leading cause of pouch failure due to the development of pelvic fibrosis and decreased distensibility of the pouch, ultimately resulting in poor pouch function. One of the leading causes of pelvic sepsis and development of a pouch fistula is Crohn's Disease (CD) of the pouch. While the majority of pouches are constructed for UC, up to 25% of patients with an IPAA will end up having a change in diagnosis from UC to CD or development of de novo CD of the pouch.\n\nThe first report of successful healing of a Crohn's fistula with mesenchymal stem cells (MSCs) was in 2003. Since them great enthusiasm has spurred several phase I phase II, and phase III trials designed to study the safety and efficacy of MSCs for perianal CD, all of which have reported encouraging results with regard to safety and efficacy. With over 300 patients now treated, there is a large body of evidence supporting the local delivery of MSCs to heal perianal Crohn's fistulas. Peri-pouch fistulas are similar to Crohn's perianal fistulas except that instead of the rectum containing the internal opening of the fistula, the internal opening is in the ileal pouch, constructed in place of the rectum.\n\nGiven the high safety profile and relative success in treating perianal Crohn's disease with mesenchymal stem cells, the investigators are using a GMP grade allogeneic bone marrow derived MSC cell line to establish safety and secondarily monitor for healing in patients with ileal pouch fistulas in the setting of Crohn's disease of the pouch. This trial will use allogeneic bone marrow derived mesenchymal stem cells (MSCs) to produce regenerative signals. The specific rationale for MSCs in IPAA is based upon 1) their anti-inflammatory properties; 2) published experience of MSC in this condition and perianal Crohn's fistula demonstrating efficacy and safety; 3) existence of cGMP methods for their isolation and growth.\n\nThis study will enroll adult men and women who have undergone IPAA at least six months prior and now have a peri-pouch fistula related to Crohn's disease of the pouch. Patients who are refractory to conventional medical therapy will be considered. Patients enrolled will be those that meet current indications."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Crohn's Disease",
                                                      "Fistula",
                                                      "Anal Fistula",
                                                      "Pouch, Ileal",
                                                      "Pouches, Ileoanal"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "crohn disease",
                                                      "mesenchymal stem cells",
                                                      "pouch fistulas"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "0",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cells (MSCs)",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Direct injection of 75 million allogeneic bone marrow derived mesenchymal stem cells (MSC) into ileal pouch fistula at baseline and possibly again after 3 months if not completely healed.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: mesenchymal stem cells (MSCs)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "mesenchymal stem cells (MSCs)",
                                                            "InterventionDescription": "Allogeneic bone marrow derived mesenchymal stem cells (MSCs) direct injection to an ileal pouch fistula in the setting of Crohn's disease of the pouch",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cells (MSCs)"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Allogeneic Bone Marrow Derived Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety and Feasibility: Number Of Adverse Events",
                                                            "PrimaryOutcomeDescription": "Evaluate the number of adverse event occurring during the trial (including clinically significant changes in physical examination, radiographic images, safety lab tests, vital signs).",
                                                            "PrimaryOutcomeTimeFrame": "Baseline, Drug administration Visit, Day 1, 1 week, 2 weeks, 1 month, 2 months, 3 month, 6 month, 12 month after each MSCs injection"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Radiographic Healing",
                                                            "SecondaryOutcomeDescription": "Number of Participants with:\n\nComplete Healing MRI with an absence of a fluid collection >2 cm in 3 of 3 dimensions, lack of edema, inflammation or sign of active inflammatory response. A remnant scar of a fistula tract may remain\n\nPartial Healing MRI with an absence of a fluid collection >2 cm in 2 of 3 dimensions, lack of edema, inflammation or sign of active inflammatory response. A remnant scar of a fistula tract may remain\n\nPartial Response MRI with an absence of a fluid collection >2 cm in 2 of 3 dimensions, lack of worsening inflammation or new tracts formed\n\nLack of Response Radiographic healing which does not meet the threshold for Partial Response\n\nDecreased symptoms Greater than 50% reduction in drainage as reported by the patient at study visits.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, 1 week, 2 weeks, 1 month, 2 months, 3 month, 6 month, 12 month after each 100% cessation of drainage on both clinical exam with deep palpation and per patient MSCs injection"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Clinical Healing",
                                                            "SecondaryOutcomeDescription": "Number of Participants with:\n\nComplete Healing 100% cessation of drainage on both clinical exam with deep palpation and per patient report and epithelization of the external fistula opening\n\nPartial Healing Greater than or equal to 50 % cessation of drainage on both clinical exam with deep palpation and per patient report and epithelization of the external fistula opening\n\nPartial Response Less than 50% cessation of drainage on both clinical exam with deep palpation and per patient report and epithelization of the external fistula opening\n\nLack of Response Clinical healing which does not meet the threshold for Partial Response\n\nDecreased symptoms Greater than 50% reduction in drainage as reported by the patient at study visits.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, 1 week, 2 weeks, 1 month, 2 months, 3 month, 6 month, 12 month after each 100% cessation of drainage on both clinical exam with deep palpation and per patient MSCs injection"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Alloimmune response to mesenchymal stem cells",
                                                            "OtherOutcomeDescription": "Measure HLA Class I & II SAB Antibody Screening - measures the presence (positive) or absence (negative) of antibodies",
                                                            "OtherOutcomeTimeFrame": "Baseline, 1 week, 3 months 12 months after each MSCs injection"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria\n\nMen and women 18-75 years of age who have undergone an ileal pouch anal anastomosis at least 6 months prior who have developed a clinical diagnosis of Crohn's disease of the pouch as determined by a combination of clinical symptoms, pouchoscopy with biopsy, enterography.\n\nSingle and multi-tract (up to 2 internal and 3 external openings) fistula tract arising from the ileal pouch, ileal anal anastomosis, or anal canal distal to anastomosis that travels to the perianal skin, perineal body, or vagina. Patients with fistulas that arise from the pouch, anastomosis, or anal canal distal to the anastomosis will both be included in enrollment.\n\nAcceptable internal openings and tract locations for the fistula to arise from include the ileal pouch body, the pouch anal anastomosis, and the anal canal distal to the anastomosis.\nAcceptable external openings and tract locations for the fistula to arise from include the perianal skin, perineal body, and/or the vaginal wall.\nConcurrent Crohn's related therapies with stable doses (>3 months) corticosteroids, 5-ASA drugs, immunomodulators, anti-TNF therapy, anti-integrin and anti-interleukin are permitted.\nHave failed conventional medical therapies described above, defined as a lack of response to systemic immune suppression (e.g. azathioprine, methotrexate, 6-mercaptopurine) or biologic (e.g. anti-TNF, anti-integrin, anti-interleukin) therapies to treat fistulizing CD for at least 3 months\nHave no contraindications to MR evaluations: e.g. pacemaker or magnetically active metal fragments, claustrophobia\nCompetent and able to provide written informed consent\nAbility to comply with protocol.\n\nExclusion Criteria\n\nInability to give informed consent.\nSevere antibiotic refractory pouchitis\nSevere cuffitis refractory to antibiotics\nChange in medical management for CD in the previous 2 months or changes anticipated in the next 2 months\nClinically significant medical conditions within the six months before administration of MSCs: e.g. myocardial infarction, active angina, congestive heart failure or other conditions that would, in the opinion of the investigators, compromise the safety of the patient.\n\nSpecific exclusions;\n\nHIV\nHepatitis B or C\nAbnormal CBC at screening\nAbnormal AST or ALT at screening\nHistory of cancer including melanoma (with the exception of localized skin cancers)\nInvestigational drug within thirty (30) days of baseline\nPregnant or breast feeding or trying to become pregnant\n\nBranching fistula tract that has > 2 internal openings or 3 external openings,\n\nPatients with greater than 3 blind/branching tracts are excluded\nFistula tracts on the left and/or right side are allowed\nAllergic to local anesthetics\nUnwilling to agree to use acceptable contraception methods during participation in study\nPatients with a non-abscessed chronic cavity will not be included in enrollment\nKnown allergy to DMSO solution",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Amy Lightner, MD",
                                                            "OverallOfficialAffiliation": "The Cleveland Clinic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "12756590",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Garc\u00eda LG, Cuellar ES, Blanco IF, Prianes LA, Montes JA, Pinto FL, Marcos DH, Garc\u00eda-Sancho L. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis. 2003 Sep;18(5):451-4. Epub 2003 May 20."
                                                      },
                                                      {
                                                            "ReferencePMID": "23006344",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS. Autologous adipose tissue-derived stem cells for the treatment of Crohn's fistula: a phase I clinical study. Cell Transplant. 2013;22(2):279-85. doi: 10.3727/096368912X656045. Epub 2012 Sep 21."
                                                      },
                                                      {
                                                            "ReferencePMID": "28400193",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Dietz AB, Dozois EJ, Fletcher JG, Butler GW, Radel D, Lightner AL, Dave M, Friton J, Nair A, Camilleri ET, Dudakovic A, van Wijnen AJ, Faubion WA. Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology. 2017 Jul;153(1):59-62.e2. doi: 10.1053/j.gastro.2017.04.001. Epub 2017 Apr 9."
                                                      },
                                                      {
                                                            "ReferencePMID": "15933795",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Herreros D, Pascual I, Peiro C, Rodr\u00edguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005 Jul;48(7):1416-23."
                                                      },
                                                      {
                                                            "ReferencePMID": "19273960",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, De-La-Quintana P, Garcia-Arranz M, Pascual M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009 Jan;52(1):79-86. doi: 10.1007/DCR.0b013e3181973487."
                                                      },
                                                      {
                                                            "ReferencePMID": "26116801",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Molendijk I, Bonsing BA, Roelofs H, Peeters KC, Wasser MN, Dijkstra G, van der Woude CJ, Duijvestein M, Veenendaal RA, Zwaginga JJ, Verspaget HW, Fibbe WE, van der Meulen-de Jong AE, Hommes DW. Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's Disease. Gastroenterology. 2015 Oct;149(4):918-27.e6. doi: 10.1053/j.gastro.2015.06.014. Epub 2015 Jun 25."
                                                      },
                                                      {
                                                            "ReferencePMID": "25829404",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cho YB, Park KJ, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Jeong HY, Yu CS. Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula. Stem Cells Transl Med. 2015 May;4(5):532-7. doi: 10.5966/sctm.2014-0199. Epub 2015 Mar 31."
                                                      },
                                                      {
                                                            "ReferencePMID": "23404825",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Lee WY, Park KJ, Cho YB, Yoon SN, Song KH, Kim DS, Jung SH, Kim M, Yoo HW, Kim I, Ha H, Yu CS. Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula. Stem Cells. 2013 Nov;31(11):2575-81. doi: 10.1002/stem.1357."
                                                      },
                                                      {
                                                            "ReferencePMID": "27477896",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S; ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016 Sep 24;388(10051):1281-90. doi: 10.1016/S0140-6736(16)31203-X. Epub 2016 Jul 29."
                                                      },
                                                      {
                                                            "ReferencePMID": "21257987",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, Minelli A, Alvisi C, Vanoli A, Calliada F, Dionigi P, Perotti C, Locatelli F, Corazza GR. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut. 2011 Jun;60(6):788-98. doi: 10.1136/gut.2010.214841. Epub 2011 Jan 21."
                                                      },
                                                      {
                                                            "ReferencePMID": "23053677",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "de la Portilla F, Alba F, Garc\u00eda-Olmo D, Herrer\u00edas JM, Gonz\u00e1lez FX, Galindo A. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial. Int J Colorectal Dis. 2013 Mar;28(3):313-23. doi: 10.1007/s00384-012-1581-9. Epub 2012 Sep 29."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022",
                                          "RemovedCountryList": {
                                                "RemovedCountry": [
                                                      "United States"
                                                ]
                                          }
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003424",
                                                            "ConditionMeshTerm": "Crohn Disease"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012003",
                                                            "ConditionMeshTerm": "Rectal Fistula"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000005402",
                                                            "ConditionMeshTerm": "Fistula"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000015212",
                                                            "ConditionAncestorTerm": "Inflammatory Bowel Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005759",
                                                            "ConditionAncestorTerm": "Gastroenteritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005767",
                                                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007410",
                                                            "ConditionAncestorTerm": "Intestinal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020763",
                                                            "ConditionAncestorTerm": "Pathological Conditions, Anatomical"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007412",
                                                            "ConditionAncestorTerm": "Intestinal Fistula"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000016154",
                                                            "ConditionAncestorTerm": "Digestive System Fistula"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012002",
                                                            "ConditionAncestorTerm": "Rectal Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M7684",
                                                            "ConditionBrowseLeafName": "Fistula",
                                                            "ConditionBrowseLeafAsFound": "Fistula",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5790",
                                                            "ConditionBrowseLeafName": "Crohn Disease",
                                                            "ConditionBrowseLeafAsFound": "Crohn's Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13997",
                                                            "ConditionBrowseLeafName": "Rectal Fistula",
                                                            "ConditionBrowseLeafAsFound": "Anal Fistula",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9596",
                                                            "ConditionBrowseLeafName": "Intestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17069",
                                                            "ConditionBrowseLeafName": "Inflammatory Bowel Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8027",
                                                            "ConditionBrowseLeafName": "Gastroenteritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21672",
                                                            "ConditionBrowseLeafName": "Pathological Conditions, Anatomical",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9598",
                                                            "ConditionBrowseLeafName": "Intestinal Fistula",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17768",
                                                            "ConditionBrowseLeafName": "Digestive System Fistula",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13996",
                                                            "ConditionBrowseLeafName": "Rectal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 9,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02112500",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "STELLAR-Pilot"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Asan Medical Center",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure",
                                          "OfficialTitle": "A Pilot Study for the Efficacy and Safety of Mesenchymal Stem Cell in Acute Severe Respiratory Failure.",
                                          "Acronym": "STELLAR"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2016",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2016",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2016",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "March 30, 2014",
                                          "StudyFirstSubmitQCDate": "April 10, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 14, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 8, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 11, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Sang Bum Hong",
                                                "ResponsiblePartyInvestigatorTitle": "MD, Professor of Ulsan University College of Medicine",
                                                "ResponsiblePartyInvestigatorAffiliation": "Asan Medical Center"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Asan Medical Center",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Although the advent of advanced medical support for respiratory failure, the mortality rate of acute severe respiratory failure is still high and the life quality is frequently compromised from pulmonary fibrosis.\n\nThe investigators hypothesize that the treatment using mesenchymal stem cell can be beneficial in patients with respiratory failure. The present study is a pilot study evaluating the efficacy and safety of mesenchymal stem cell treatment in patients with respiratory failure.",
                                          "DetailedDescription": "Although the advent of advanced medical support for respiratory failure, the mortality rate of acute severe respiratory failure is still reported to be more than 40%. The respiratory distress syndrome may develop in all ages resulting in progressive pulmonary fibrosis. A number of survivors from respiratory failure suffer from the sequelas of pulmonary fibrosis.\n\nHowever, the treatments of respiratory failure are limited to the correction of baseline disease, cardiopulmonary support, and conservative management to minimize the lung injury. There has not been any effective and specific treatment for respirator distress nor medicine to reduce mortality.\n\nThere have been reports of mesenchymal stem cell experimental animals with chronic obstructive pulmonary disease, interstitial lung disease, and sepsis. In addition, the mesenchymal stem cell treatment showed beneficial effect in bleomycin endotoxin induced lung injury.\n\nAuthors hypothesize that the mesenchymal stem cell treatment in patients with respiratory failure will show efficacy. We would conduct the present pilot study to evaluate the efficacy and safety in patients with respiratory failure and intend to suggest an additional alternative treatment option for those without additional treatment option."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Respiratory Distress Syndrome, Adult"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cell Infusion",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stem cells cultured and extracted from bone marrow of enrolled patients are infused.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cell",
                                                            "InterventionDescription": "Mesenchymal stem cells will be intravenously infused. Mesenchymal stem cells will be cultured and extracted from the bone marrow of the patients.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cell Infusion"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Lungcellgram"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Oxygen index at 3 days after mesenchymal stem cell infusion",
                                                            "PrimaryOutcomeDescription": "Oxygen index at 3 days after mesenchymal stem cell infusion. Oxygen index is calculated as follows; ((FiO2) x (Mean airway pressure)) / (PaO2)",
                                                            "PrimaryOutcomeTimeFrame": "3 days after mesenchymal stem cell infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Lung mechanics",
                                                            "SecondaryOutcomeDescription": "Lung mechanics includes arterial oxygen saturation, tidal volume, minute ventilation, and ratio of PaO2/FiO2.",
                                                            "SecondaryOutcomeTimeFrame": "at 3, 14, and 28 days after mesenchymal stem cell infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Hemodynamic parameters",
                                                            "SecondaryOutcomeDescription": "Systolic, diastolic, and mean arterial blood pressure Amount of required vasopressor Heart rate",
                                                            "SecondaryOutcomeTimeFrame": "at 3, 14, and 28 days after mesenchymal stem cell infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Mortality",
                                                            "SecondaryOutcomeDescription": "Death from any cause at 14 and 28 days after mesenchymal stem cell infusion",
                                                            "SecondaryOutcomeTimeFrame": "at 14 and 28 days after mesenchymal stem cell infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Plasma cytokines",
                                                            "SecondaryOutcomeDescription": "Interleukin (IL)-1, IL-6, IL-8, and IL-10",
                                                            "SecondaryOutcomeTimeFrame": "at 3, 14, and 28 days after mesenchymal stem cell infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Markers for inflammation and infection",
                                                            "SecondaryOutcomeDescription": "Lactate, DIC score, SOFA score, C-reactive protein, and procalcitonin",
                                                            "SecondaryOutcomeTimeFrame": "at 3, 14, and 28 days after mesenchymal stem cell infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ventilator weaning parameters",
                                                            "SecondaryOutcomeDescription": "Failure of ventilator weaning, weaning time, ventilation time",
                                                            "SecondaryOutcomeTimeFrame": "at 3, 14, and 28 days after mesenchymal stem cell infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "ICU and hospital stay",
                                                            "SecondaryOutcomeDescription": "Total duration of ICU stay and hospital stay",
                                                            "SecondaryOutcomeTimeFrame": "at 28 days after mesenchymal stem cell infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nVentilator care from respiratory failure\nVentilator care for 7 or more days\n\nat least one of the followings\n\nPaO2/FiO2 = 200 or less when PEEP 5 cmH2O or more.\nPaCO2 = 50 mmHg or more when plateau pressure of 30 cmH2O or more.\npH = 7.25 or less when plateau pressure of 30 cmH2O or more.\nNo other treatment option except for lung transplantation and not candidate for recipient (organ failure, comorbid infection, economy,...)\nVentilatory care with weaning failure 3 times or more\n\nVentilator care requiring 7 days or more from the first self respiration to weaning of ventilator.\n\nPEEP, positive endexpiratory pressure\n\nExclusion Criteria:\n\nSevere aplastic anemia\nMalignant hematologic disorder or history of stem cell treatment.\nCurrently uncontrolled malignancy or history of solid cancer within 2 years\nHIV Infection\nExpected life < 3 months from other cause than the respiratory failure\nPregnancy or breast feeding\nExpected hypersensitivity for study drug",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "20 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Sang Bum Hong, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+82-10-6824-9767",
                                                            "CentralContactEMail": "hongsangbum@gmail.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Dong Hyun Lee, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+82-10-6476-0706",
                                                            "CentralContactEMail": "rvotvt@gmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Sang Bum Hong, M.D.",
                                                            "OverallOfficialAffiliation": "Asan Medical Center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Asan Medical Center",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Seoul",
                                                            "LocationZip": "138-736",
                                                            "LocationCountry": "Korea, Republic of",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Sang Bum Hong, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+82-10-6824-9767",
                                                                              "LocationContactEMail": "hongsangbum@gmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Sang Bum Hong, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "17356114",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest. 2007 Mar;131(3):913-920. doi: 10.1378/chest.06-1743. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "16236739",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005 Oct 20;353(16):1685-93."
                                                      },
                                                      {
                                                            "ReferencePMID": "20384521",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "D'Agostino B, Sullo N, Siniscalco D, De Angelis A, Rossi F. Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin Biol Ther. 2010 May;10(5):681-7. doi: 10.1517/14712591003610614. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "19691441",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Lee JW, Gupta N, Serikov V, Matthay MA. Potential application of mesenchymal stem cells in acute lung injury. Expert Opin Biol Ther. 2009 Oct;9(10):1259-70. doi: 10.1517/14712590903213651. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "17212702",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens. 2007 Jan;69(1):1-9. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "17641052",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007 Aug 1;179(3):1855-63."
                                                      },
                                                      {
                                                            "ReferencePMID": "19721001",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16357-62. doi: 10.1073/pnas.0907996106. Epub 2009 Aug 31."
                                                      },
                                                      {
                                                            "ReferencePMID": "17569781",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11002-7. Epub 2007 Jun 14."
                                                      },
                                                      {
                                                            "ReferencePMID": "19497992",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009 Jul;175(1):303-13. doi: 10.2353/ajpath.2009.080629. Epub 2009 Jun 4."
                                                      },
                                                      {
                                                            "ReferencePMID": "15891110",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005 Aug;33(2):145-52. Epub 2005 May 12."
                                                      },
                                                      {
                                                            "ReferencePMID": "18508443",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Zhen G, Liu H, Gu N, Zhang H, Xu Y, Zhang Z. Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Front Biosci. 2008 May 1;13:3415-22."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012131",
                                                            "ConditionMeshTerm": "Respiratory Insufficiency"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14120",
                                                            "ConditionBrowseLeafName": "Respiratory Insufficiency",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome, Adult",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome, Adult",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome, Adult",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 10,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01219452",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSCKX002"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Qingdao University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy",
                                          "OfficialTitle": "Effects of Intramuscular Injection of Umbilical Cord Mesenchymal Stem Cell on the Ventricular Function of Children With Idiopathic Dilated Cardiomyopathy"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2010",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2012",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2012",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "October 12, 2010",
                                          "StudyFirstSubmitQCDate": "October 12, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 13, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 27, 2010",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 28, 2010",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyOldNameTitle": "Qingdao University",
                                                "ResponsiblePartyOldOrganization": "Organization: Stem Cell Research Center of Medical School Hospital of Qingdao University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Qingdao University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The main aim of the study is to determine whether intramuscular injection of umbilical cord mesenchymal stem cells can improve the ventricular function of children with idiopathic dilated cardiomyopathy(IDCM); Secondary end-points will be: 1)To explore the possible mechanism of the improvement of ventricular function in children with IDCM and 2) to evaluate the safety of intramuscular injection of umbilical cord mesenchymal stem cell.",
                                          "DetailedDescription": "Children with Idiopathic dilated cardiomyopathy class II to III NYHA with ejection fraction over 20% were selected for phase II clinical trial, umbilical cord mesenchymal stem cells were injected into limb muscle and followed for 6 months."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Dilated Cardiomyopathy"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Dilated Cardiomyopathy",
                                                      "Umbilical cord",
                                                      "Mesenchymal stem cells",
                                                      "Children"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "intramuscular injection of umbilical cord mesenchymal stem cell",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "umbilical cord mesenchymal stem cells",
                                                            "InterventionDescription": "Multiple intra muscular injection of mesenchymal stem cells derived from human umbilical cord.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "echocardiography",
                                                            "PrimaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "24h HOLTER",
                                                            "SecondaryOutcomeTimeFrame": "2 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The level of serum BNP,TNI,HGF\u3001LIF and G/M-CSF",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The expression level of c-kit,CD31,CD133 on peripheral blood mononuclear cells",
                                                            "SecondaryOutcomeTimeFrame": "2 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nChildren of both genders with established clinical and echocardiographic diagnosis of dilated cardiomyopathy whose parents accept to participate in the trail.\nThey should have symptoms and /or signs of heart failure, despite optimized medical treatment.\nEjection fraction of left ventricular should be less than 50%, but more than 20%.\n\nExclusion Criteria:\n\nassociate coronary artery disease.\nany history or suspicion of a toxic , pharmacologic or deposit etiology.\nassociated malignant or pre -malignant systemic disease.\nassociated hematologic disorder.\na history of sustained ventricular tachycardia or fibrillation.\na history of syncope during the previous year, or with an active infectious disease or positive tests to viral disease.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "1 Year",
                                          "MaximumAge": "14 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Jianxia Hu, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-0532-82911676",
                                                            "CentralContactEMail": "qdyxyhjx@126.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Hong Gao, MS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-0532-82911676",
                                                            "CentralContactEMail": "honggaogloria@gmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "zipu li, MD Phd",
                                                            "OverallOfficialAffiliation": "The Affiliated Hospital of Qingdao University",
                                                            "OverallOfficialRole": "Study Director"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Stem Cell Research Center of Medical School Hospital of Qingdao University",
                                                            "LocationCity": "Qingdao",
                                                            "LocationState": "Shandong",
                                                            "LocationZip": "266003",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Jianxia Hu, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "86-0532-82911676",
                                                                              "LocationContactEMail": "qdyxyhjx@126.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Hong Gao, MS",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "86-0532-82911676",
                                                                              "LocationContactEMail": "honggaogloria@gmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Zipu Li, MD PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Pin Sun, MD",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Nana Nie, MS",
                                                                              "LocationContactRole": "Sub-Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009202",
                                                            "ConditionMeshTerm": "Cardiomyopathies"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000002311",
                                                            "ConditionMeshTerm": "Cardiomyopathy, Dilated"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000006331",
                                                            "ConditionAncestorTerm": "Heart Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002318",
                                                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006332",
                                                            "ConditionAncestorTerm": "Cardiomegaly"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000083083",
                                                            "ConditionAncestorTerm": "Laminopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M11306",
                                                            "ConditionBrowseLeafName": "Cardiomyopathies",
                                                            "ConditionBrowseLeafAsFound": "Cardiomyopathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4719",
                                                            "ConditionBrowseLeafName": "Cardiomyopathy, Dilated",
                                                            "ConditionBrowseLeafAsFound": "Dilated Cardiomyopathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8571",
                                                            "ConditionBrowseLeafName": "Heart Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8572",
                                                            "ConditionBrowseLeafName": "Cardiomegaly",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2393",
                                                            "ConditionBrowseLeafName": "Laminopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1876",
                                                            "ConditionBrowseLeafName": "Dilated Cardiomyopathy",
                                                            "ConditionBrowseLeafAsFound": "Dilated Cardiomyopathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1877",
                                                            "ConditionBrowseLeafName": "Dilated Cardiomyopathy 1A",
                                                            "ConditionBrowseLeafAsFound": "Idiopathic Dilated Cardiomyopathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 11,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03601416",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Xia Yunqiu"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Children's Hospital of Chongqing Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia",
                                          "OfficialTitle": "Intravenous Human Umbilical-Cord-Derived Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasias in Children"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2019",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 1, 2019",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "June 1, 2021",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 31, 2021",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "July 17, 2018",
                                          "StudyFirstSubmitQCDate": "July 17, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 26, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "January 11, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 15, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Xia Yunqiu",
                                                "ResponsiblePartyInvestigatorTitle": "doctor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Children's Hospital of Chongqing Medical University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Children's Hospital of Chongqing Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study is an open-label, single-center, dose escalation study to evaluate of safety and efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs) in children with moderate and severe bronchopulmonary dysplasia.",
                                          "DetailedDescription": "Bronchopulmonary dysplasia (BPD) is one of the most common chronic lung diseases with poor prognosis, especially in preterm infants with moderate and severe BPD. However, there is lack of effective therapies for this disease.\n\nhUC-MSCs are widely used in clinic due to their low immunogenicity and convenient to get.Many animal study had shown that hUC-MSCs had therapeutic effects on a variety of animal models of lung disease.Furthermore,there are a large number of clinical trials of MSCs applied to various system diseases and the safety was verified.So,the main purpose of this study is to evaluate the safety and efficacy of hUC-MSCs in participants with moderate and severe bronchopulmonary dysplasia."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Bronchopulmonary Dysplasia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "human umbilical cord -derived mesenchymal stem cells",
                                                      "moderate and severe bronchopulmonary dysplasia"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "57",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Transplantation of Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stem cell will be given to participants with moderate and severe bronchopulmonary dysplasia.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Transplantation of mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "No Transplantation of Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Mesenchymal stem cell will be not given to participants with moderate and severe bronchopulmonary dysplasia.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: No Transplantation of Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Transplantation of mesenchymal stem cell",
                                                            "InterventionDescription": "Human umbilical cord-derived mesenchymal stem cell will be given to participants through intravenous infusion.\n\nDose A - 1 million cells per kg Dose B - 5 million cells per kg",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Transplantation of Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "No Transplantation of Mesenchymal Stem Cell",
                                                            "InterventionDescription": "Human umbilical cord-derived mesenchymal stem cell will be not given to participants through intravenous infusion.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "No Transplantation of Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "the accumulative duration of oxygen therapy",
                                                            "PrimaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for moderate and severe bronchopulmonary dysplasia.",
                                                            "PrimaryOutcomeTimeFrame": "from the time of diagnosis to the time of stopping oxygen therapy"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of blood pressure in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for moderate and severe bronchopulmonary dysplasia. Blood pressure is measured by electronic sphygmomanometer .",
                                                            "SecondaryOutcomeTimeFrame": "24 hours after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes of heart rate in participants",
                                                            "SecondaryOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for moderate and severe bronchopulmonary dysplasia.",
                                                            "SecondaryOutcomeTimeFrame": "24 hours after administration"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Changes of respiratory rate in participants",
                                                            "OtherOutcomeDescription": "To evaluate the safety of human umbilical cord -derived mesenchymal stem cells for moderate and severe bronchopulmonary dysplasia.",
                                                            "OtherOutcomeTimeFrame": "24 hours after administration"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Changes of high-resolution chest CT in participants",
                                                            "OtherOutcomeDescription": "To evaluate the safety and efficacy of human umbilical cord -derived mesenchymal stem cells for moderate and severe bronchopulmonary dysplasia.",
                                                            "OtherOutcomeTimeFrame": "within 2 years after administration"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nParticipants with moderate and severe bronchopulmonary dysplasia are not well treated by routine therapy\nThe legal representative or the participant had signed consent.\n\nExclusion Criteria:\n\n1. Severe underlying diseases (e.g. systemic and hematological malignancies, heart failure, liver and kidney failure, immune deficiency, severe infectious diseases, III-IV grade pulmonary hypertension, Lung transplantation, current indications of acute surgery after lung transplantation) 2. Participants whose age is more than 1 year old.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "28 Days",
                                          "MaximumAge": "1 Year",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Yunqiu Xia",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "023-63622066",
                                                            "CentralContactEMail": "sunny_199001@foxmail.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Lin Zou",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "023-63622066"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Zhou Fu",
                                                            "OverallOfficialAffiliation": "Children's Hospital of Chongqing Medical University",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Children's Hospital of Chongqing Medical University",
                                                            "LocationCity": "Chongqing",
                                                            "LocationState": "Chongqing",
                                                            "LocationZip": "400014",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Yunqiu Xia",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "13637719980",
                                                                              "LocationContactEMail": "sunny_199001@foxmail.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "28341525",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ahn SY, Chang YS, Kim JH, Sung SI, Park WS. Two-Year Follow-Up Outcomes of Premature Infants Enrolled in the Phase I Trial of Mesenchymal Stem Cells Transplantation for Bronchopulmonary Dysplasia. J Pediatr. 2017 Jun;185:49-54.e2. doi: 10.1016/j.jpeds.2017.02.061. Epub 2017 Mar 21."
                                                      },
                                                      {
                                                            "ReferencePMID": "26928452",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Laube M, Stolzing A, Thome UH, Fabian C. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth. Int J Biochem Cell Biol. 2016 May;74:18-32. doi: 10.1016/j.biocel.2016.02.023. Epub 2016 Feb 27. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "22837858",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Hansmann G, Fernandez-Gonzalez A, Aslam M, Vitali SH, Martin T, Mitsialis SA, Kourembanas S. Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ. 2012 Apr-Jun;2(2):170-81. doi: 10.4103/2045-8932.97603."
                                                      },
                                                      {
                                                            "ReferencePMID": "32005282",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Wu X, Xia Y, Zhou O, Song Y, Zhang X, Tian D, Li Q, Shu C, Liu E, Yuan X, He L, Liu C, Li J, Liang X, Yang K, Fu Z, Zou L, Bao L, Dai J. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial). Trials. 2020 Jan 31;21(1):125. doi: 10.1186/s13063-019-3935-x."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000001997",
                                                            "ConditionMeshTerm": "Bronchopulmonary Dysplasia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000006965",
                                                            "ConditionMeshTerm": "Hyperplasia"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055397",
                                                            "ConditionAncestorTerm": "Ventilator-Induced Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M4425",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9168",
                                                            "ConditionBrowseLeafName": "Hyperplasia",
                                                            "ConditionBrowseLeafAsFound": "Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27305",
                                                            "ConditionBrowseLeafName": "Ventilator-Induced Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T874",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 12,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03106662",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "213S196"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Ankara University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies",
                                          "OfficialTitle": "Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Hematological Malignancies"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2018",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2017",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "October 2017",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "November 13, 2015",
                                          "StudyFirstSubmitQCDate": "April 4, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 10, 2017",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "January 8, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 10, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Onder Arslan",
                                                "ResponsiblePartyInvestigatorTitle": "MD, Department of Hematology, Clinical Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Ankara University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Ankara University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "The Scientific and Technological Research Council of Turkey",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Mesenchymal stem cells (MSCs) have been used in the treatment and prevention of graft-versus host disease (GVHD). In this study the investigators aim to present the efficacy of mesenchymal stem cells in graft versus host disease prophylaxis and effect of engraftment in haploidentical recipients. Forty patients aged older than 18 who have indications for haploidentical hematopoietic stem cell transplantation will be included to the study. MSCs will be isolated from donor bone marrows and infused to the patient after conditioning regimen on day +6. If the haploidentical transplantation results improve with MSCs treatment it would be possible to ameliorate the problem of HLA-matched donor paucity in Turkey and prefer haploidentical donors.",
                                          "DetailedDescription": "Mesenchymal stem cells (MSCs) have been utilized in the treatment and prevention of graft-versus-host disease(GVHD) after allogeneic hematopoietic stem cell transplantation (alloSCT). However, studies on MSC use in alloSCT from haploidentical donors (haploSCT) have been limited.\n\nIn this study, the investigators aim 1) to evaluate MSCs' efficacy in GVHD prophylaxis and effect on engraftment of the haploidentical graft, 2) to improve the success rate of haploSCT by further decreasing GVHD incidence and graft failure rate. With higher haploSCT success rates, haploidentical donors would be important alternative graft sources in patients without HLA-matched donors.\n\nForty patients who present to Ankara University, School of Medicine, Division of Hematology with hematological malignancies and have indications for haploSCT will be included in the study after informed consent is obtained. MSCs will be procured and isolated from donor bone marrows. MSCs will be isolated, cultured, and stored in the good manufacturing practice (GMP) laboratory in Ankara University Stem Cell Institute. Donor bone marrow will be harvested, four to six weeks prior to transplantation, for MSC isolation and culture. Patients will receive either an ablative or non-ablative induction regimen based on their age, diagnosis, and the disease status at the time of transplantation. Donor bone marrow will be harvested a second time on the day of transplantation and the procured bone marrow graft will be infused to the patient the same day. GVHD prophylaxis will include post-transplantation cyclophosphamide (Cy) on days +3 and +4 (50 mg/kg/day), tacrolimus, and mycophenolate mofetil. Stored MSCs will be infused to the patient on day +6. The endpoints include graft failure rate, GVHD incidence, transplant-related mortality, disease-free survival, and overall survival.\n\nThe investigators aim to evaluate the utility of MSCs in improving haploSCT results and to enhance the reliability and success of haploSCT. Successful transplants from haploidentical donors would ameliorate the problem of matched donor paucity in countries with a limited number of hematopoietic stem cell donors, such as Turkey, and would establish haploidentical donors an alternative donor source for patients without matched donors in Turkey. As haploidentical donors may be parents or children, rapid and easy access to donors would decrease wait times for alloSCT. Moreover, national current account deficit may be reduced through using grafts obtained from haploidentical donors residing in Turkey instead of grafts from foreign stem cell/umbilical cord banks.\n\nIn this project, the investigators seek to develop clinical therapy applications in concordant with the ambition of \"renewal and repair of human cells, tissues, and organs through cellular therapy and cellular products\" that is included in the The Scientific and Technological Research Council of Turkey 1003 Call for Projects."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Hematopoietic Stem Cell Transplantation"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stem cell",
                                                      "haploidentical hematopoietic stem cell transplantation",
                                                      "graft-versus-host disease",
                                                      "engraftment"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 3"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "6",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cell in Haplo-SCT",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "After preferred conditioning regimen for the patient, cyclophosphamide 50 mg/kg/day will be administered at +3 and +4 post transplant day. At +6 post transplant day, 2-8x10^8 cell/kg mesenchymal stem cells will be infused.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stem cells",
                                                                        "Drug: cyclophosphamide administration"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cells",
                                                            "InterventionDescription": "After preferred conditioning regimen for the patient, cyclophosphamide 50 mg/kg/day will be administered at +3 and +4 post transplant day. At +6 post transplant day, 2-8x10^8 cell/kg mesenchymal stem cells will be infused.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cell in Haplo-SCT"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "cyclophosphamide administration",
                                                            "InterventionDescription": "After preferred conditioning regimen for the patient, cyclophosphamide 50 mg/kg/day will be administered at +3 and +4 post transplant day.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cell in Haplo-SCT"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Effect of mesenchymal stem cells on overall survival in haploidentical stem cell transplantation",
                                                            "PrimaryOutcomeTimeFrame": "36 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Effect of mesenchymal stem cells on graft versus host disease incidence in haploidentical stem cell transplantation",
                                                            "SecondaryOutcomeTimeFrame": "36 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Effect of mesenchymal stem cells on graft failure incidence in haploidentical stem cell transplantation",
                                                            "SecondaryOutcomeTimeFrame": "36 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosed with haematological malignancy\nIndication of haploidentical hematopoietic stem cell transplantation\nNo restrictions for transplantation\n\nExclusion Criteria:\n\nAny restriction for transplantation\nNo indication of haploidentical hematopoietic stem cell transplantation",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Ankara University School of Medicine Department of Hematology",
                                                            "LocationCity": "Ankara",
                                                            "LocationCountry": "Turkey"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000019337",
                                                            "ConditionMeshTerm": "Hematologic Neoplasms"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000009369",
                                                            "ConditionAncestorTerm": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009371",
                                                            "ConditionAncestorTerm": "Neoplasms by Site"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M20467",
                                                            "ConditionBrowseLeafName": "Hematologic Neoplasms",
                                                            "ConditionBrowseLeafAsFound": "Hematological Malignancies",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC04",
                                                            "ConditionBrowseBranchName": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionMeshList": {
                                                "InterventionMesh": [
                                                      {
                                                            "InterventionMeshId": "D000003520",
                                                            "InterventionMeshTerm": "Cyclophosphamide"
                                                      }
                                                ]
                                          },
                                          "InterventionAncestorList": {
                                                "InterventionAncestor": [
                                                      {
                                                            "InterventionAncestorId": "D000007166",
                                                            "InterventionAncestorTerm": "Immunosuppressive Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000007155",
                                                            "InterventionAncestorTerm": "Immunologic Factors"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000045505",
                                                            "InterventionAncestorTerm": "Physiological Effects of Drugs"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000018501",
                                                            "InterventionAncestorTerm": "Antirheumatic Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000018906",
                                                            "InterventionAncestorTerm": "Antineoplastic Agents, Alkylating"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000000477",
                                                            "InterventionAncestorTerm": "Alkylating Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000045504",
                                                            "InterventionAncestorTerm": "Molecular Mechanisms of Pharmacological Action"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000000970",
                                                            "InterventionAncestorTerm": "Antineoplastic Agents"
                                                      },
                                                      {
                                                            "InterventionAncestorId": "D000019653",
                                                            "InterventionAncestorTerm": "Myeloablative Agonists"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M5879",
                                                            "InterventionBrowseLeafName": "Cyclophosphamide",
                                                            "InterventionBrowseLeafAsFound": "Tablet",
                                                            "InterventionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M9364",
                                                            "InterventionBrowseLeafName": "Immunosuppressive Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M9353",
                                                            "InterventionBrowseLeafName": "Immunologic Factors",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M19757",
                                                            "InterventionBrowseLeafName": "Antirheumatic Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M20095",
                                                            "InterventionBrowseLeafName": "Antineoplastic Agents, Alkylating",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M2972",
                                                            "InterventionBrowseLeafName": "Alkylating Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ANeo",
                                                            "InterventionBrowseBranchName": "Antineoplastic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ARhu",
                                                            "InterventionBrowseBranchName": "Antirheumatic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 13,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02302599",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "CHIN-PLAGH-ST-003"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Chinese PLA General Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells to Treat Type 2 Diabetes",
                                          "OfficialTitle": "Efficacy and Safety of Umbilical-cord Mesenchymal Stem Cells in Chinese Adults With Type 2 Diabetes: a Single Center, Double-blind, Randomized, Placebo-controlled Trial",
                                          "Acronym": "UC-MSCs"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "February 2021",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2013",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2020",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2020",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "November 12, 2014",
                                          "StudyFirstSubmitQCDate": "November 26, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "November 27, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "February 1, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "February 3, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Yiming Mu",
                                                "ResponsiblePartyInvestigatorTitle": "Director",
                                                "ResponsiblePartyInvestigatorAffiliation": "Chinese PLA General Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Chinese PLA General Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Umbilical cord mesenchymal stem cells indicate the therapeutic effects and safety on type 2 diabetes by characteristics of secretion and immune Immunomodulation.",
                                          "DetailedDescription": "Umbilical cord mesenchymal stem cells can improve insulin resistance of the target tissues, reduce the islet progressive damage, ease or regenerate of the islet beta cells and improve hyperglycemic state of diabetes by secreting a variety of cytokines. It can induce damaged alpha cells differentiate into beta cells in the islet transformation to realize the islet beta cells in situ regeneration by improving microenvironment of islet beta cells. Umbilical cord mesenchymal stem cells also have immunosuppressive effect, it can promote islet cell repair and regeneration by the inhibition of T cell mediated immune response to beta cells."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Type 2 Diabetes",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignInterventionModelDescription": "UC-MSCs (1.5\u00d7106/kg) or the same volume of placebo (suspension liquid without UC-MSCs)",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignMaskingDescription": "All investigators and participants were masked to treatment allocation. The independent data monitoring committee and the statisticians supporting the committee's activities were the only people with access to unblinded data.",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "103",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients receive Umbilical cord mesenchymal stem cells intravenous infusion for three times with an interval of 4 weeks in the absence of disease progression or unacceptable toxicity",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Controlled suspension liquid",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients receive Controlled suspension liquid",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Controlled suspension liquid"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Umbilical cord mesenchymal stem cells",
                                                            "InterventionDescription": "Infusion treatment",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Controlled suspension liquid",
                                                            "InterventionDescription": "Infusion treatment",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Controlled suspension liquid"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The efficacy of umbilical cord mesenchymal stem cells in Chinese adults with T2D",
                                                            "PrimaryOutcomeDescription": "proportion of patients with HbA1c <7.0% and daily insulin reduction \u226550% from baseline to 48 weeks",
                                                            "PrimaryOutcomeTimeFrame": "48 weeks from baseline"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Other efficacy parameter of umbilical-cord mesenchymal stem cells in Chinese adults with T2D",
                                                            "SecondaryOutcomeDescription": "Changes of insulin requirement, HbA1c and proportion of patients reaching the HbA1c target (<7.0%)",
                                                            "SecondaryOutcomeTimeFrame": "48 weeks from baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Other efficacy parameter of umbilical-cord mesenchymal stem cells in Chinese adults with T2D",
                                                            "SecondaryOutcomeDescription": "Change of islet \u03b2 cell function and insulin resistance",
                                                            "SecondaryOutcomeTimeFrame": "48 weeks from baseline"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "safety parameter of umbilical-cord mesenchymal stem cells in Chinese adults with T2D",
                                                            "SecondaryOutcomeDescription": "Fever, pruritus, nausea and vomiting, anaphylactic shock, phlebitis\uff0ctumor formation, infection, impaired liver and kidney function.",
                                                            "SecondaryOutcomeTimeFrame": "48 weeks from baseline"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\n20 \u2264 age \u2264 65 years;\nDuration of type 2 diabetes \u226420 years;\n24.0 kg/m2 \u2264 BMI \u226440.0 kg/m2;\nStable exogenous insulin dose between 0.5-1.0 U/Kg/Day with or without oral hypoglycemic agents (Dipeptidyl peptidase-4 (DPP-4) inhibitor, Glucagon like peptide 1 receptor (GLP-1R) agonist and Sodium-glucose co-transporter 2 (SGLT-2) inhibitor excluded) for at least 3 months;\n7.0% \u2264 HbA1c \u2264 12.0%;\nFasting C-peptide \u2265 1ng/ml;\nWillingness to participate in the trial.\n\nExclusion Criteria:\n\nPatients with ketonuria, tumor, serum creatinine level more than 175\u03bcmol/L, myocardial infarction in the previous year, current angina or heart failure, more than one major vascular event, retinopathy requiring laser treatment, malignant hypertension, uncorrected endocrine disorder, occupations precluding insulin therapy;\nSevere concurrent illness limiting life expectancy, inadequate understanding of the study protocol, drug abuse, pregnant willing and allergic constitution.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "20 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "weidong HAN",
                                                            "OverallOfficialAffiliation": "Chinese PLA General Hospital",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "yiming MU",
                                                            "OverallOfficialAffiliation": "Chinese PLA General Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Chinese PLA General Hospital",
                                                            "LocationCity": "Beijing",
                                                            "LocationState": "Beijing",
                                                            "LocationZip": "100039",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "23770360",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Hao H, Liu J, Shen J, Zhao Y, Liu H, Hou Q, Tong C, Ti D, Dong L, Cheng Y, Mu Y, Liu J, Fu X, Han W. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. Biochem Biophys Res Commun. 2013 Jul 5;436(3):418-23. doi: 10.1016/j.bbrc.2013.05.117. Epub 2013 Jun 11."
                                                      },
                                                      {
                                                            "ReferencePMID": "16681924",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Wang XL, Lu JM, Pan CY, Mu YM, Dou JT, Ba JM. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system]. Zhonghua Yi Xue Za Zhi. 2006 Mar 14;86(10):674-7. Chinese."
                                                      },
                                                      {
                                                            "ReferencePMID": "22618776",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Si Y, Zhao Y, Hao H, Liu J, Guo Y, Mu Y, Shen J, Cheng Y, Fu X, Han W. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes. 2012 Jun;61(6):1616-25. doi: 10.2337/db11-1141."
                                                      },
                                                      {
                                                            "ReferencePMID": "35505375",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Zang L, Li Y, Hao H, Liu J, Cheng Y, Li B, Yin Y, Zhang Q, Gao F, Wang H, Gu S, Li J, Lin F, Zhu Y, Tian G, Chen Y, Gu W, Du J, Chen K, Guo Q, Yang G, Pei Y, Yan W, Wang X, Meng J, Zhang S, Ba J, Lyu Z, Dou J, Han W, Mu Y. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial. Stem Cell Res Ther. 2022 May 3;13(1):180. doi: 10.1186/s13287-022-02848-6."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Chinese PLA General Hospital Endocrinology medical characteristics",
                                                            "SeeAlsoLinkURL": "http://www.301hospital.com.cn"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003924",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 2"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6271",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 2",
                                                            "ConditionBrowseLeafAsFound": "Type 2 Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 14,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02804945",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2015-0327"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "NCI-2016-01184",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "NCI CTRP"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "M.D. Anderson Cancer Center",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies",
                                          "OfficialTitle": "A Pilot Study of Mesenchymal Stem Cells for Treatment of Acute Respiratory Distress Syndrome in Patients With Malignancies"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2020",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 24, 2017",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "June 13, 2019",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 13, 2019",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 15, 2016",
                                          "StudyFirstSubmitQCDate": "June 15, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 17, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 8, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 10, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "M.D. Anderson Cancer Center",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Katz Foundation",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "Yes",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The goal of this clinical research study is to learn about the safety of giving mesenchymal stem cells (MSCs) to patients who have ARDS. Researchers also want to learn if these cells can help control ARDS when given with drugs that are routinely used to treat ARDS.\n\nIn this study, participants will receive 1 infusion of MSCs.\n\nThis is an investigational study. MSC infusions for the treatment of ARDS is investigational.\n\nUp to 20 patients will take part in this study. All will be enrolled at MD Anderson.",
                                          "DetailedDescription": "The MSCs:\n\nMSCs are a type of stem cell that can be removed from bone marrow and grown into many different cell types that can be used to treat cancer and other diseases. The MSCs used in this study were collected from healthy donors and are stored and grown in a laboratory at MD Anderson. The product you will receive is from a healthy donor that is not related to you.\n\nMSC Administration:\n\nIf you are found to be eligible to take part in this study, you will receive MSCs by vein over about 1-2 hours 1 time on Day 1.\n\nStudy Visits:\n\nOn Days 1 and 3:\n\nBlood (about 2 tablespoons) will be drawn for routine tests, to check your heart, kidney, and liver function, and for biomarker testing.\nBlood (about \u00bd teaspoon) will be drawn to check the oxygen level in your blood.\n\nOn Days 14 and 30:\n\n\u00b0Blood (about 2 tablespoons) will be drawn for routine tests, to check your heart, kidney, and liver function, and for biomarker testing.\n\nOn Days 30 and 60:\n\n\u00b0You will be checked for possible reactions to your treatment, including graft-versus-host disease (GVHD - a reaction of the donor's immune cells against your body). This will be checked by physical exam, by the doctor reviewing your side effects, and blood from standard of care blood draws.\n\nLength of Study:\n\nYour participation on this study will end after the Day 60 study visit. You will be taken off study early if you are not able to receive the MSC infusion(s), if intolerable side effects occur, if the doctor thinks it is in your best interest, or if you are unable to follow study directions."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Blood And Marrow Transplantation",
                                                      "Adult Respiratory Distress Syndrome"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Blood And Marrow Transplantation",
                                                      "Adult Respiratory Distress Syndrome",
                                                      "ARDS",
                                                      "Allogeneic human mesenchymal stem cells",
                                                      "hMSCs",
                                                      "Placebo",
                                                      "Plasma-Lyte A solution",
                                                      "Standard of Care",
                                                      "Recent onset pulmonary toxicity"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Participants receive Mesenchymal Stem Cells (MSCs) for adult respiratory distress syndrome (ARDS).\n\nParticipants receive a maximum dose of 3 x 10^6 cell/Kg by vein one time on Day 1.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cells (MSCs)"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cells (MSCs)",
                                                            "InterventionDescription": "Participants receive a maximum dose of 3 x 10^6 cell/Kg by vein one time on Day 1.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Adverse Events of Participants Treated with Allogeneic Human Mesenchymal Stem Cells (hMSCs) With Acute Respiratory Distress Syndrome (ARD)",
                                                            "PrimaryOutcomeDescription": "Adverse Events determined by CTCAE version 4.",
                                                            "PrimaryOutcomeTimeFrame": "30 days"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Clinical Improvement of Participants Treated with Allogeneic Human Mesenchymal Stem Cells (hMSCs) With Acute Respiratory Distress Syndrome (ARD)",
                                                            "SecondaryOutcomeDescription": "Clinical improvement defined as decreased mechanical ventilation after the mesenchymal stem cell (MSC) infusion.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, 7 days and 30 days"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Improvement in PF or S/F Ratio of Participants Treated with Allogeneic Human Mesenchymal Stem Cells (hMSCs) With Acute Respiratory Distress Syndrome (ARD)",
                                                            "SecondaryOutcomeDescription": "An improvement in PF or S/F ratio defined as decreased mechanical ventilatory requirement.",
                                                            "SecondaryOutcomeTimeFrame": "Baseline, 7 days and 30 days"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nARDS characterized by hypoxemia and bilateral radiographic opacities not fully explained by cardiac failure or fluid overload as judged by the treating physician using all available data. Moderate ARDS includes patients with malignancies with the previous presentation and a P/F ratio </= 200 or SF ratio of </= 214. The duration of the hypoxemia criterion and the radiograph criterion must be within 10 days of the time of enrollment.\nPatients age >/=18 years.\nTreated with appropriate maximal medical therapy for pulmonary toxicity.\nNegative pregnancy test in a woman with childbearing potential defined as not post-menopausal for 12 months or no previous surgical sterilization.\nPatient or legally appropriate proxy must be able to understand study instructions and sign consent.\n\nExclusion Criteria:\n\nUnstable ventricular tachycardia or fibrillation.\nMoribund patients not expected to survive up to 48 hours.\nPatients with ARDS resulting from trauma.\nPatients with documented deep venous thrombosis or pulmonary embolism within the past 3 months.\nPatients with severe chronic liver disease (Childs-Pugh score > 10).\nPatients with previous solid organ transplant.\nPregnant and/or lactating women.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Amanda L. Olson, MD",
                                                            "OverallOfficialAffiliation": "M.D. Anderson Cancer Center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "University of Texas MD Anderson Cancer Center",
                                                            "LocationCity": "Houston",
                                                            "LocationState": "Texas",
                                                            "LocationZip": "77030",
                                                            "LocationCountry": "United States"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "University of Texas MD Anderson Cancer Center Website",
                                                            "SeeAlsoLinkURL": "http://www.mdanderson.org"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012128",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012127",
                                                            "ConditionMeshTerm": "Respiratory Distress Syndrome, Newborn"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000055371",
                                                            "ConditionMeshTerm": "Acute Lung Injury"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012120",
                                                            "ConditionAncestorTerm": "Respiration Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14117",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14116",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Newborn",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27297",
                                                            "ConditionBrowseLeafName": "Acute Lung Injury",
                                                            "ConditionBrowseLeafAsFound": "Adult Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14109",
                                                            "ConditionBrowseLeafName": "Respiration Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4927",
                                                            "ConditionBrowseLeafName": "Respiratory Distress Syndrome, Infant",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T192",
                                                            "ConditionBrowseLeafName": "Acute Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Respiratory Distress Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M21013",
                                                            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M85407",
                                                            "InterventionBrowseLeafName": "Plasma-lyte 148",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PhSol",
                                                            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 15,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03778333",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC-progressive MS"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Karolinska Institutet",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden",
                                          "OfficialTitle": "Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "December 2018",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 1, 2012",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 31, 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "January 14, 2015",
                                          "StudyFirstSubmitQCDate": "December 14, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "December 19, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "December 14, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "December 19, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Ellen Iacobaeus",
                                                "ResponsiblePartyInvestigatorTitle": "Principal investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "Karolinska Institutet"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Karolinska Institutet",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSCs) in Multiple Sclerosis (MS) with progressive disease status."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Autologous Mesenchymal Stem Cells",
                                                      "Multiple Sclerosis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stem Cells",
                                                      "Multiple Sclerosis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignInterventionModelDescription": "Open-label phase 1, single-center, pre-post comparison study",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "7",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Open label single arm study",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "All patients will be treated with 1 single dose of IV infusion of autologous bone-marrow derived mesenchymal stem cells (1-2 million cells/kg body weight) and their therapeutic response will be followed over 48 weeks.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Autologous mesenchymal stem cells",
                                                            "InterventionDescription": "IV therapy with autologous bone-marrow derived mesenchymal stem cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Open label single arm study"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "To evaluate number of participants with an adverse event related to the treatment.",
                                                            "PrimaryOutcomeDescription": "Adverse events is defined as any untoward or undesirable medical occurence in the form of signs, symptoms, abnormal findings or diseases that emerge during the study period, regardless of causal relationship to the study drug.",
                                                            "PrimaryOutcomeTimeFrame": "48 weeks"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "To evaluate effects on MS disease activity measured by cumulative number of MRI T2 lesions.",
                                                            "PrimaryOutcomeDescription": "Brain MRI examination",
                                                            "PrimaryOutcomeTimeFrame": "48 weeks"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate effects on MS disease activity measured by change in EDSS (expanded disability status scale).",
                                                            "SecondaryOutcomeDescription": "EDSS assessed by neurologist.",
                                                            "SecondaryOutcomeTimeFrame": "48 weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "To evaluate effect on peripheral blood immune cell populations.",
                                                            "SecondaryOutcomeDescription": "Peripheral blood samples.",
                                                            "SecondaryOutcomeTimeFrame": "24 weeks"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of MS\n\nActive relapsing remitting MS (RRMS) as evidenced by presence of \u2265 1 clinically documented relapse in the past 12 months or \u22652 clinically documented relapses in the last 24 months.\nSecondary progressive MS with clinical progression as evidenced by an increase of 1 EDSS point (or 0,5 p if EDSS \u2265 5 at time for study start) in the last year or evidenced by \u22651 relapse or \u2265 GEL at MRI performed within the last year.\nPrimary progressive MS with clinical progression as evidenced by an increase of 1 EDSS point (or 0,5 p if EDSS \u2265 5 at time for study start) in the last year.\nAge_ 18-65 years\nDisease duration: 2-20 years\nEDSS 3,0-7,0\n\nExclusion Criteria:\n\nSubtype of MS not fulfilling inclusion criteria\nTreatment with any immunosuppressive therapy, including natalizumab and fingolimod, within the 3 months prior to randomization\nTreatment with interferon-beta or glatiramer acetate within the 30 days prior to randomization\nTreatment with corticosteroids within the 30 days prior to randomization\nRelapse occurred during the 60 days prior to randomization\nPrevious history of a malignancy other than basal cell carcinoma of the skin or carcinoma in situ that has been in remission for more than one year\nSeverely limited life expectancy by another co-morbid illness\nActive or chronic severe infection.\nHistory of previous diagnosis of myelodysplasia or previous hematologic disease or current clinically relevant abnormalities of white blood cell counts\nPregnancy or risk or pregnancy (this includes patients that are unwilling to practice active contraception during the duration of the study)\neGFR < 60 mL/min/1.73m2 or known renal failure or inability to undergo MRI examination.\nInability to give written informed consent in accordance with research ethics board guidelines",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Karolinska Institute, Karolinska University Hospital Solna",
                                                            "LocationCity": "Stockholm",
                                                            "LocationZip": "171 76",
                                                            "LocationCountry": "Sweden"
                                                      },
                                                      {
                                                            "LocationFacility": "Karolinska Institute, Karolinska University Hospital",
                                                            "LocationCity": "Stockholm",
                                                            "LocationZip": "17176",
                                                            "LocationCountry": "Sweden"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009103",
                                                            "ConditionMeshTerm": "Multiple Sclerosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000020528",
                                                            "ConditionMeshTerm": "Multiple Sclerosis, Chronic Progressive"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012598",
                                                            "ConditionMeshTerm": "Sclerosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020278",
                                                            "ConditionAncestorTerm": "Demyelinating Autoimmune Diseases, CNS"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020274",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases of the Nervous System"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003711",
                                                            "ConditionAncestorTerm": "Demyelinating Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M11212",
                                                            "ConditionBrowseLeafName": "Multiple Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Multiple Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14567",
                                                            "ConditionBrowseLeafName": "Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21466",
                                                            "ConditionBrowseLeafName": "Multiple Sclerosis, Chronic Progressive",
                                                            "ConditionBrowseLeafAsFound": "Progressive Multiple Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21251",
                                                            "ConditionBrowseLeafName": "Demyelinating Autoimmune Diseases, CNS",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21247",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases of the Nervous System",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6061",
                                                            "ConditionBrowseLeafName": "Demyelinating Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 16,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01694927",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "LIT-2012-ACF-001"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Clinica las Condes, Chile",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients",
                                          "OfficialTitle": "Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients",
                                          "Acronym": "MSC-SCI"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2013",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Enrolling by invitation",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2012"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2013",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "June 2014",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 25, 2012",
                                          "StudyFirstSubmitQCDate": "September 25, 2012",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 27, 2012",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "July 2, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "July 3, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor-Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Cl\u00ednica Las Condes. LIT INNOVA CORFO",
                                                "ResponsiblePartyInvestigatorTitle": "Clinical Researcher LIT. Innova CORFO 09IEI6568",
                                                "ResponsiblePartyInvestigatorAffiliation": "Clinica las Condes, Chile"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Cl\u00ednica Las Condes. LIT INNOVA CORFO",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The aim of this study is to evaluate the use of autologous expanded mesenchymal stem cells intralesional transplantation as a safe and potentially beneficial treatment for patients with spinal cord injury."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Spinal Cord Injury"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stem cell",
                                                      "Spinal cord injury"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Procedure: Autologous Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Procedure",
                                                            "InterventionName": "Autologous Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Expanded Intralesional Autologous Mesenchymal Stem Cells Transplantation",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety of Autologous Expanded Mesenchymal Stem Cells transplantation in SCI patients",
                                                            "PrimaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Functional improvement in muscle strength",
                                                            "SecondaryOutcomeDescription": "According to motor index score",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Functional Improvement in sphincters control",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Functional improvement in spasticity control",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAmerican Spinal Injury Association Impairment (ASIA) Scale A, B and C\nCervical (under C4), thoracic o lumbar spine lesion\nComplete or Incomplete SCI\nPlatelet count over 100.000/ul\n\nExclusion Criteria:\n\nAcute SCI (less than 3 months)\nActive infectious diseases\nPregnancy\nNeurodegenerative diseases\nPrimary hematologic diseases\nCoagulopathies\nHepatic dysfunction\nPregnancy",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "2 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Andr\u00e9s Chah\u00edn, MD",
                                                            "OverallOfficialAffiliation": "Cl\u00ednica Las Condes, Santiago",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Rodrigo M Mardones, MD",
                                                            "OverallOfficialAffiliation": "Cl\u00ednica Las Condes, Santiago",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Catalina Larrain, MD",
                                                            "OverallOfficialAffiliation": "Cl\u00ednica Las Condes, Santiago",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Cl\u00ednica Las Condes",
                                                            "LocationCity": "Santiago",
                                                            "LocationState": "RM",
                                                            "LocationZip": "7591468",
                                                            "LocationCountry": "Chile"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "19903102",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Pal R, Venkataramana NK, Bansal A, Balaraju S, Jan M, Chandra R, Dixit A, Rauthan A, Murgod U, Totey S. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy. 2009;11(7):897-911. doi: 10.3109/14653240903253857."
                                                      },
                                                      {
                                                            "ReferencePMID": "21303266",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E. Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev. 2011 Aug;20(8):1297-308. doi: 10.1089/scd.2010.0466. Epub 2011 Mar 17."
                                                      },
                                                      {
                                                            "ReferencePMID": "16793729",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Moviglia GA, Fernandez Vi\u00f1a R, Brizuela JA, Saslavsky J, Vrsalovic F, Varela G, Bastos F, Farina P, Etchegaray G, Barbieri M, Martinez G, Picasso F, Schmidt Y, Brizuela P, Gaeta CA, Costanzo H, Moviglia Brandolino MT, Merino S, Pes ME, Veloso MJ, Rugilo C, Tamer I, Shuster GS. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy. 2006;8(3):202-9."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000013119",
                                                            "ConditionMeshTerm": "Spinal Cord Injuries"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000014947",
                                                            "ConditionMeshTerm": "Wounds and Injuries"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000013118",
                                                            "ConditionAncestorTerm": "Spinal Cord Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002493",
                                                            "ConditionAncestorTerm": "Central Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020196",
                                                            "ConditionAncestorTerm": "Trauma, Nervous System"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15068",
                                                            "ConditionBrowseLeafName": "Spinal Cord Injuries",
                                                            "ConditionBrowseLeafAsFound": "Spinal Cord Injury",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafAsFound": "Injury",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15067",
                                                            "ConditionBrowseLeafName": "Spinal Cord Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4894",
                                                            "ConditionBrowseLeafName": "Central Nervous System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21176",
                                                            "ConditionBrowseLeafName": "Trauma, Nervous System",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 17,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01068951",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "AS2010-0180"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Uppsala University Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells",
                                          "OfficialTitle": "Open Study to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells in Treatment of Recently Diagnosed Patients With Type 1 Diabetes Mellitus"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "February 2014",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2013",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 2013",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "February 16, 2010",
                                          "StudyFirstSubmitQCDate": "February 16, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 17, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "February 4, 2014",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "February 5, 2014",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Per-Ola Carlsson",
                                                "ResponsiblePartyInvestigatorTitle": "Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Uppsala University Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Uppsala University Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {},
                                    "DescriptionModule": {
                                          "BriefSummary": "The main hypothesis of the investigators study is that the development of autoimmune diabetes may be halted att diagnosis by the immune modulatory properties of mesenchymal stem cells."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Type 1 Diabetes"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "type 1 diabetes",
                                                      "mesenchymal stem cells",
                                                      "intervention"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Not Applicable"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Prevention",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Comparison of active treatment with autologous mesenchymal stem cells (in addition to standard treatment) to standard treatment of patients newly diagnosed with type 1 diabetes mellitus.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control",
                                                            "ArmGroupType": "No Intervention"
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stem cells",
                                                            "InterventionDescription": "Autologous transplantation of the patients own mesenchymal stem cells (approximately 2 x 106 cells/kg body weight) intravenously.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The concentration of stimulated c-peptide at 90 minutes after the start of a mixed meal tolerance test at 365+/-10 days following the infusion or not with mesenchymal stem cells",
                                                            "PrimaryOutcomeTimeFrame": "1 year after intervention"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAbility to provide written informed consent\nMentally stable and able to comply with the procedures of the study protocol\nClinical history compatible with type 1 diabetes diagnosed less than 10 days of enrolment Stimulate c-peptide >0.1 nmol/l\n\nExclusion Criteria:\n\nPatients with BMI>30\nPatients with unstable cardiovascular status\nPatients with active infections, unless treatment is not judged necessary by the investigators\nPatients with serological evidence of infection with HIV, hepatitis B or hepatitis C.\nSexually active females who are not a) postmenopausal, b) surgically sterile or c) using an acceptable method of contraception: oral contraceptives, Norplant, Depo-provera and barrier devices combined with spermicidal gel are acceptable.\nPatients with known or previous malignancy. Patient with any condition or any circumstance that in the opinion of the investigator would make it unsafe to undergo treatment with autologous MSC.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "40 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Per-Ola Carlsson, MD, PhD",
                                                            "OverallOfficialAffiliation": "Uppsala University Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Uppsala University Hospital",
                                                            "LocationCity": "Uppsala",
                                                            "LocationZip": "SE-75185",
                                                            "LocationCountry": "Sweden"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "25204974",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Carlsson PO, Schwarcz E, Korsgren O, Le Blanc K. Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015 Feb;64(2):587-92. doi: 10.2337/db14-0656. Epub 2014 Sep 9."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003922",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6269",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafAsFound": "Type 1 Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 18,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04318600",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2014001"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Yan'an Affiliated Hospital of Kunming Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis",
                                          "OfficialTitle": "Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus Nephritis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2014",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 1, 2014",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 1, 2017",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "January 1, 2019",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "March 11, 2020",
                                          "StudyFirstSubmitQCDate": "March 20, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 24, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 20, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 24, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Yan'an Affiliated Hospital of Kunming Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "The First People's Hospital of Yunnan",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study would further evaluate the safety and efficacy of human amniotic mesenchymal stem cell (hA-MSC) for the treatment of lupus nephritis (LN).",
                                          "DetailedDescription": "Eleven patients with WHO class III, IV or V LN were given hA-MSC (Peripheral intravenous infusion, dose 1\u00d7106/kg cells, once every month for three times). At the same time, five patients with LN who were not given hA-MSC as the blank control group. All patients did not received intravenous corticosteroids pulse therapy, but the use of oral corticosteroids and intravenous cyclophosphamide, or oral mycophenolate mofetil, tacrolimus , leflunomide were allowed."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Lupus Nephritis",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Lupus Nephritis",
                                                      "Human Amniotic Mesenchymal Stem Cell",
                                                      "cell therapy",
                                                      "clinical trail"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Single",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "16",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "human amniotic mesenchymal stem cell treatment group",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: human amniotic mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "blank control group",
                                                            "ArmGroupType": "No Intervention"
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "human amniotic mesenchymal stem cell",
                                                            "InterventionDescription": "human amniotic mesenchymal stem cell (hA-MSC) for the treatment of lupus nephritis patients with WHO class III, IV or V LN were given hA-MSC (Peripheral intravenous infusion, dose 1\u00d7106/kg cells, once every month for three times).",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "human amniotic mesenchymal stem cell treatment group"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Incidence of Adverse Events",
                                                            "PrimaryOutcomeDescription": "The patient's discomfort and clinical symptoms during the study were recorded, as well as the related laboratory test indicators and physical examination abnormalities of the subjects during the study. Describe the association with Amniotic mesenchymal stem cell therapy and calculate the incidence of treatment-related acute and chronic adverse events.",
                                                            "PrimaryOutcomeTimeFrame": "60 weeks"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in 24h urine protein quantification before and after treatment\uff1b",
                                                            "SecondaryOutcomeDescription": "24-hour urinary protein quantification from baseline to 60 weeks of treatment.",
                                                            "SecondaryOutcomeTimeFrame": "60 weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in eGFR before and after treatment;",
                                                            "SecondaryOutcomeDescription": "changes in estimated glomerular filtration rate (eGFR) from baseline to 60 weeks of treatment.",
                                                            "SecondaryOutcomeTimeFrame": "60 weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes in SLEDAI score before and after treatment\uff1b",
                                                            "SecondaryOutcomeDescription": "changes in SLEDAI score from baseline to 60 weeks of treatment. SLEDAI score: 0~4 points basically no activity;5-9 minutes light activity;10-14 minutes of moderate activity;\u226515 minutes of severe activity.",
                                                            "SecondaryOutcomeTimeFrame": "60 weeks"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Enrollment criteria:\n\nAdult patients (age 14-60 years) who were diagnosed as lupus nephritis, regardless of gender, uncontrolled disease course;\nPathological examination of puncture biopsy resulting in diagnosis of type II, III, or IV lupus nephritis;\nSLEDAI score >8;\nproteinuria greater than 1 g/day and active urinary sediments;\nLupus nephritis treatment according to guidelines and norms before human amniotic mesenchymal stem cells therapy;\nIf there is a possibility of pregnancy in female, must be negative pregnancy test, not in lactation, and confirm that is receiving the method of contraception recognized by the researchers, and agree to maintain the method of contraception throughout the study. Sexually active male patients must agree to the use of an appropriate contraceptive method for birth control from the first administration of the study treatment until 24 weeks after the last administration.\nThe subjects should be fully informed, voluntarily sign the informed consent, and agree to participate in all visits, examinations, and treatments as required by the experimental protocol.\n\nExclusion criteria:\n\nPatients with kidney biopsy diagnosis of type I, VI lupus nephritis or a diagnosis of another glomerular disease;\nPatients with abnormal renal function (serum creatinine \u2265 the upper limit of normal);\nPatients with active liver disease or abnormal liver function test results (ALT or AST \u22652 times the upper limit of normal);\nPatients with blood leukocyte count <2.5 \u00d7 109/L, hemoglobin <90 g/L, platelet count <100 \u00d7 109/L, or those who have other hematologic diseases (severe anemia, idiopathic thrombocytopenic purpura, splenomegaly, coagulation dysfunction, etc.);\nPatients with serious and unstable cardiovascular or cerebrovascular diseases (unstable angina pectoris, coronary artery disease, cerebrovascular disease, transient ischemic attack, congestive heart failure, etc.), acute and difficult to control the disease, after treatment has not been effectively controlled severe hypertension (blood pressure >160/100 mm Hg), or organ transplantation;\nPatients with uncontrolled infection;\nPatients with tumors or abnormal tumor marker levels; 8. Patients with blood-borne diseases (i.e., HIV, syphilis, hepatitis B, and hepatitis C);\nPregnancy, the potential for pregnancy, or lactation;\nPatients with a history of allergy, especially patients allergic to human blood albumin;\nPatients with mental illness affecting their voluntarism, ability to make decisions, and ability to communicate\uff1b\nA history of alcoholism or known drug addiction in the last 2 years;\nParticipation in another clinical trial within the last 3 months;\nPatients judged inappropriate for this study by the physicians.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "14 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "35412950",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Naeem A, Gupta N, Naeem U, Khan MJ, Elrayess MA, Cui W, Albanese C. A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells. Cell Cycle. 2022 Aug;21(15):1543-1556. doi: 10.1080/15384101.2022.2060641. Epub 2022 Apr 12."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009393",
                                                            "ConditionMeshTerm": "Nephritis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000008181",
                                                            "ConditionMeshTerm": "Lupus Nephritis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007674",
                                                            "ConditionAncestorTerm": "Kidney Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014570",
                                                            "ConditionAncestorTerm": "Urologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005921",
                                                            "ConditionAncestorTerm": "Glomerulonephritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008180",
                                                            "ConditionAncestorTerm": "Lupus Erythematosus, Systemic"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M11490",
                                                            "ConditionBrowseLeafName": "Nephritis",
                                                            "ConditionBrowseLeafAsFound": "Nephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10330",
                                                            "ConditionBrowseLeafName": "Lupus Nephritis",
                                                            "ConditionBrowseLeafAsFound": "Lupus Nephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9850",
                                                            "ConditionBrowseLeafName": "Kidney Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16471",
                                                            "ConditionBrowseLeafName": "Urologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8183",
                                                            "ConditionBrowseLeafName": "Glomerulonephritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10329",
                                                            "ConditionBrowseLeafName": "Lupus Erythematosus, Systemic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3523",
                                                            "ConditionBrowseLeafName": "Lupus Nephritis",
                                                            "ConditionBrowseLeafAsFound": "Lupus Nephritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2525",
                                                            "ConditionBrowseLeafName": "Glomerulonephritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 19,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01297972",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "CONEP 16119"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Sao Paulo",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia",
                                          "OfficialTitle": "Bone Marrow Mesenchymal Stem Cells in the Treatment of Refractory Severe Acquired Aplastic Anemia"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "February 2014",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 2011"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2013",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "November 2013",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "February 16, 2011",
                                          "StudyFirstSubmitQCDate": "February 16, 2011",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 17, 2011",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "February 2, 2014",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "February 4, 2014",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Diego Villa Cl\u00e9",
                                                "ResponsiblePartyInvestigatorTitle": "MD",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Sao Paulo"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Sao Paulo",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Mesenchymal stem cells have been tested in many autoimmune disorders with encouraging results and may be an alternative to the treatment of immune-mediated severe acquired aplastic anemia.",
                                          "DetailedDescription": "Acquired aplastic anemia is a bone marrow failure syndrome characterized by and empty bone marrow and low blood counts. Most of the cases are immune-mediated. Allogeneic bone marrow transplant is the preferable treatment modality for patients younger than 40 years with a matched sibling donor. Patients not eligible for transplant are treated with intensive immunosuppressive therapy often based on anti-thymocyte globulin and cyclosporine.\n\nHowever, up to one third of patients treated with immunosuppression are refractory and one third of those who response eventually relapse. Refractory and relapsed cases may be the result of insufficient immunosuppression and these cases may benefit from additional immunosuppression. Mesenchymal stem cells infusion may be a potential treatment option, considering its properties to modulate the immune system.\n\nRefractory or relapsed patients with aplastic anemia will be treated with conventional immunosuppressive regimen (anti-thymocyte globulin plus cyclosporine) combined with intravenous infusion of allogeneic unrelated bone marrow mesenchymal stem cells."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Aplastic Anemia"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Aplastic Anemia",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "9",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Intravenous bone marrow mesenchymal stem cells infusion",
                                                            "InterventionDescription": "After standard immunosuppressive therapy with rabbit antithymocyte globulin 3,5 mg/Kg/day during 5 days, allogeneic unrelated bone marrow derived mesenchymal stem cells will be infused intravenously. Oral cyclosporine 5 mg/Kg/day (with dose correction weekly to keep serum cyclosporine level between 150-250 mg/dl) up to 6 months will be added."
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of Participants with Adverse Events as a Measure of Safety and Tolerability of intravenous allogeneic unrelated mesenchymal stem cells infusion in patients with severe acquired aplastic anemia.",
                                                            "PrimaryOutcomeDescription": "Adverse events like allergic reactions,infectious diseases,organ dysfunction or other related to mesenchymal stem cells infusion will be assessed.",
                                                            "PrimaryOutcomeTimeFrame": "After the mesenchymal stem cells infusion up to 6 mounth after"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Level of cytopenias",
                                                            "SecondaryOutcomeTimeFrame": "weekly until 6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Transfusional requirements",
                                                            "SecondaryOutcomeDescription": "Units of blood or platelets transfused after the mesenchymal stem cells infusion will be measured and compared to previously.",
                                                            "SecondaryOutcomeTimeFrame": "weekly until 6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of infections and febrile neutropenia",
                                                            "SecondaryOutcomeTimeFrame": "weekly until 6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis of Acquired Aplastic Anemia\nRelapse/refractory to at least 1 immunosuppressive first line treatment\nNot eligible to allogeneic bone marrow transplantation\n\nExclusion Criteria:\n\nPrevious or current malignancy\nActive or latent infectious disease\nPositive serologic tests for HIV, HCV, HBV, HTLV-1 and 2, Syphilis or Chagas disease\nPrevious drug reaction for antithymocyte globulin, cyclosporin or corticosteroids\nSevere organic impairment (renal, hepatic, cardiac, pulmonary)\nUncontrolled hypertension or diabetes\nPregnancy\nPrevious history of allergic reaction to penicillin or streptomycin\nSevere psychiatric disorder",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Diego V Cl\u00e9, MD",
                                                            "OverallOfficialAffiliation": "University of S\u00e3o Paulo",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Rodrigo T Calado, MD",
                                                            "OverallOfficialAffiliation": "University of S\u00e3o Paulo",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Hospital das Cl\u00ednicas da Faculdade de Medicina de Ribeir\u00e3o Preto da Universidade de S\u00e3o Paulo",
                                                            "LocationCity": "Ribeir\u00e3o Preto",
                                                            "LocationState": "S\u00e3o Paulo",
                                                            "LocationZip": "14048900",
                                                            "LocationCountry": "Brazil"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "16778145",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood. 2006 Oct 15;108(8):2509-19. Epub 2006 Jun 15. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "12592355",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Fouillard L, Bensidhoum M, Bories D, Bonte H, Lopez M, Moseley AM, Smith A, Lesage S, Beaujean F, Thierry D, Gourmelon P, Najman A, Gorin NC. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia. 2003 Feb;17(2):474-6."
                                                      },
                                                      {
                                                            "ReferencePMID": "26589752",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Cl\u00e9 DV, Santana-Lemos B, Tellechea MF, Prata KL, Orellana MD, Covas DT, Calado RT. Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia. Cytotherapy. 2015 Dec;17(12):1696-705. doi: 10.1016/j.jcyt.2015.09.006."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000000740",
                                                            "ConditionMeshTerm": "Anemia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000000741",
                                                            "ConditionMeshTerm": "Anemia, Aplastic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000080983",
                                                            "ConditionAncestorTerm": "Bone Marrow Failure Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001855",
                                                            "ConditionAncestorTerm": "Bone Marrow Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M3222",
                                                            "ConditionBrowseLeafName": "Anemia",
                                                            "ConditionBrowseLeafAsFound": "Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3223",
                                                            "ConditionBrowseLeafName": "Anemia, Aplastic",
                                                            "ConditionBrowseLeafAsFound": "Aplastic Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12270",
                                                            "ConditionBrowseLeafName": "Pancytopenia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2241",
                                                            "ConditionBrowseLeafName": "Bone Marrow Failure Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4286",
                                                            "ConditionBrowseLeafName": "Bone Marrow Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T460",
                                                            "ConditionBrowseLeafName": "Aplastic Anemia",
                                                            "ConditionBrowseLeafAsFound": "Aplastic Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M18113",
                                                            "InterventionBrowseLeafName": "Cyclosporine",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M5882",
                                                            "InterventionBrowseLeafName": "Cyclosporins",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M9364",
                                                            "InterventionBrowseLeafName": "Immunosuppressive Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M255749",
                                                            "InterventionBrowseLeafName": "Thymoglobulin",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M3431",
                                                            "InterventionBrowseLeafName": "Antilymphocyte Serum",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infe",
                                                            "InterventionBrowseBranchName": "Anti-Infective Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "ARhu",
                                                            "InterventionBrowseBranchName": "Antirheumatic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Derm",
                                                            "InterventionBrowseBranchName": "Dermatologic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 20,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02140528",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Royan-Bone-012"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royan Institute",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures",
                                          "OfficialTitle": "Evaluation the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2017",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "August 2013",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "May 14, 2014",
                                          "StudyFirstSubmitQCDate": "May 15, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "May 16, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 26, 2017",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 27, 2017",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Royan Institute",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study is a case-control prospective, clinal trial to assess the safety and efficacy of the allogeneic adipose derived mesenchymal stem cell transplantation on the healing of recent tibial fracture in 40 patients.",
                                          "DetailedDescription": "In this study all eligible patients divided in 2 group.20 patients received allogeneic adipose derived mesenchymal stem cell in the fractured site (case group) and other patients received the placebo in the fractured site (control group) .\n\nTo assess the outcomes, we will evaluate the patients at 2, 6 weeks and 3, 6 months after transplantation by: X-ray, BMD , VAS and biochemical analysis with laboratory tests."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Tibial Fracture"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Allogenic adipose derived mesenchymal stem cell tibial fracture"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Double",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "40",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cell receipients",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Transplantation of allogenic adipose derived mesenchymal stem cells in patients with tibial fracture.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stem cell injection"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Placebo injection in the site of fracture in patients with tibia fracture.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stem cell injection",
                                                            "InterventionDescription": "Injection of adipose derived mesenchymal stem cell in the site of tibia fracture .",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cell receipients"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "stem cell transplantation"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Placebo",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of patients with union after transplantation of mesenchymal stem cell in case group in comparison with control group",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge 18 to 65 years\nThe presence of tibial fracture based on X ray\ntibial fracture is limited to diaphysial\n\nExclusion Criteria:\n\nAddiction\nPregnancy\nliver or kidney disease or uncontrolled diabetes or heart and lung disease\nimmune deficiency",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Hamid Gourabi, PhD",
                                                            "OverallOfficialAffiliation": "Head of Royan Institute",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Nasser Aghdami, MD,PhD",
                                                            "OverallOfficialAffiliation": "Head of regenerative medicine department &cell therapy center of Royan Institute",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Mohsen Emaddedin, MD",
                                                            "OverallOfficialAffiliation": "Department or regenerative medicine of Royan Institute.",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Aziz Ahmadi, MD",
                                                            "OverallOfficialAffiliation": "Scientific board of Iranian Orthopedic Association",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Maedeh Ghorbani, MD",
                                                            "OverallOfficialAffiliation": "Department of Regenerative Medicine",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Afshin Farhadi, MD",
                                                            "OverallOfficialAffiliation": "Scientific board of Iranian Orthopedic Association",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Royan Institute",
                                                            "LocationCity": "Tehran",
                                                            "LocationCountry": "Iran, Islamic Republic of"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Related Info",
                                                            "SeeAlsoLinkURL": "http://Royaninstitute.org"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000050723",
                                                            "ConditionMeshTerm": "Fractures, Bone"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013978",
                                                            "ConditionMeshTerm": "Tibial Fractures"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000014947",
                                                            "ConditionAncestorTerm": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007869",
                                                            "ConditionAncestorTerm": "Leg Injuries"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M25523",
                                                            "ConditionBrowseLeafName": "Fractures, Bone",
                                                            "ConditionBrowseLeafAsFound": "Fracture",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15889",
                                                            "ConditionBrowseLeafName": "Tibial Fractures",
                                                            "ConditionBrowseLeafAsFound": "Tibial Fractures",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10033",
                                                            "ConditionBrowseLeafName": "Leg Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 21,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01224327",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSCHC005"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Qingdao University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients",
                                          "OfficialTitle": "The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients."
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2010",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 2012",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2012",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "October 18, 2010",
                                          "StudyFirstSubmitQCDate": "October 19, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 20, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 19, 2010",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 20, 2010",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyOldNameTitle": "Wang, Yangang MD",
                                                "ResponsiblePartyOldOrganization": "Stem Cell Research Center of Medical School Hospital of Qingdao University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Qingdao University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to investigate the efficacy of umbilical cord mesenchymal stem cells (MSCs) infusion via hepatic artery in the treatment of liver cirrhosis.",
                                          "DetailedDescription": "To investigate the efficacy of umbilical cord mesenchymal stem cells (MSCs) infusion via hepatic artery in the treatment of liver cirrhosis. Patients with liver cirrhosis were randomly separated into two groups. Umbilical cord MSCs were infused to patients using interventional method via hepatic artery for One group. After the catheter placed at proper hepatic artery was confirmed by angiography, umbilical cord MSCs were infused slowly for 15-20minutes. The control group accepted conserved therapy."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Liver Cirrhosis",
                                                      "Radiology",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Liver cirrhosis",
                                                      "Radiology",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "50",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Umbilical cord mesenchymal stem cells were infused to patients using interventional method via hepatic artery. After the catheter placed at proper hepatic artery was confirmed by angiography,umbilical cord MSCs were infused slowly for 15-20minutes.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: umbilical cord Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Conserved therapy",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Patients received comprehensive treatment including antiviral drugs, lowering aminotransferase and jaundice medicine.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Conserved therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "umbilical cord Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Umbilical cord mesenchymal stem cells were infused to patients using interventional method via hepatic artery. After the catheter placed at proper hepatic artery was confirmed by angiography,umbilical cord MSCs were infused slowly for 15-20minutes.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Conserved therapy",
                                                            "InterventionDescription": "Oral or intravenous administration",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Conserved therapy"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Drug therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The result of liver function and liver histological improvement.",
                                                            "PrimaryOutcomeTimeFrame": "every 4 weeks"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "The disappearance or reduction of abdominal dropsy",
                                                            "SecondaryOutcomeTimeFrame": "every 4 weeks"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The clinical symptom improve(including food appetite,debilitation,abdominal distension,edema of lower limbs )",
                                                            "SecondaryOutcomeTimeFrame": "every 4 weeks"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAged 18~70 years.\nLiver cirrhosis\nwritten consent\n\nExclusion Criteria:\n\nThe end-stage of liver cirrhosis.\nSevere problems in other vital organs(e.g.the heart,renal or lungs).\nHepatocellular carcinoma or other malignancies\nPregnancy\nsepsis\nPresence of significant extrahepatic biliary disease (e.g. CBD stone, PSC, etc.)\nCardiac, renal or respiratory failure\nActive thrombosis of the portal or hepatic veins",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Jianxia Hu, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-0532-82911676",
                                                            "CentralContactEMail": "qdyxyhjx@126.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Hong Gao, MS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-0532-82911676",
                                                            "CentralContactEMail": "honggaogloria@gmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Zibin Tian, MD",
                                                            "OverallOfficialAffiliation": "The Affiliated Hospital of Qingdao University",
                                                            "OverallOfficialRole": "Study Director"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Stem Cell Research Center of Medical School Hospital of Qingdao University",
                                                            "LocationCity": "Qingdao",
                                                            "LocationState": "Shandong",
                                                            "LocationZip": "266003",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Jianxia Hu, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "86-0532-82911676",
                                                                              "LocationContactEMail": "qdyxyhjx@126.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Hong Gao, MS",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "86-0532-82911676",
                                                                              "LocationContactEMail": "honggaogloria@gmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Zibin Tian, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000008103",
                                                            "ConditionMeshTerm": "Liver Cirrhosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000005355",
                                                            "ConditionMeshTerm": "Fibrosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008107",
                                                            "ConditionAncestorTerm": "Liver Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M10255",
                                                            "ConditionBrowseLeafName": "Liver Cirrhosis",
                                                            "ConditionBrowseLeafAsFound": "Liver Cirrhosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7637",
                                                            "ConditionBrowseLeafName": "Fibrosis",
                                                            "ConditionBrowseLeafAsFound": "Cirrhosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10259",
                                                            "ConditionBrowseLeafName": "Liver Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M10262",
                                                            "InterventionBrowseLeafName": "Liver Extracts",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M3466",
                                                            "InterventionBrowseLeafName": "Antiviral Agents",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Hemat",
                                                            "InterventionBrowseBranchName": "Hematinics"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infe",
                                                            "InterventionBrowseBranchName": "Anti-Infective Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 22,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01763086",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NFH-MSC-allo-HSCT-2013"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Nanfang Hospital of Southern Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant",
                                          "OfficialTitle": "Mesenchymal Stem Cells From Third-party Donors for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2013",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 2015",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "January 2016",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 5, 2013",
                                          "StudyFirstSubmitQCDate": "January 5, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 8, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 15, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 16, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Nanfang Hospital of Southern Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Peking University People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Sun Yat-sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangdong Provincial People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangzhou General Hospital of Guangzhou Military Command",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Southern Medical University, China",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Third Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangzhou First People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Zhongshan People's Hospital, Guangdong, China",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to evaluate the utility of treating patients experiencing poor graft function after allogeneic hematopoietic stem cell transplantation with ex-vivo-expanded BM-drived mesenchymal stem cells from third-party donors. Our first objective was to evaluate the effect of such treatment on poor graft function, and second object was to investigate the safety of such treatment.",
                                          "DetailedDescription": "Allogeneic hematopoietic stem cell transplantation(allo-HSCT) can cure many hematologic diseases. Although good progress has been made in the prevention and treatment of side effects associated with transplantation, poor graft function (PGF) remains an important complication that occurs in 5-27% of patients, and is associated with considerable morbidity and mortality related to infections or hemorrhagic complications. Treatment of PGF usually involves the prescription of hematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF), or repeat transplantation, but these methods are associated with short-term effect and a significant risk of graft-versus-host disease\uff08GVHD\uff09 development, respectively.\n\nMesenchymal stem cells (MSCs) are a form of multipotent adult stem cells that can be isolated from bone marrow (BM), adipose tissue, and cord blood. Clinical applications of human MSCs are evolving rapidly with goals of improving hematopoietic engraftment, preventing and treating graft-versus-host disease after allo-HSCT and so on. However, the efficacy of treatment of PGF that develops after allo-HSCT using expanded BM-derived MSCs from a third-party donor is rarely reported. If such treatment could be shown to be effective and safe, BM-derived MSCs could potentially be used as an universal donor material. This would have a major impact because the generation of donor-specific MSCs is time-consuming, costly, and often impractical if the clinical status of a patient is urgent.\n\nIn the present study, the investigators will prospectively evaluate the efficacy and safety of ex-vivo-expanded BM-derived MSCs from third-party donors in treating patients with PGF after allo-HSCT."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Stem Cell Transplantation, Hematopoietic",
                                                      "Mesenchymal Stem Cells",
                                                      "Poor Graft Function",
                                                      "Hematological Diseases"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Poor Graft Function",
                                                      "Mesenchymal Stem Cells",
                                                      "Allogeneic hematopoietic stem cell transplantation",
                                                      "Third-party Donors"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "60",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stem cells 1\u00d710^6 cells/kg, intravenously",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stem cells",
                                                            "InterventionDescription": "Mesenchymal stem cells will be intravenously infused via a central venous catheter,at a dose of 1\u00d710^6 cells/kg, over 15 min. The vital signs of all patients will be closely monitored during and for 24h after MSCs administration. If the NEU and PLT levels do not attain the completely response(CR)standards within 14d, a second course of MSCs treatment will be given.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "hematopoietic recovery",
                                                            "PrimaryOutcomeDescription": "Hematopoietic reconstitution post-transplantation is defined as reconstitution of both neutrophil and platelet numbers. Neutrophil reconstitution is defined as occurring on the first 3 consecutive days with an neutrophil(NEU)>0.5\u00d710^9/L, and platelet (PLT) reconstitution is defined as the first >20\u00d710^9/L for 3 consecutive days.",
                                                            "PrimaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "infections, primary underlying disease relapse and any toxic side effects of MSCs treatment",
                                                            "SecondaryOutcomeDescription": "Infections will be mainly focused within the first 100 days after MSCs treatment. Toxic side effects of treatment includes acute toxicity and late side effects. Acute toxicity principally involves the heart,live and kidney. Late toxic side effects involves principally the development of secondary tumors and relapse of the primary disease.",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nA patient age of 14-65 years\nPoor graft function developing after allo-HSCT\nSubjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study\n\nExclusion Criteria:\n\nAny abnormality in a vital sign (e.g., heart rate, respiratory rate, or blood pressure)\nPatients with any conditions not suitable for the trial (investigators' decision)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "14 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Ren Lin, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86-020-61641613",
                                                            "CentralContactEMail": "lansinglinren@hotmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Qifa Liu, MD",
                                                            "OverallOfficialAffiliation": "Nanfang Hospital of Southern Medical University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Department of Hematology,Nanfang Hospital, Southern Medical University",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Guangzhou",
                                                            "LocationState": "Guangdong",
                                                            "LocationZip": "510515",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Ren Lin, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+86-020-61641613",
                                                                              "LocationContactEMail": "lansinglinren@hotmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Qifa Liu, MD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "22023454",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "S\u00e1nchez-Guijo FM, L\u00f3pez-Villar O, L\u00f3pez-Anglada L, Villar\u00f3n EM, Munti\u00f3n S, D\u00edez-Campelo M, Perez-Sim\u00f3n JA, San Miguel JF, Caballero D, del Ca\u00f1izo MC. Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation. Transfusion. 2012 May;52(5):1086-91. doi: 10.1111/j.1537-2995.2011.03400.x. Epub 2011 Oct 24."
                                                      },
                                                      {
                                                            "ReferencePMID": "19309241",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Meuleman N, Tondreau T, Ahmad I, Kwan J, Crokaert F, Delforge A, Dorval C, Martiat P, Lewalle P, Lagneaux L, Bron D. Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev. 2009 Nov;18(9):1247-52. doi: 10.1089/scd.2009.0029."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006402",
                                                            "ConditionMeshTerm": "Hematologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafAsFound": "Hematological Diseases",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 23,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT00504803",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "TJB0601"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Liege",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease",
                                          "OfficialTitle": "Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning: a Pilot Study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2011",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 2006"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2010",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2010",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "July 19, 2007",
                                          "StudyFirstSubmitQCDate": "July 19, 2007",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 20, 2007",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "September 1, 2011",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 2, 2011",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Yves Beguin",
                                                "ResponsiblePartyInvestigatorTitle": "Prof",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Liege"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Liege",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning from HLA-mismatched PBSC or cord blood: a Pilot Study"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Hematological Malignancies"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "HCT, nonmyeloablative, mesenchymal stem cells, GVHD"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Prevention",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "1",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "MSC co-infusion with either HLA-mismatched PBSC or cord blood",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Procedure: Mesenchymal stem cell infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Procedure",
                                                            "InterventionName": "Mesenchymal stem cell infusion",
                                                            "InterventionDescription": "Infusion of mesenchymal stem cells on the same day as hematopoietic stem cell infusion.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "1"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Day-100 incidence of non-relapse mortality",
                                                            "PrimaryOutcomeTimeFrame": "100 days"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "1. Hematopoietic engraftment and graft rejection. 2. Incidence of grade II-IV and III-IV acute GVHD. 3. Immunologic reconstitution",
                                                            "SecondaryOutcomeTimeFrame": "365 days"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "V.1. Patients\n\nV.1.1. Diseases\n\nHematological malignancies confirmed histologically and not rapidly progressing:\n\nAML in CR;\nALL in CR;\nCML unresponsive/intolerant to Imatinib but not in blast crisis;\nOther myeloproliferative disorders not in blast crisis and not with extensive myelofibrosis;\nMDS with < 5% blasts;\nMultiple myeloma;\nCLL;\nNon-Hodgkin's lymphoma (aggressive NHL should have chemosensitive disease);\nHodgkin's disease.\n\nV.1.2. Clinical situations\n\nTheoretical indication for a standard allo-transplant, but not feasible because:\n\nAge > 55 yrs;\nUnacceptable end organ performance;\nPatient's refusal.\nIndication for a standard auto-transplant: perform mini-allotransplantation 2-6 months after standard autotransplant.\n\nV.1.3. Other inclusion criteria\n\nMale or female; fertile female patients must use a reliable contraception method;\nAge < 75 yrs.\nInformed consent given by patient or his/her guardian if of minor age.\n\nV.1.4. Exclusion criteria\n\nAny condition not fulfilling inclusion criteria;\nHIV positive;\nTerminal organ failure, except for renal failure (dialysis acceptable);\nUncontrolled infection, arrhythmia or hypertension;\nPrevious radiation therapy precluding the use of 2 Gy TBI;\nHLA-identical donor.\n\nV.2. PBSC donors\n\nV.2.1. Inclusion criteria\n\nRelated to the recipient (sibling, parent or child) or unrelated;\nMale or female;\nWeight > 15 Kg (because of leukapheresis);\nFulfills generally accepted criteria for allogeneic PBSC donation;\nInformed consent given by donor or his/her guardian if of minor age, as per donor center standard procedures.\n\nV.2.2. Exclusion criteria\n\nAny condition not fulfilling inclusion criteria;\nHIV positive;\nUnable to undergo leukapheresis because of poor vein access or other reasons.\n\nV.2.3. HLA matching\n\nRelated or unrelated donors who have 1-2 HLA mismatches, as either :\n\nOne antigenic mismatch at HLA-A or -B or -C or -DRB1 or -DQB1\nOne allelic mismatch at HLA-A or -B or -C or -DRB1 or -DQB1\nTwo allelic mismatches at HLA-A or -B or -C or -DRB1 or -DQB1\nOne antigenic mismatch + 1 allelic mismatch at HLA-A or -B or -C or -DRB1 or -DQB1.\nOne antigenic mismatch at -DQB1 and one other antigenic mismatch at HLA-A or -B or -C or -DRB1\n\nV.3. Cord blood unit\n\nBanked cord blood units will be used if they fulfill the following criteria:\n\nNo more than 2/6 HLA mismatches (antigenic mismatch at HLA-A or HLA-B or allelic mismatch at HLA-DRB1)\n> 2.5 x 107 TNC/kg\nStandard validation by FACT/Netcord criteria.",
                                          "HealthyVolunteers": "Accepts Healthy Volunteers",
                                          "Gender": "All",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Frederic Baron, MD, PhD",
                                                            "OverallOfficialAffiliation": "CHU-ULg",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Yves Beguin, MD, PhD",
                                                            "OverallOfficialAffiliation": "CHU-ULg",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Chantal Lechanteur, PhD",
                                                            "OverallOfficialAffiliation": "CHU-ULg",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Etienne Baudoux, MD",
                                                            "OverallOfficialAffiliation": "CHU-ULg",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Evelyne Willems, MD",
                                                            "OverallOfficialAffiliation": "CHU-ULg",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "CHU Sart Tilman",
                                                            "LocationCity": "Liege",
                                                            "LocationZip": "4000",
                                                            "LocationCountry": "Belgium"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "20109568",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y. Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000019337",
                                                            "ConditionMeshTerm": "Hematologic Neoplasms"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000009369",
                                                            "ConditionAncestorTerm": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009371",
                                                            "ConditionAncestorTerm": "Neoplasms by Site"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M20467",
                                                            "ConditionBrowseLeafName": "Hematologic Neoplasms",
                                                            "ConditionBrowseLeafAsFound": "Hematological Malignancies",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC04",
                                                            "ConditionBrowseBranchName": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 24,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03863002",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Tianjin Weikai Bioeng., Ltd"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Tianjin Weikai Bioeng., Ltd.",
                                                "OrgClass": "INDUSTRY"
                                          },
                                          "BriefTitle": "Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure",
                                          "OfficialTitle": "Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2018",
                                          "OverallStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 1, 2019",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 1, 2021",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "October 1, 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "February 18, 2019",
                                          "StudyFirstSubmitQCDate": "March 2, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 5, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "March 18, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 20, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Tianjin Weikai Bioeng., Ltd.",
                                                "LeadSponsorClass": "INDUSTRY"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Tianjin Nankai Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure",
                                          "DetailedDescription": "Acute-on-chronic liver failure (ACLF) which occurs in patients with chronic liver disease, is a serious live-threatening disease. Currently, the clinical management, such as liver protection, anti-virus medicine, and artificial liver support, has not significantly improve the outcomes, the mortality still remains over 50%. Liver transplantation is the only effective treatment of ACLF, but this therapy is limited by the shortage of donor organs, potential surgical complications, immunological rejection and high medical costs. Mesenchymal stem cell (MSC) is one of adult stem cells, which has been suggested to play a role in amelioration of liver disease, such as: trans-differentiation of MSCs into hepatocytes, immunomodulation, inhibition of fibrosis development, protective effects on hepatic cell and restoration of hepatic cell proliferation capacity."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Liver Failure, Acute on Chronic"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "mesenchymal stem cell"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)",
                                                      "DesignMaskingDescription": "both participants and the study team are unblinded to the treatment allocation"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "45",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Standard Medical Treatment",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "Standard Medical Treatment (SMT): All patients received SMT, including nutritional supplementation; administration of human serum albumin (serum albumin <30 g/L), fresh frozen plasma (200-400 mL/day until the INR was <1.5), S-adenosylmethionine (1.0 g/day); or anti-virus treatment for hepatic viruses-related cases, and appropriate treatment for complications such as infections (including of the respiratory tract, urinary tract, biliary tract, and digestive tract and spontaneous peritonitis), encephalopathy, gastrointestinal bleeding, and hepatorenal syndrome [HRS])."
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal Stem Cell (MSC): The MSC group received infusions of 1.0 to 10x10^5cells/kg MSCs through the peripheral vein once a week for 4 weeks, in addition to SMT.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cell",
                                                            "InterventionDescription": "Mesenchymal stem cell transplantation via peripheral vein: 1.0-10x10^5 MSCs/kg body weight administered via peripheral vein at week 0, 1, 2, 3 weeks",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "survival rate",
                                                            "PrimaryOutcomeDescription": "Number of participants alive",
                                                            "PrimaryOutcomeTimeFrame": "72 weeks after treatment"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Adverse reactions",
                                                            "SecondaryOutcomeDescription": "Number of participants with adverse reactions (e.g. fever, rash, and diarrhea )",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "White blood cell",
                                                            "SecondaryOutcomeDescription": "Change of white blood cell count",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Platelet",
                                                            "SecondaryOutcomeDescription": "Change of platelet count",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Hemoglobin",
                                                            "SecondaryOutcomeDescription": "Change of hemoglobin level",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Creatinine",
                                                            "SecondaryOutcomeDescription": "Change of creatinine level as a surrogate marker of liver function",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "ALT",
                                                            "SecondaryOutcomeDescription": "Change of alanine aminotransferase (ALT) level as a marker of liver function",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "ALB",
                                                            "SecondaryOutcomeDescription": "Change of albumin (ALB) level as a maker of liver function",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "TBil",
                                                            "SecondaryOutcomeDescription": "Change of total Bilirubin (TBil) level as a marker of liver function",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "INRs",
                                                            "SecondaryOutcomeDescription": "Change of international normalized ratio (INRs) level as a marker of liver function",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "AFP",
                                                            "SecondaryOutcomeDescription": "Change of alpha fetoprotein (AFP) level as a marker of liver function",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "MELD scores",
                                                            "SecondaryOutcomeDescription": "Model for End-Stage Liver Disease (MELD) score for assessing the severity of chronic liver disease is measured as absolute change to baseline score",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Tumor formation",
                                                            "SecondaryOutcomeDescription": "Number of participants with hepatocellular carcinoma or extrahepatic malignant tumors",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Liver failure-associated serious complications",
                                                            "SecondaryOutcomeDescription": "Number of participants with liver failure-associated serious complications, such as infections, encephalopathy, gastrointestinal bleeding and HRS",
                                                            "SecondaryOutcomeTimeFrame": "Week 1, 2, 4, 8, 12, 24, 36, 48"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nInformed consent\nMeeting the definition of ACLF: patients with previously diagnosed or undiagnosed chronic liver disease acute decompensated within 4 weeks; significant GI symptom as such fatigue, jaundice; serum total bilirubin [TBil] \u226510 X the upper limit of normal; coagulopathy (international normalized ratio [INR] \u22651.5 or prothrombin activity [PTA] <40%); complicated within 4 weeks by ascites and/or encephalopathy as determined by physical examination.\nModel for End-Stage Liver Disease (MELD) scores ranging 17-30, (MELD(i) = 0.957 \u00d7 ln(Cr) + 0.378 \u00d7 ln(bilirubin) + 1.120 \u00d7 ln(INR) + 0.643);\nChronic liver disease with definitive etiology such as viral hepatitis, alcohol liver disease, drug induced liver injury or autoimmune liver diseases\nBody weight \u226550kg\n\nExclusion Criteria:\n\nSerious complications in the previous 2 months (e.g., gastrointestinal bleeding: hemoglobin below 90g/L, serious infection such as sepsis, ascites ultrafiltration, and/or dialysis);\nMalignant jaundice induced by obstructive jaundice or hemolytic jaundice;\nHepatocellular carcinoma (HCC) diagnosed by radiologic imaging and/or alpha fetoprotein (AFP);\nTumor diagnosed by ultrasound, CT, MR examination;\nModerate or severe chronic heart failure (NYHA III-IV), renal replacement therapy, severe chronic pulmonary disease (GOLD III-IV)\nExtrahepatic cholestasis\nHepatic, portal and splenic vein thrombosis diagnosed by doppler ultrasound\nArtificial liver support\nPrevious liver transplantation\nDrug abuse in the past 5 years;\nMental disorders and/or has a family history of mental disorder.\nHIV infection\nPregnant or breast-feeding females\nHighly allergic\nPatients can not cooperate or mobility\nEnrolled in other clinical trials with 3 months\nPatients who can not provide prior informed consent or refusal to participate",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "16 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Xiuli Cong, MD, PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86 18512507567",
                                                            "CentralContactEMail": "cong_xiuli@163.com"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Tianjin Weikai Bioeng., Ltd.",
                                                            "LocationCity": "Tianjin",
                                                            "LocationState": "Tianjin",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Xiuli Cong, MD, PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+86 18512507567",
                                                                              "LocationContactEMail": "cong_xiuli@163.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000017093",
                                                            "ConditionMeshTerm": "Liver Failure"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000048550",
                                                            "ConditionMeshTerm": "Hepatic Insufficiency"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000058625",
                                                            "ConditionMeshTerm": "End Stage Liver Disease"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000065290",
                                                            "ConditionMeshTerm": "Acute-On-Chronic Liver Failure"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000017114",
                                                            "ConditionMeshTerm": "Liver Failure, Acute"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000008107",
                                                            "ConditionAncestorTerm": "Liver Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004066",
                                                            "ConditionAncestorTerm": "Digestive System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M18567",
                                                            "ConditionBrowseLeafName": "Liver Failure",
                                                            "ConditionBrowseLeafAsFound": "Liver Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25123",
                                                            "ConditionBrowseLeafName": "Hepatic Insufficiency",
                                                            "ConditionBrowseLeafAsFound": "Liver Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18583",
                                                            "ConditionBrowseLeafName": "Liver Failure, Acute",
                                                            "ConditionBrowseLeafAsFound": "Liver Failure, Acute",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M28321",
                                                            "ConditionBrowseLeafName": "End Stage Liver Disease",
                                                            "ConditionBrowseLeafAsFound": "Chronic Liver Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M29651",
                                                            "ConditionBrowseLeafName": "Acute-On-Chronic Liver Failure",
                                                            "ConditionBrowseLeafAsFound": "Acute on Chronic Liver Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10259",
                                                            "ConditionBrowseLeafName": "Liver Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8035",
                                                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6407",
                                                            "ConditionBrowseLeafName": "Digestive System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC06",
                                                            "ConditionBrowseBranchName": "Digestive System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M10262",
                                                            "InterventionBrowseLeafName": "Liver Extracts",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Hemat",
                                                            "InterventionBrowseBranchName": "Hematinics"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 25,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01788059",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "900939"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Emdadi Kamyab Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital",
                                          "OfficialTitle": "The Efficacy of Mesenchymal Stem Cells for Stimulate the Union in Treatment of Non-united Tibial and Femoral Fractures in Shahid Kamyab Hospital"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "December 2013",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 2013",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "November 2013",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "January 17, 2013",
                                          "StudyFirstSubmitQCDate": "February 7, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "February 11, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "December 26, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "December 30, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "mohammad taghi peivandi",
                                                "ResponsiblePartyInvestigatorTitle": "MD",
                                                "ResponsiblePartyInvestigatorAffiliation": "Emdadi Kamyab Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Emdadi Kamyab Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Because the rate of non union of long bone in lower extremities specially in tibia in this two last decade due to malnutrition and smoking and other risk factors was increased, so many patient in our country suffer from non union on the other hand it seems that the use of the mesenchymal stem cells can irritate the union rate. Therefore the investigators decide to inject the mesenchymal stem cell derived from iliac bone marrow after centrifuge with ficoll procedure to non union site in patient that are resistant to other treatment. Then the investigators will follow the patient with monthly radiography and evaluate the callus volume and clinical union and any side effect of this treatment.clinical union consider to relief pain in non union site and be stable in examination."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Nonunion Fracture"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "nonunion",
                                                      "mesenchymal stem cell",
                                                      "long bone"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "19",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "stem cells drived from iliac bone marrow with centrifuge and ficoll method then inject to non union site 2-3 ml with approximately 40 X 10E6 Mesenchymal Stem Cells (MSC) will be injected in the nonunion site of the bone fracture under fluoroscopic gide and general or spinal anesthesia as deemed appropriate by the anesthetist.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: injection the mesenchymal stem cell in non union site"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "injection the mesenchymal stem cell in non union site",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "clinical and radiological union at 1 month to 6 months",
                                                            "PrimaryOutcomeDescription": "patients receiving Mesenchymal Stem Cells that develop a partial or complete callus at 1, 2, 3, 4 ,5 and 6 months evaluate with standard X-rays",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "\u2022Safety of Mesenchymal Stem Cells injection in nonunion fractures. Follow-up for revealing any significant immediate or late adverse effects.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of adverse events in patients (e.g infection , malignancy , ...) Adverse events will be continuously monitored",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nEvery patient with non union in the site of long bone fracture\nAge more than 18 and under 60 years old\nFracture having no radiological callus after 6 months and absence of any hypertrophic bone reaction.\nNo infection in site of surgery\nBe able and willing to participate in the study\nWritten informed consent\n\nExclusion Criteria:\n\nEvidence of malignancy\nPregnancy or breastfeeding\nPatient positive by serology or PCR for HIV, hepatitis B or C infection the patient with Accompanied fracture such as hip fracture that could not weight bearing",
                                          "HealthyVolunteers": "Accepts Healthy Volunteers",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "mohammad taghi peivandi, MD",
                                                            "OverallOfficialAffiliation": "Emdadi Kamyab Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Emdai Kamyab Hospital",
                                                            "LocationCity": "Mashhad",
                                                            "LocationState": "Khorasan",
                                                            "LocationCountry": "Iran, Islamic Republic of"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "AnnotationSection": {
                                    "AnnotationModule": {
                                          "UnpostedAnnotation": {
                                                "UnpostedResponsibleParty": "mohammad taghi peivandi, MD, Emdadi Kamyab Hospital",
                                                "UnpostedEventList": {
                                                      "UnpostedEvent": [
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "February 13, 2014"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "March 27, 2014"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "May 17, 2014"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "June 14, 2014"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "August 2, 2017"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "February 16, 2018"
                                                            }
                                                      ]
                                                }
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022",
                                          "SubmissionTracking": {
                                                "SubmissionInfoList": {
                                                      "SubmissionInfo": [
                                                            {
                                                                  "SubmissionReleaseDate": "February 13, 2014",
                                                                  "SubmissionResetDate": "March 27, 2014"
                                                            },
                                                            {
                                                                  "SubmissionReleaseDate": "May 17, 2014",
                                                                  "SubmissionResetDate": "June 14, 2014"
                                                            },
                                                            {
                                                                  "SubmissionReleaseDate": "August 2, 2017",
                                                                  "SubmissionResetDate": "February 16, 2018"
                                                            }
                                                      ]
                                                }
                                          }
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000050723",
                                                            "ConditionMeshTerm": "Fractures, Bone"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000005264",
                                                            "ConditionMeshTerm": "Femoral Fractures"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000005599",
                                                            "ConditionMeshTerm": "Fractures, Ununited"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000014947",
                                                            "ConditionAncestorTerm": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007869",
                                                            "ConditionAncestorTerm": "Leg Injuries"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M25523",
                                                            "ConditionBrowseLeafName": "Fractures, Bone",
                                                            "ConditionBrowseLeafAsFound": "Fracture",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7554",
                                                            "ConditionBrowseLeafName": "Femoral Fractures",
                                                            "ConditionBrowseLeafAsFound": "Femoral Fractures",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7872",
                                                            "ConditionBrowseLeafName": "Fractures, Ununited",
                                                            "ConditionBrowseLeafAsFound": "Nonunion Fracture",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10033",
                                                            "ConditionBrowseLeafName": "Leg Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M3259",
                                                            "InterventionBrowseLeafName": "Anesthetics",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "CNSDep",
                                                            "InterventionBrowseBranchName": "Central Nervous System Depressants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 26,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01763099",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NFH-MSC-auto-HSCT-2013"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Nanfang Hospital of Southern Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure",
                                          "OfficialTitle": "Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure Following Autologous Hematopoietic Stem Cell Transplantation"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2013",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 2015",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "January 2016",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "January 5, 2013",
                                          "StudyFirstSubmitQCDate": "January 5, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "January 8, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 15, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 16, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Nanfang Hospital of Southern Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Peking University People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Sun Yat-sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangdong Provincial People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangzhou General Hospital of Guangzhou Military Command",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Southern Medical University, China",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Third Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangzhou First People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Zhongshan People's Hospital, Guangdong, China",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to evaluate the utility of treating patients experiencing graft failure after autologous hematopoietic stem cell transplantation with ex-vivo-expanded BM-drived mesenchymal stem cells from third-party donors or mesenchymal stem cells combined with cord blood. The first objective of this study was to evaluate the effect of such treatment on graft failure, and second object was to investigate the safety of such treatment.",
                                          "DetailedDescription": "Autologous hematopoietic stem cell transplantation (auto-HSCT) are considered the standard of care for many malignancies, such as lymphoma, myeloma and some leukemias, and so on. Graft failure after auto-HSCT is a formidable complication. It occurs in 2-9.5% of patients and is associated with considerable morbidity and mortality related to infections and hemorrhagic complications. There are various options for the management of graft failure. The most common treatment of graft failure is growth factors such as granulocyte colony-stimulating factor (G-CSF)and recombinant erythropoietin,but it usually effective in the short term and no effect on platelet counts.\n\nMesenchymal stem cells (MSCs) are a form of multipotent adult stem cells that can be isolated from bone marrow (BM), adipose tissue, and cord blood. Clinical applications of human MSCs are evolving rapidly with goals of improving hematopoietic engraftment, preventing and treating graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation and so on.As an important source of hematopoietic stem cell, cord blood has been widely used in clinical practice. It is reported that cord blood combined with MSCs can increase engraftment after allogeneic hematopoietic stem cell transplantation. However, to our knowledge, the report about efficacy of treatment of graft that develops after auto-HSCT using expanded BM-derived MSCs from a third-party donor combined with cord blood is absent.If such treatment could be shown to be effective and safe, BM-derived MSCs could potentially be used as an universal donor material. This would have a major impact because the generation of donor-specific MSCs is time-consuming, costly, and often impractical if the clinical status of a patient is urgent.\n\nIn the present study, the investigators will prospectively evaluate the efficacy and safety of ex-vivo-expanded BM-derived MSCs from third-party donors or MSCs combined with cord blood in treating patients with graft failure after auto-HSCT."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Hematopoietic Stem Cell Transplantation",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord Blood",
                                                      "Graft Failure",
                                                      "Hematological Diseases"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Autologous Hematopoietic Stem Cell Transplantation",
                                                      "Mesenchymal Stem Cells",
                                                      "Cord Blood",
                                                      "Graft failure"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "60",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stem cells group refers to treatment with mesenchymal stem cells (1\u00d710^6 cells/kg, intravenously)",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells and cord blood",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Mesenchymal stem cells and cord blood group refers to treatment with mesenchymal stem cells (at a dose of 1\u00d710^6 cells/kg) and cord blood",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stem cells and cord blood"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stem cells",
                                                            "InterventionDescription": "Mesenchymal stem cells will be intravenously infused via a central venous catheter(at a dose of 1\u00d710^6 cells/kg, over 15 min) in day 1 and day 15 of the cycle. If the NEU and PLT levels do not attain the completely response(CR)standards after this cycle, mesenchymal stem cells combined with cord blood will be given. If the NEU and PLT levels attain the completely response(CR)or partly response(PR) standards after this cycle, another cycle with the same strategy will be given.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stem cells and cord blood",
                                                            "InterventionDescription": "Mesenchymal stem cells will be given (at a dose of 1\u00d710^6 cells/kg,intravenously infused via a central venous catheter)on day 1.day 15, day 29 and day 43 of the cycle. Cord blood will be given intravenously infused via a central venous catheter on day 2 of the cycle.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells and cord blood"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "hematopoietic recovery",
                                                            "PrimaryOutcomeDescription": "Hematopoietic reconstitution post-transplantation is defined as reconstitution of both neutrophil and platelet numbers. Neutrophil reconstitution is defined as occurring on the first 3 consecutive days with an neutrophil(NEU)>0.5\u00d710^9/L, and platelet (PLT) reconstitution is defined as the first >20\u00d710^9/L for 3 consecutive days.",
                                                            "PrimaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "infections, primary underlying disease relapse and any toxic side effects of MSCs treatment",
                                                            "SecondaryOutcomeDescription": "Infections will be mainly focused within the first 100 days after MSCs treatment. Toxic side effects of treatment includes acute toxicity and late side effects. Acute toxicity principally involves the heart,live and kidney. Late toxic side effects involves principally the development of secondary tumors and relapse of the primary disease.",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nA patient age of 14-65 years\nGraft failure developing after auto-HSCT\nSubjects (or their legally acceptable representatives) must have signed an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study\n\nExclusion Criteria:\n\nAny abnormality in a vital sign (e.g., heart rate, respiratory rate, or blood pressure)\nPatients with any conditions not suitable for the trial (investigators' decision)",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "14 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Ren Lin, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86-020-61641613",
                                                            "CentralContactEMail": "lansinglinren@hotmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Qifa Liu, MD",
                                                            "OverallOfficialAffiliation": "Nanfang Hospital of Southern Medical University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Department of Hematology,Nanfang Hospital, Southern Medical University",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Guangzhou",
                                                            "LocationState": "Guangdong",
                                                            "LocationZip": "510515",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Ren Lin, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+86-020-61641613",
                                                                              "LocationContactEMail": "lansinglinren@hotmail.com"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "11277170",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ko\u00e7 ON, Lazarus HM. Mesenchymal stem cells: heading into the clinic. Bone Marrow Transplant. 2001 Feb;27(3):235-9. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "19796274",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Smith AR, Wagner JE. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol. 2009 Oct;147(2):246-61. doi: 10.1111/j.1365-2141.2009.07828.x. Review."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006402",
                                                            "ConditionMeshTerm": "Hematologic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafAsFound": "Hematological Diseases",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 27,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01956903",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "CSM/EICH2010"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "2010-020947-11",
                                                            "SecondaryIdType": "EudraCT Number"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment of Refractory Acute Graft-Versus-Host Disease by Sequential Infusion of Allogenic Mesenchymal Stem Cell.",
                                          "OfficialTitle": "Phase 1/2 Study of Treatment of Refractory Acute Graft-Versus-Host Disease After First Line Therapy by Sequential Infusion of Expanded In-Vitro Allogenic Mesenchymal Stem Cell",
                                          "Acronym": "CSM/EICH2010"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2013",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2013",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "September 2013",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "September 30, 2013",
                                          "StudyFirstSubmitQCDate": "September 30, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 8, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "September 30, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 8, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine the safety and efficacy of sequential infusion of allogenic mesenchymal stem cells (MSC) expanded \"in vitro\" in treating patients with acute graft-versus-host disease refractory to first-line therapy.",
                                          "DetailedDescription": "Ethical considerations:\n\nThe study will be conducted in accordance with the requirements expressed in the Declaration of Helsinki (Hong Kong revision, September 1989) and following the recommendations of the Good Clinical Practice of the Clinical Trials (document 111/3976/88, July 1990 ) and Spanish legislation (Royal Decree 561/1993, published in April 16th Official State Bulletin \"BOE\"; May 13th, 1993) laying down the requirements for conducting clinical drug trials.\n\nEvery subject will receive a written document called \"Patient Information Sheet\" that contains information about the following aspects of clinical trial: a) Aim of the study, methodology, study treatment and alternative therapies, expected benefits for himself or society, risks of the study and possible adverse events, number of visits and additional tests.\n\nb) Voluntary nature of their participation and ability to withdraw at any time, without thereby altering the doctor-patient relationship.\n\nc) People who have access to the data of the volunteer and how they maintain the confidentiality of the data.\n\nd) How to contact with the investigator if necessary.\n\nThe investigator will obtain the informed consent of the subject or, failing that, from a legal representative. The subject is preferably expressed written consent or, alternatively, orally to the research team independent witnesses who declare in writing under its responsibility.\nThe person participating in the clinical trial or his representative may revoke the consent at any time.\n\nData Access:\n\nIn order to ensure the confidentiality of the trial data, only have access to them, the researcher and his team, the test monitor and the Clinical Research Ethics Committee of the corresponding center or purposes under test and relevant health authorities.\nProtection of data: The content of the data collection forms and the documents generated during the study, will be protected from unauthorized uses by people outside the research and, therefore, will be considered strictly confidential and will not be disclosed to third parties except to those specified in the preceding paragraph.\n\nData Collection:\n\nData colection forms will be dated and signed by the authorized principal investigator.\nUnknown data will be collected as \"NA\"(not available).\nUnusual or extreme results, or that do not match the expected sequence will be checked and corrected by initialing, signing and providing an explanation.\nLaboratory results that exceed normal limits established by the laboratory of the center, should be checked by the researcher and their significance will be noted next to the data, by initialing and signing.\n\nStatistical Analysis:\n\nBaseline data will be analyzed using descriptive statistics and demographics (mean, median, standard deviation, minimum, maximum, and number of valid cases) for quantitative variables and absolute and relative frequencies for categorical variables.\nThe primary efficacy objective is to determine the response rate of graft versus host disease (confidence intervals 95%).\nThe primary safety objective is to determine the incidence of adverse events and toxicity related to the administration of the CSM (confidence intervals 95%).\nSecondary objectives: analyze overall survival and disease-free survival by the Kaplan-Meier method."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Chronic Graft-Versus-Host Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "mesenchymal stem cell transplantation"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "15",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Allogenic Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Sequential Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell (MSC). Dosage 0,7 x 10e6 MSC/Kg/dose (cumulative minimum dose: 2,8 x 10e6 CSM/Kg.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Genetic: Allogenic Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Genetic",
                                                            "InterventionName": "Allogenic Mesenchymal Stem Cell",
                                                            "InterventionDescription": "Expanded in-Vitro Allogenic Mesenchymal Stem Cell (authorized by Spain, \"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios\" with number 06-076)",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Allogenic Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Adverse effects",
                                                            "PrimaryOutcomeDescription": "Infusion related.\nInfection Rate.",
                                                            "PrimaryOutcomeTimeFrame": "from infusion to 100 days after stem cell transplant"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "efficacy",
                                                            "SecondaryOutcomeDescription": "Acute Graft-Versus-Host Disease response rate.",
                                                            "SecondaryOutcomeTimeFrame": "Acute Graft-Versus-Host Disease period (100 days)"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with hematologic malignancies who have undergone allogenic stem cell transplantation and who are diagnosed with acute graft-versus-host-disease refractory to first-line treatment.\nPatients must have adequate cardiac function without evidence of uncontrolled hypertension, congestive heart failure or myocardial infarction within 6 months prior to the process.\nAdequate pulmonary function with no evidence of severe obstructive or restrictive pulmonary disease.\nBe able to understand the information and sign the informed consent.\n\nExclusion Criteria:\n\nPatients with uncontrolled disease or in progress at the time of treatment.\nPatients with uncontrolled bacterial, viral or fungal infection.\nPatients with inadequate cardiac or pulmonary function.\nPatients who do not have the required donor.\nWomen pregnant or at risk of pregnancy by inadequate contraceptive measures.\nPatients who in the opinion of the investigator are not able to participate in the study.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Ferm\u00edn M S\u00e1nchez Guijo, MD",
                                                            "OverallOfficialAffiliation": "Hospital Universitario de Salamanca, Salamanca. Spain.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Felipe Prosper, MD",
                                                            "OverallOfficialAffiliation": "Cl\u00ednica Universitaria de Navarra, Spain.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Eduardo Olavarr\u00eda, MD",
                                                            "OverallOfficialAffiliation": "Hospital de Navarra, Spain",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Roc\u00edo Parody, MD",
                                                            "OverallOfficialAffiliation": "Hospital Universitario Virgen del Roc\u00edo, Seville, Spain.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Carmen Regidor, MD",
                                                            "OverallOfficialAffiliation": "Hospital Universitario Puerta del Hierro, Spain",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Carmen Mart\u00ednez, MD",
                                                            "OverallOfficialAffiliation": "Hospital Clinic i Provincial de Barcelona, Spain",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Rodrigo Martino, MD",
                                                            "OverallOfficialAffiliation": "Hospital de la Santa Creu i Sant Pau, Spain",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Jos\u00e9 Antonio P\u00e9rez-Sim\u00f3n, MD",
                                                            "OverallOfficialAffiliation": "Hospital Universitario Virgen del Roc\u00edo, Seville, Spain.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular",
                                                            "LocationCity": "Madrid",
                                                            "LocationZip": "28010",
                                                            "LocationCountry": "Spain"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 28,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03130374",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "RRPCEM_MSC1"
                                          },
                                          "Organization": {
                                                "OrgFullName": "The Republican Research and Practical Center for Epidemiology and Microbiology",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells",
                                          "OfficialTitle": "Treatment of Laryngotracheal Stenosis Using Autologous Olfactory-mucosa-derived Mesenchymal Stem Cells"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "June 2019",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 3, 2017",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 4, 2019",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "May 20, 2019",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "April 12, 2017",
                                          "StudyFirstSubmitQCDate": "April 22, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 26, 2017",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "June 5, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "June 7, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Andrei Y. Hancharou",
                                                "ResponsiblePartyInvestigatorTitle": "Head of the Laboratory for Immunology and Cellular Biotechnology,",
                                                "ResponsiblePartyInvestigatorAffiliation": "The Republican Research and Practical Center for Epidemiology and Microbiology"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "The Republican Research and Practical Center for Epidemiology and Microbiology",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Belarusian Medical Academy of Post-Graduate Education",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "The Republican Center for Research and Practice in Otolaryngology",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis",
                                          "DetailedDescription": "Trial evaluating the safety and efficacy of olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis.\n\nMesenchymal stem cells are obtained from tissue biopsy of olfactory mucosa using explant method. Biomass of autologous mesenchymal stem cells in 10% human albumin solution is injected submucosally around and over the tissue after removal of a granuloma tissue during surgical intervention."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Tracheal Stenosis",
                                                      "Laryngeal Stenosis",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "mesenchymal stem cells",
                                                      "Tracheal Stenosis",
                                                      "Laryngeal Stenosis",
                                                      "cell therapy"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "12",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cell treated group",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients treated according to current clinical protocols plus autologous olfactory mucosa-derived mesenchymal stem cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Olfactory mucosa-derived mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control group",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "Patients treated according to current clinical protocols"
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Olfactory mucosa-derived mesenchymal stem cells",
                                                            "InterventionDescription": "Olfactory mucosa-derived mesenchymal stem cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cell treated group"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of patients who didn't require the repeated surgical interventions",
                                                            "PrimaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Tracheostomy decannulation",
                                                            "SecondaryOutcomeDescription": "Removal of the tracheostomy tube after the treatment.",
                                                            "SecondaryOutcomeTimeFrame": "6 month"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nconfirmed diagnosis of chronic laryngeal or tracheal stenosis;\nabsence of cartilage damage.\n\nExclusion Criteria:\n\nrefuse of patient to participate in the trial;\nacute infectious diseases;\nchronic mental disorders with severe manifestations;\npregnancy/lactation;\nintercurrent severe chronic diseases;\nHIV, Hepatites B/C;\nactive tuberculosis;\nalcohol use disorder/drug addiction;\ncachexia of any origin;\nmalignant neoplasms.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "85 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Andrei Y Hancharou, Dr",
                                                            "OverallOfficialAffiliation": "Head of the Laboratory for Immunology and Cellular Biotechnology, The Republican Research and Practical Center for Epidemiology and Microbiology",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Valery L Chekan, Dr",
                                                            "OverallOfficialAffiliation": "Associate Professor of the Belarusian Medical Academy of Post-Graduate Education",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "The Republican Center for Research and Practice in Otolaryngology",
                                                            "LocationCity": "Minsk",
                                                            "LocationZip": "220000",
                                                            "LocationCountry": "Belarus"
                                                      },
                                                      {
                                                            "LocationFacility": "The Republican Research and Practical Center for Epidemiology and Microbiology",
                                                            "LocationCity": "Minsk",
                                                            "LocationZip": "220114",
                                                            "LocationCountry": "Belarus"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000014135",
                                                            "ConditionMeshTerm": "Tracheal Stenosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000007829",
                                                            "ConditionMeshTerm": "Laryngostenosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003251",
                                                            "ConditionMeshTerm": "Constriction, Pathologic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000020763",
                                                            "ConditionAncestorTerm": "Pathological Conditions, Anatomical"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014133",
                                                            "ConditionAncestorTerm": "Tracheal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007818",
                                                            "ConditionAncestorTerm": "Laryngeal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010038",
                                                            "ConditionAncestorTerm": "Otorhinolaryngologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000015619",
                                                            "ConditionAncestorTerm": "Respiratory System Abnormalities"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000013",
                                                            "ConditionAncestorTerm": "Congenital Abnormalities"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M5627",
                                                            "ConditionBrowseLeafName": "Constriction, Pathologic",
                                                            "ConditionBrowseLeafAsFound": "Stenosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16041",
                                                            "ConditionBrowseLeafName": "Tracheal Stenosis",
                                                            "ConditionBrowseLeafAsFound": "Tracheal Stenosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9997",
                                                            "ConditionBrowseLeafName": "Laryngostenosis",
                                                            "ConditionBrowseLeafAsFound": "Laryngeal Stenosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21672",
                                                            "ConditionBrowseLeafName": "Pathological Conditions, Anatomical",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16039",
                                                            "ConditionBrowseLeafName": "Tracheal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9987",
                                                            "ConditionBrowseLeafName": "Laryngeal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12113",
                                                            "ConditionBrowseLeafName": "Otorhinolaryngologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12",
                                                            "ConditionBrowseLeafName": "Congenital Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17372",
                                                            "ConditionBrowseLeafName": "Respiratory System Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC09",
                                                            "ConditionBrowseBranchName": "Ear, Nose, and Throat Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 29,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02285673",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "DMD-UC-MSC-1"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Acibadem University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy",
                                          "OfficialTitle": "Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy: Phase 1/2 Study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2014",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "November 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "February 2015",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "November 2015",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "November 5, 2014",
                                          "StudyFirstSubmitQCDate": "November 6, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "November 7, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "November 6, 2014",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 7, 2014",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Ercument Ovali",
                                                "ResponsiblePartyInvestigatorTitle": "Specialist, Haematology",
                                                "ResponsiblePartyInvestigatorAffiliation": "Acibadem University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Acibadem University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Duchenne muscular dystrophy (DMD) is a genetic disorder caused by an absence of dystrophin and characterized by progressive muscle degeneration. There is no cure for DMD at present but, there are several strategies under-researched for treatment of DMD such as steroid treatment, gene theraphy, exon skipping, stop codon read through and gene repair, cell theraphy and theraphy with drug that help to produce utrophin protein.\n\nThe aim of this study is investigate the eficacy of human umblical cord mesenchymal stem cells on DMD and understanding if wild type gene can be transfered to the patient."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Duchenne Muscular Dystrophy"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "umbilical cord, mesenchymal stem cell"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Umbilical Cord Mesenchymal Stem Cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Umbilical Cord Mesenchymal Stem Cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Umbilical Cord Mesenchymal Stem Cell",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Umbilical Cord Mesenchymal Stem Cell"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Duchenne muscular dystrophy gene expression",
                                                            "PrimaryOutcomeTimeFrame": "up to 9 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\n- Patients with diagnosis of DMD that is proven clinically and genetically Age between 7-20 Patients need partial respiratory support, during the day Patients have less than or equal to stage I NIH, Liver, renal and cardiac function Patients without cancer Patients without allergic disease Patients without bleeding diathesis,\n\nExclusion Criteria:\n\nPatients need complete respiratory support Patients have more than to stage II NIH, Liver, renal and cardiac function Patients have bleeding diathesis and allergic disease",
                                          "HealthyVolunteers": "No",
                                          "Gender": "Male",
                                          "MinimumAge": "7 Years",
                                          "MaximumAge": "20 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Ercument Ovali, Prof.Dr.",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+905325729174",
                                                            "CentralContactEMail": "ercument.ovali@acibademlabcell.com.tr"
                                                      },
                                                      {
                                                            "CentralContactName": "Cengiz Yakicier, Prof.Dr.",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "05362998743",
                                                            "CentralContactEMail": "cengiz.yakicier@asg.com.tr"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Acibadem Labcell",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Istanbul",
                                                            "LocationState": "Uskudar",
                                                            "LocationZip": "34662",
                                                            "LocationCountry": "Turkey",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Ercument Ovali, Prof. Dr.",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+905325729174",
                                                                              "LocationContactEMail": "ercument.ovali@acibadem.com.tr"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "15117830",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res. 2004 Apr 30;94(8):1023-31. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "9891887",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Miller JB, Schaefer L, Dominov JA. Seeking muscle stem cells. Curr Top Dev Biol. 1999;43:191-219. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "21784508",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, Garralda ME, Bourke J, Wells DJ, Dickson G, Wood MJ, Wilton SD, Straub V, Kole R, Shrewsbury SB, Sewry C, Morgan JE, Bushby K, Muntoni F. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet. 2011 Aug 13;378(9791):595-605. doi: 10.1016/S0140-6736(11)60756-3. Epub 2011 Jul 23."
                                                      },
                                                      {
                                                            "ReferencePMID": "23907995",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Mendell JR, Rodino-Klapac LR, Sahenk Z, Roush K, Bird L, Lowes LP, Alfano L, Gomez AM, Lewis S, Kota J, Malik V, Shontz K, Walker CM, Flanigan KM, Corridore M, Kean JR, Allen HD, Shilling C, Melia KR, Sazani P, Saoud JB, Kaye EM; Eteplirsen Study Group. Eteplirsen for the treatment of Duchenne muscular dystrophy. Ann Neurol. 2013 Nov;74(5):637-47. doi: 10.1002/ana.23982. Epub 2013 Sep 10."
                                                      },
                                                      {
                                                            "ReferencePMID": "21428760",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Goemans NM, Tulinius M, van den Akker JT, Burm BE, Ekhart PF, Heuvelmans N, Holling T, Janson AA, Platenburg GJ, Sipkens JA, Sitsen JM, Aartsma-Rus A, van Ommen GJ, Buyse G, Darin N, Verschuuren JJ, Campion GV, de Kimpe SJ, van Deutekom JC. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N Engl J Med. 2011 Apr 21;364(16):1513-22. doi: 10.1056/NEJMoa1011367. Epub 2011 Mar 23. Erratum in: N Engl J Med. 2011 Oct 6;365(14):1361."
                                                      },
                                                      {
                                                            "ReferencePMID": "18598348",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Kerkis I, Ambrosio CE, Kerkis A, Martins DS, Zucconi E, Fonseca SA, Cabral RM, Maranduba CM, Gaiad TP, Morini AC, Vieira NM, Brolio MP, Sant'Anna OA, Miglino MA, Zatz M. Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J Transl Med. 2008 Jul 3;6:35. doi: 10.1186/1479-5876-6-35."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "AnnotationSection": {
                                    "AnnotationModule": {
                                          "UnpostedAnnotation": {
                                                "UnpostedResponsibleParty": "Ercument Ovali, Specialist, Haematology, Acibadem University",
                                                "UnpostedEventList": {
                                                      "UnpostedEvent": [
                                                            {
                                                                  "UnpostedEventType": "Release",
                                                                  "UnpostedEventDate": "February 13, 2021"
                                                            },
                                                            {
                                                                  "UnpostedEventType": "Reset",
                                                                  "UnpostedEventDate": "March 4, 2021"
                                                            }
                                                      ]
                                                }
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022",
                                          "SubmissionTracking": {
                                                "SubmissionInfoList": {
                                                      "SubmissionInfo": [
                                                            {
                                                                  "SubmissionReleaseDate": "February 13, 2021",
                                                                  "SubmissionResetDate": "March 4, 2021"
                                                            }
                                                      ]
                                                }
                                          }
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009136",
                                                            "ConditionMeshTerm": "Muscular Dystrophies"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000020388",
                                                            "ConditionMeshTerm": "Muscular Dystrophy, Duchenne"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000020966",
                                                            "ConditionAncestorTerm": "Muscular Disorders, Atrophic"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009135",
                                                            "ConditionAncestorTerm": "Muscular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009468",
                                                            "ConditionAncestorTerm": "Neuromuscular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000040181",
                                                            "ConditionAncestorTerm": "Genetic Diseases, X-Linked"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M11245",
                                                            "ConditionBrowseLeafName": "Muscular Dystrophies",
                                                            "ConditionBrowseLeafAsFound": "Muscular Dystrophy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21338",
                                                            "ConditionBrowseLeafName": "Muscular Dystrophy, Duchenne",
                                                            "ConditionBrowseLeafAsFound": "Duchenne Muscular Dystrophy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3741",
                                                            "ConditionBrowseLeafName": "Atrophy",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11244",
                                                            "ConditionBrowseLeafName": "Muscular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21850",
                                                            "ConditionBrowseLeafName": "Muscular Disorders, Atrophic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11563",
                                                            "ConditionBrowseLeafName": "Neuromuscular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24030",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, X-Linked",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3963",
                                                            "ConditionBrowseLeafName": "Muscular Dystrophy",
                                                            "ConditionBrowseLeafAsFound": "Muscular Dystrophy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T698",
                                                            "ConditionBrowseLeafName": "Becker Muscular Dystrophy",
                                                            "ConditionBrowseLeafAsFound": "Duchenne Muscular Dystrophy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1945",
                                                            "ConditionBrowseLeafName": "Duchenne Muscular Dystrophy",
                                                            "ConditionBrowseLeafAsFound": "Duchenne Muscular Dystrophy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 30,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04078308",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "RI-SCBT-94000019"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "IRCT2016070428786N1",
                                                            "SecondaryIdType": "Registry Identifier",
                                                            "SecondaryIdDomain": "Iranian Registry of Clinical Trials (IRCT)"
                                                      },
                                                      {
                                                            "SecondaryId": "94000019",
                                                            "SecondaryIdType": "Other Grant/Funding Number",
                                                            "SecondaryIdDomain": "Royan Institute"
                                                      },
                                                      {
                                                            "SecondaryId": "REP-441",
                                                            "SecondaryIdType": "Other Grant/Funding Number",
                                                            "SecondaryIdDomain": "Iranian Stem Cell Council, Vice-presidency for Science and Technology, Presidency of the Islamic Republic of Iran"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royan Institute",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients",
                                          "OfficialTitle": "Phase I/II Clinical Trial to Examine the Safety and Efficacy of Transplantation of Mesenchymal Stem Cells in New-onset Type 1 Diabetes Patients",
                                          "Acronym": "MSCTXT1DM"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2019",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "July 6, 2015",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 26, 2019",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 1, 2020",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 24, 2019",
                                          "StudyFirstSubmitQCDate": "September 2, 2019",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 6, 2019",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 2, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 6, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Royan Institute",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Tehran University of Medical Sciences",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Iranian Stem Cell Council",
                                                            "CollaboratorClass": "UNKNOWN"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Study Objects: Diabetes is an autoimmune disease which is mainly caused an immune reaction to beta cells in the pancreas. In this study, mesenchymal stem cells will be used for immune response modulation and improving regeneration. Study design and method: In a Triple blinded randomized placebo-controlled phase I/II clinical trial, 20 patients with newly diagnosed type-1 diabetes who would be visited in Children's Growth and Development Research Center of Tehran University of Medical Sciences and Royan Institute Cell Therapy Center, would be assessed through two groups including the case group and the placebo group. Participants: Patients of both sexes in a range of 8 to 40 years old who have been diagnosed to have type-1 diabetes in no more than 6 weeks, antibody against beta cells diagnosed in their blood, fasting c-peptide more than or equal to 0.3 ng/ml, and are not suffered from other acute or chronic diseases and cancers, would be studied. Interventions: Intravascular transplantation of autologous mesenchymal stem cells in the case group; placebo injection in the control group. Outcome variables: safety and efficacy.",
                                          "DetailedDescription": "Diabetes is an autoimmune disease which is mainly caused by an immune reaction to beta cells in the pancreas. Today, insulin injection is a routine treatment for diabetes. Although injected insulin maintains blood glucose, this method cannot result in physiologic reaction to blood glucose changes. Moreover, patients are encountered with diabetes complications like neuropathy, nephropathy, visual and cardiovascular problems, and hypoglycemic unawareness. Therefore, based on previous studies, a treatment option that leads to pancreatic beta cell restoration and inhibits the immune response to these cells could be a hopeful clinical choice. In this clinical trial, autologous bone marrow-derived mesenchymal stem cells will be used for immune response modulation and improving regeneration. Hence, based on inclusion and exclusion criteria, 20 patients with type-1 diabetes will be selected and after clarifying the procedure and fulfilling the agreement to participate in this trial, they will be sorted in two groups. Bone marrow is aspirated from patients bone and after isolation of Mesenchymal stem cells and characterization of these cells, patients in case group will be intravenously injected by 1 million autologous mesenchymal stem cells per kg of patient's body weight in each dose in week 0 and 3, whereas the control group receives a placebo. Then patients will be followed up for 1 year. During this time, different parameters would be evaluated in weeks 1, 2,4, and Months 2,3,6,9 and 12. Laboratory screenings will be done during this period to evaluate the safety and efficacy of this treatment."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Diabetes Mellitus",
                                                      "Diabetes Mellitus, Type 1",
                                                      "Diabetes Mellitus, Insulin-Dependent"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Diabetes Mellitus",
                                                      "Diabetes Mellitus, Type 1",
                                                      "Cell Transplantation",
                                                      "Autologous Transplantation",
                                                      "Mesenchymal Stem Cell"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Crossover Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cells Transplantation",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "The patients with Type 1 Diabetes, who will receive Intravenous injection of autologous bone-marrow derived mesenchymal stem cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Intravenous Injection of autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "The patients with Type 1 Diabetes, who will receive intravenous injection of normal saline (sodium chloride 0.9%)",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Intravenous injection of placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Intravenous Injection of autologous mesenchymal stem cells",
                                                            "InterventionDescription": "Intravenous injection 1 millions of bone-marrow derived autologous Mesenchymal Stem Cells (MSCs) per kg of patient's body weight in each dose, weeks 0 & 3",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cells Transplantation"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Intravenous injection of placebo",
                                                            "InterventionDescription": "Intravenous injection of normal saline (sodium chloride 0.9%)",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of participants with treatment-related adverse events as assessed by CTCAE v5.0",
                                                            "PrimaryOutcomeDescription": "Safety will be assessed by evaluating patients based on CTCAE (v.5) to assess treatment-related adverse events after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "PrimaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change from baseline number of hypoglycemic Unawareness episodes at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "PrimaryOutcomeDescription": "Number of hypoglycemic unawareness episodes will be assessed by evaluating patients' blood glucose monitoring sheets",
                                                            "PrimaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline Fasting Blood Sugar (FBS) at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing Fasting Blood Sugar (FBS) at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells and compare the results with baseline Fasting Blood Sugar (FBS)",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline C-peptide at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing serum C-peptide at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells and compare the results with baseline serum C-peptide level",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline HbA1C at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing HbA1C at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells and compare the results with baseline HbA1C",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline 2-hour postprandial blood glucose at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing 2-hour postprandial blood glucose at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells and compare the results with baseline 2-hour postprandial blood glucose",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline daily dose of exogenous insulin injected by patients (IU/kg/day) at 12 Months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Exogenous Insulin requirement of patients will be measured based on their daily insulin injection report sheets, total injected insulin units per day will be divided by patient's weight in order to be comparable between different patients.",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from baseline Lability Index (LI) at 12 Months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing 2 weeks of blood glucose report sheets, calculation is based on the changes in blood glucose levels over time",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline SF-36 Quality of life (QOL) questionnaire score at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing change in patients' Quality of life by answering SF-36 questionnaire before transplantation and 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells; This questionnaire asks about general aspects of patients' life.\n\nThe results would be reported as the total score and the scale range is from 0% to 100%. 0% is considered as worse condition and 100% is considered as the best condition.",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Change from Baseline Diabetes Specific Quality of life (DQOL) questionnaire score at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing change in patients' Quality of life by answering Diabetes Specific Quality of Life (DQOL) questionnaire before transplantation and 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells; This questionnaire asks about different aspects of patients' life in relation to diabetes.\n\nThe results would be reported as the total score and the scale range is from 0% to 100%. 0% is considered as worse condition and 100% is considered as the best condition.",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes from baseline Autoantibodies levels in patients' blood at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing patients Islet Cell Antibodies (ICA), Glutamic Acid Decarboxylase Antibodies (GADA), Insulinoma-Associated protein-2 Antibodies (IA-2A) levels after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Changes from baseline serum cytokines levels in patients' blood at 12 months after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeDescription": "Assessing serum cytokines levels of patients after intravenous transplantation of autologous bone marrow derived Mesenchymal Stem Cells",
                                                            "SecondaryOutcomeTimeFrame": "12 months after the first infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion criteria:\n\nType 1 diabetes detection in less than 6 weeks\nDiabetes diagnosis according to American Diabetes Association (ADA)\nPresence of Antibodies against pancreatic beta cells\nFasting C-peptide \u2265 0.3 ng/ml\n\nExclusion Criteria\n\nPregnancy or breastfeeding\nCancer\nAny acute or severe disease (According to physicians' diagnosis: such as cardiac, pulmonary, hepatic, kidney, mental, \u2026 diseases)\nPositive results for: Human Immunodeficiency Virus (HIV), Human T-Lymphotropic Virus (HTLV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Cytomegalovirus (CMV)\nImmune deficient or hyper aesthesia\nHistory of severe ketoacidosis",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "8 Years",
                                          "MaximumAge": "40 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Abdolhossein Shahverdi, PhD",
                                                            "OverallOfficialAffiliation": "Royan Institute, ACECR, Tehran, I.R. Iran",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Hossein Baharvand, PhD",
                                                            "OverallOfficialAffiliation": "Department of Stem Cells Biology and Technology, Cell Science Research Center, Royan Institute for Stem Cells Biology & Technology, ACECR, Tehran, I.R. Iran",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Ali Rabbani, MD",
                                                            "OverallOfficialAffiliation": "Tehran University of Medical Sciences, Tehran, I.R. Iran",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Ensiyeh Hajizadeh saffar, MD,PhD",
                                                            "OverallOfficialAffiliation": "Department of Stem Cells Biology and Technology, Cell Science Research Center, Royan Institute for Stem Cells Biology & Technology, ACECR, Tehran, I.R. Iran",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Royan Institute",
                                                            "LocationCity": "Tehran",
                                                            "LocationZip": "16635-148",
                                                            "LocationCountry": "Iran, Islamic Republic of"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "35725652",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, Hedayati Asl AA, Abbasi Kakroodi F, Jaroughi N, Mohseni Meybodi MA, Setoodeh A, Abbasi F, Hosseini SE, Moeini Nia F, Salman Yazdi R, Navabi R, Hajizadeh-Saffar E, Baharvand H. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial. Stem Cell Res Ther. 2022 Jun 20;13(1):264. doi: 10.1186/s13287-022-02941-w."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Royan Stem Cell webpage",
                                                            "SeeAlsoLinkURL": "http://www.royanstemcell.ir/"
                                                      },
                                                      {
                                                            "SeeAlsoLinkLabel": "Royan Institute webpage",
                                                            "SeeAlsoLinkURL": "http://www.royaninstitute.org/cmsen/index.php"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003922",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 1"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6269",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafAsFound": "Diabetes Mellitus, Type 1",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 31,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02166489",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Royan-Kidney-003"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royan Institute",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease",
                                          "OfficialTitle": "Evaluation the Effect of Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Autosomal Dominant Polycystic Kidney Disease"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2015",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "March 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2015",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "January 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 14, 2014",
                                          "StudyFirstSubmitQCDate": "June 17, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 18, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 3, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 5, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Royan Institute",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study was designed to provide confirmation of safety of mesenchymal stem cells (MSCs) therapy in chronic renal failure due to autosomal dominant polycystic kidney disease (ADPKD).",
                                          "DetailedDescription": "The investigators will assess the 18-month safety and potential efficacy of autologous MSCs as therapy for ADPKD. A total of 6 patients with ADPKD IV injection of high doses 2\u00d7106 of autologous mesenchymal stem cells / kg their weight, which will be derived from biopsies of their bone marrow. Assessments will be made at 1, 3, 6, 12 and 18 months after cell injection. Changes in GFR rate were evaluated by scan isotope."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Chronic Renal Failure",
                                                      "Polycystic Kidney Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "autologous mesenchymal stem cells",
                                                      "polycystic kidney disease",
                                                      "intravenous injection",
                                                      "CRF"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "6",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cell transplantation",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous injection of mesenchymal stem cell in patients with PKD",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Intravenous injection autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Intravenous injection autologous mesenchymal stem cells",
                                                            "InterventionDescription": "Intravenous injection of mesenchymal stem cell in patients with PKD",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cell transplantation"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Mass formation",
                                                            "PrimaryOutcomeDescription": "Evaluation the probability of mass formation in patients with PKD after mesenchyma l stem cell transplantation.",
                                                            "PrimaryOutcomeTimeFrame": "1 month"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Glomerular Filtration Rate (GFR)",
                                                            "SecondaryOutcomeDescription": "Evaluation the acceleration of Glomerular Filtration Rate (GFR) in patients after mesenchymal stem cell transplantation.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMale and Female\nADPKD symptoms\nADPKD confirmed with sonography and genetic testing\nPatient's age between 18 - 60 years\nGFR GFR 25-60 mL/min/1.73 m2\nAbility to understand and willingness to sign consent from\n\nExclusion Criteria:\n\nPregnancy or breastfeeding\nAssociated Cardiovascular disease\nDiabetes requiring medical intervention\nOther systemic diseases involving the kidneys, such as cancer, autoimmune diseases, blood diseases, liver disease, etc.\nHospitalization due to illness in the last two months\nLife expectancy of less than two years\nAny allergies to the ingredients used in the cell culture",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Hamid Gourabi, PhD",
                                                            "OverallOfficialAffiliation": "Head of Royan Institute",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Nasser Aghdami, MD,PhD",
                                                            "OverallOfficialAffiliation": "Head of Department of Regenerative Medicine & Cell therapy center of Royan Institute",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Atieh Makhlough, MD",
                                                            "OverallOfficialAffiliation": "Mazandaran University of Medical Sciences, Mazandaran, Iran.",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Reza Moghadasali, PhD",
                                                            "OverallOfficialAffiliation": "Department of Regenerative Medicine And Royan Cell Therapy Center Royan Institute For stem Cell Biology and Technology",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Royan Institute",
                                                            "LocationCity": "Tehran",
                                                            "LocationCountry": "Iran, Islamic Republic of"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "28535817",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Makhlough A, Shekarchian S, Moghadasali R, Einollahi B, Hosseini SE, Jaroughi N, Bolurieh T, Baharvand H, Aghdami N. Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Res Ther. 2017 May 23;8(1):116. doi: 10.1186/s13287-017-0557-7."
                                                      }
                                                ]
                                          },
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Related Info",
                                                            "SeeAlsoLinkURL": "http://Royaninstitute.org"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007674",
                                                            "ConditionMeshTerm": "Kidney Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000051437",
                                                            "ConditionMeshTerm": "Renal Insufficiency"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000007690",
                                                            "ConditionMeshTerm": "Polycystic Kidney Diseases"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000007676",
                                                            "ConditionMeshTerm": "Kidney Failure, Chronic"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000051436",
                                                            "ConditionMeshTerm": "Renal Insufficiency, Chronic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000014570",
                                                            "ConditionAncestorTerm": "Urologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000052177",
                                                            "ConditionAncestorTerm": "Kidney Diseases, Cystic"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000015",
                                                            "ConditionAncestorTerm": "Abnormalities, Multiple"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000000013",
                                                            "ConditionAncestorTerm": "Congenital Abnormalities"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000072661",
                                                            "ConditionAncestorTerm": "Ciliopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9850",
                                                            "ConditionBrowseLeafName": "Kidney Diseases",
                                                            "ConditionBrowseLeafAsFound": "Kidney Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9851",
                                                            "ConditionBrowseLeafName": "Kidney Failure, Chronic",
                                                            "ConditionBrowseLeafAsFound": "Chronic Renal Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25871",
                                                            "ConditionBrowseLeafName": "Renal Insufficiency",
                                                            "ConditionBrowseLeafAsFound": "Renal Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9864",
                                                            "ConditionBrowseLeafName": "Polycystic Kidney Diseases",
                                                            "ConditionBrowseLeafAsFound": "Polycystic Kidney Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18389",
                                                            "ConditionBrowseLeafName": "Polycystic Kidney, Autosomal Dominant",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25870",
                                                            "ConditionBrowseLeafName": "Renal Insufficiency, Chronic",
                                                            "ConditionBrowseLeafAsFound": "Chronic Renal Failure",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16471",
                                                            "ConditionBrowseLeafName": "Urologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M26136",
                                                            "ConditionBrowseLeafName": "Kidney Diseases, Cystic",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12",
                                                            "ConditionBrowseLeafName": "Congenital Abnormalities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14",
                                                            "ConditionBrowseLeafName": "Abnormalities, Multiple",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M1076",
                                                            "ConditionBrowseLeafName": "Ciliopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T591",
                                                            "ConditionBrowseLeafName": "Autosomal Dominant Multiple Pterygium Syndrome",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 32,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01216865",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSCDF001"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Qingdao University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot",
                                          "OfficialTitle": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2009",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2011"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2012",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 2013",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "October 6, 2010",
                                          "StudyFirstSubmitQCDate": "October 6, 2010",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 7, 2010",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 12, 2010",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 13, 2010",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyOldNameTitle": "Wang, Yangang MD",
                                                "ResponsiblePartyOldOrganization": "Stem Cell Research Center of Medical School Hospital of Qingdao University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Qingdao University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for diabetic foot is safe and effective in the management of diabetic foot ischemia, the therapeutic effect of stem cells is caused by improving blood circulation in ischemic limb which would in turn promote ulcer healing, prevent amputation of limb and relieve the Sevier pain of ischemia.",
                                          "DetailedDescription": "Type 2 diabetic patients with diabetic foot were enrolled and randomized to either transplanted group or control group. Patients in transplanted group received the stem cells treatment,Patients in control group received the standard treatment. After culture in vitro, umbilical cord mesenchymal stem cells should go through safety evaluation which include culture and check of pathogenic microorganisms (bacteria, mycoplasma, chlamydia, eumycete and viruses) of the cells medium and karyotype analysis of the mesenchymal stem cells. Only the safe cells were harvested and transplanted by multiple intramuscular injections into the impaired lower limbs. Follow-up index include: efficacy (pain,ulcer healing rate, lower limb amputation rate and ,ankle-brachial index,magnetic resonance angiography,electromyogram) and safety (infection of the injection site, fever, and tumour generation)."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Diabetic Foot",
                                                      "Critical Limb Ischemia",
                                                      "Mesenchymal Stem Cells",
                                                      "Umbilical Cord"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Diabetic foot",
                                                      "critical limb ischemia",
                                                      "mesenchymal stem cells",
                                                      "umbilical cord"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "50",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Multiple intra muscular injection of mesenchymal stem cells derived from human umbilical cord.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Standard Therapy",
                                                            "ArmGroupType": "Active Comparator",
                                                            "ArmGroupDescription": "Any therapy for diabetic foot which is routinely practiced and accepted in China",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Standard Therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "umbilical cord mesenchymal stem cells",
                                                            "InterventionDescription": "5*10/7 per ischemic limb",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Standard Therapy",
                                                            "InterventionDescription": "Any thing directed to improve blood perfusion in the limb example.Heparin,Antiplatelet agents etc",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Standard Therapy"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Drug therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Angiographic evaluation of angiogenesis at ischemic limb",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Pain",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Ankle-Brachial pressure index",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Wound healing (wound size, wound stage)",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Walking distance",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Rate and extent of amputations",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nDiabetes mellitus Type 2\nAge 18 - 75 years\nSubject has an Ankle-brachial index < 0.9\nSubject has had previous conservative treatment which resulted in little or no improvement\nSubject has had no stem cell treatment within the past 6 months\nNo sufficient response to best standard care delivered for six weeks.\nNo surgical or radiological interventional option for revascularisation as confirmed by a vascular surgeon and an interventional radiologist\nSigned informed consent\nAbsence of life-threatening complications from the ischemic limb\nLife expectancy more than 2 years\nNegative pregnancy test when applicable\n\nExclusion Criteria:\n\nDiabetic retinopathy\nHistory of neoplasm or hematological disease\nUncontrolled high blood pressure (>180/110)\nSevere cardiac insufficiency (New York Heart Association [NYHA] IV) or ejection fraction<30%\nMalignant ventricular arrythmia\nDeep venous thrombosis during the last 3 months\nActive bacterial infection\nBody mass index > 35 Kg/m2\nStroke or myocardial infarction during the last 3 months",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Jianxia Hu, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-0532-82911676",
                                                            "CentralContactEMail": "qdyxyhjx@126.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Hong Gao, MS",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-0532-82911676",
                                                            "CentralContactEMail": "honggaogloria@gmail.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Yangang Wang, MD Phd",
                                                            "OverallOfficialAffiliation": "The Affiliated Hospital of Qingdao University",
                                                            "OverallOfficialRole": "Study Director"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Stem Cell Research Center of Medical School Hospital of Qingdao University",
                                                            "LocationCity": "Qingdao",
                                                            "LocationState": "Shandong",
                                                            "LocationZip": "266003",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Jianxia Hu, MD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "86-0532-82911676",
                                                                              "LocationContactEMail": "qdyxyhjx@126.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Hong Gao, MS",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "86-0532-82911676",
                                                                              "LocationContactEMail": "honggaogloria@gmail.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Yangang Wang, MD PhD",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000017719",
                                                            "ConditionMeshTerm": "Diabetic Foot"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000007511",
                                                            "ConditionMeshTerm": "Ischemia"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003925",
                                                            "ConditionAncestorTerm": "Diabetic Angiopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014652",
                                                            "ConditionAncestorTerm": "Vascular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002318",
                                                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000016523",
                                                            "ConditionAncestorTerm": "Foot Ulcer"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007871",
                                                            "ConditionAncestorTerm": "Leg Ulcer"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012883",
                                                            "ConditionAncestorTerm": "Skin Ulcer"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012871",
                                                            "ConditionAncestorTerm": "Skin Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000048909",
                                                            "ConditionAncestorTerm": "Diabetes Complications"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003920",
                                                            "ConditionAncestorTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003929",
                                                            "ConditionAncestorTerm": "Diabetic Neuropathies"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9695",
                                                            "ConditionBrowseLeafName": "Ischemia",
                                                            "ConditionBrowseLeafAsFound": "Ischemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M19085",
                                                            "ConditionBrowseLeafName": "Diabetic Foot",
                                                            "ConditionBrowseLeafAsFound": "Diabetic Foot",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6272",
                                                            "ConditionBrowseLeafName": "Diabetic Angiopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16552",
                                                            "ConditionBrowseLeafName": "Vascular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18071",
                                                            "ConditionBrowseLeafName": "Foot Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16358",
                                                            "ConditionBrowseLeafName": "Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10035",
                                                            "ConditionBrowseLeafName": "Leg Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14838",
                                                            "ConditionBrowseLeafName": "Skin Ulcer",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14826",
                                                            "ConditionBrowseLeafName": "Skin Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25157",
                                                            "ConditionBrowseLeafName": "Diabetes Complications",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6276",
                                                            "ConditionBrowseLeafName": "Diabetic Neuropathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M8731",
                                                            "InterventionBrowseLeafName": "Heparin",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M45326",
                                                            "InterventionBrowseLeafName": "Calcium heparin",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M13017",
                                                            "InterventionBrowseLeafName": "Platelet Aggregation Inhibitors",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "FiAg",
                                                            "InterventionBrowseBranchName": "Fibrinolytic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AnCoag",
                                                            "InterventionBrowseBranchName": "Anticoagulants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "PlAggInh",
                                                            "InterventionBrowseBranchName": "Platelet Aggregation Inhibitors"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 33,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01941394",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NRCH-MSC"
                                          },
                                          "Organization": {
                                                "OrgFullName": "National Research Center for Hematology, Russia",
                                                "OrgClass": "NETWORK"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells Infusion for aGVHD Prophylaxis Transplantation",
                                          "OfficialTitle": "Pilot Study for Safety and Effectiveness Assessment of Bone Marrow Mesenchymal Stem Cell Infusion for Acute Graft-versus-host Disease Prophylaxis and Treatment After Allogenic Bone Marrow Transplantation"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2013",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 2007"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 2014",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "October 2014",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "August 30, 2013",
                                          "StudyFirstSubmitQCDate": "September 12, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 13, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "September 12, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 13, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Elena N.Parovichnikova",
                                                "ResponsiblePartyInvestigatorTitle": "Head of BMT department",
                                                "ResponsiblePartyInvestigatorAffiliation": "National Research Center for Hematology, Russia"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "National Research Center for Hematology, Russia",
                                                "LeadSponsorClass": "NETWORK"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Infusion of Mesenchymal Stem Cell (MSC) at day of recovery after bone marrow transplant (BMT) for patients with AL, AA and MM for acute Graft-versus-host Disease (GVHD) prophylaxis and treatment.",
                                          "DetailedDescription": "Infusion of mesenchymal stem cells at day of recovery after BMT for patients with AL, AA and MM for acute GVHD prophylaxis and treatment. Infusion at dose 1 cells mln/kg at day of white blood cells recovery."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Graft-versus-host Disease",
                                                      "Relapse"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "GVHD",
                                                      "Relapse",
                                                      "Overall Survival"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Prevention",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "70",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "With MSC",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "infusion of Mesenchymal stem cells at dose 1 mln cells per kg",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Without MSC",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "Without MSC infusion"
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal stem cells",
                                                            "InterventionDescription": "Mesenchymal stem cells infusion",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "With MSC"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Mesenchymal stem cells infusion"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "GVHD",
                                                            "PrimaryOutcomeTimeFrame": "Every 30 day for 1 year after BMT"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Overall survival",
                                                            "SecondaryOutcomeTimeFrame": "Every 30 day for 1 year after BMT"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Relapse-free survival",
                                                            "SecondaryOutcomeTimeFrame": "Every 30 day for 1 year after BMT"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Infection rate",
                                                            "SecondaryOutcomeTimeFrame": "Every 30 day for 1 year after BMT"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nallogenic BMT from related or unrelated donor\n\nExclusion Criteria:\n\nSevere infection\nRelapse\nadmission to ICU\nrefusal of research\npatients with graft failure",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Elena Parovichnikova, Prof MD PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+79161252623",
                                                            "CentralContactEMail": "elenap@blood.ru"
                                                      },
                                                      {
                                                            "CentralContactName": "Larisa Kuzmina, MD PhD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+79161487131",
                                                            "CentralContactEMail": "kuzlara@rambler.ru"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Elena Parovichnikova, Prof MD PhD",
                                                            "OverallOfficialAffiliation": "National Research Center for Hematology",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "BMT department",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Moscow",
                                                            "LocationCountry": "Russian Federation",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Elena Parovichnikova, Prof MD PhD",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "+79161487131",
                                                                              "LocationContactEMail": "kuzlara@rambler.ru"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Elena Parovichnikova",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "22242033",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Kuzmina LA, Petinati NA, Parovichnikova EN, Lubimova LS, Gribanova EO, Gaponova TV, Shipounova IN, Zhironkina OA, Bigildeev AE, Svinareva DA, Drize NJ, Savchenko VG. Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. Stem Cells Int. 2012;2012:968213. doi: 10.1155/2012/968213. Epub 2011 Dec 25."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012008",
                                                            "ConditionMeshTerm": "Recurrence"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000020969",
                                                            "ConditionAncestorTerm": "Disease Attributes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14002",
                                                            "ConditionBrowseLeafName": "Recurrence",
                                                            "ConditionBrowseLeafAsFound": "Relapse",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21853",
                                                            "ConditionBrowseLeafName": "Disease Attributes",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 34,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02824653",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "AFBMTC-GVHD-2015"
                                          },
                                          "Organization": {
                                                "OrgFullName": "National Institute of Blood and Marrow Transplant (NIBMT), Pakistan",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD",
                                          "OfficialTitle": "Allogenic Bone Marrow Mesenchymal Stem Cells Infusion in Patients With Steroid-refractory GVHD- A Phase I/II Clinical Trial"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2017",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2015"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 28, 2016",
                                          "StudyFirstSubmitQCDate": "July 1, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 7, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 24, 2017",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 25, 2017",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "National Institute of Blood and Marrow Transplant (NIBMT), Pakistan",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Graft versus host disease is a serious and often life-threatening complication in allogeneic haematopoietic stem cell transplantation. Although corticosteroids are the first-choice of treatment in these patients, but about 30-50% patients do not respond to it and develop steroid-refractory GVHD. Mesenchymal stem cells (MSC) have emerged as a promising treatment option in these patients. This phase-I/II clinical trial aims at establishing the safety and clinical efficacy of allogenic ex-vivo cultured MSCs to treat steroid-refractory GVHD in a Pakistani HSCT cohort.",
                                          "DetailedDescription": "Allogeneic haematopoietic stem cell transplant has become first choice of treatment for many malignant and non malignant haematological disorders. Although great progress has been made to prevent and minimize transplant-associated complications, yet graft versus host disease (GVHD) remains a significant complication affecting these the outcome in these patients. It is a severe inflammatory condition that arises when recipient tissues are attacked by immune mediated donor T cells during transplantation. Acute GVHD predominately affects the skin, upper and lower GI tract, liver and occasionally the eye and oral mucosa, whereas chronic GVHD resembles more with autoimmune disorders in its clinical symptoms. These symptoms can be organ-specific or generalized throughout body.\n\nThe pathophysiology of GVHD shows that it has different phases. In first phase i.e., afferent phase, damage to host tissue occurs. In second phase i.e., Induction and expansion phase, donor T cells are triggered and activated by recipient and donor APC as well as the inflammatory cytokines. Activated T cells produce IL-2 and IFN-\u03b3 (or Th1 response). Allogeneic immune response is amplified by IL-2, which activates more T cells and natural killer cell responses, triggering macrophages to release TNF-\u03b1 and further inflammation damages skin and gut. The third phase i.e., effector phase, is characterized by cytotoxic damage against host cells by activated donor T-cell-mediated through Fas-Fas ligand interaction, perforin-granzyme and TNF-\u03b1. The latter has a central role in the pathophysiology, stimulating cytokine production (IL-1, IL-6, IL-10, IL-12 and TNF-\u03b1). This dysregulation leads to the clinical manifestations of acute GVHD.\n\nThe cells involved in GVHD pathophysiology include CD4+ T cells; for maintaining the expansion of CD8+ T cells that mediate GVHD, APCs; these have role in the initiation phase of acute GVHD as described in murine models and Natural killer (NK) cells; contribute to tissue damage in the effector phase by releasing inflammatory cytokines and nitric oxide. However, natural killer cells mediate cell death by two important pathways: Fas-Fas-ligand-mediated apoptosis and perforin-granzyme-B-mediated cytolysis.\n\nHLA differences between donor and recipient are the major predictor of GVHD. Other affecting factors include age, gender mismatch between donor and recipient, minor histocomapatability antigen expression difference(mHA) in otherwise identical HSCT, donor age, source and dose of stem cells (PBSCT greater risk than BM), intensity of conditioning and GVHD prophylaxis.\n\nSteroids are the first line therapy for acute GVHD patients and are standard treatment for grade II-IV acute GVHD. Adverse effects of glucocorticoids include hypertension hyperglycemia and psychosis, immunosuppression, infections, myopathy, osteoporosis and avascular necrosis of bone, cataracts and fat re-distribution etc. If acute GVHD is not improved after 5-7 days treatment with steroids then it is considered as steroid-refractory. Various agents that are being investigated from last two decades as second line therapy include low-dose MTX, MMF, extracorporeal photopheresis, IL-2R targeting, antibody therapy against CD3, CD7, CD25, CD52, CD147, IL-2R, IL-1, and TNF-\u03b1 (i.e., basiliximab, daclizumab, denileukin, diftitox and alemtuzumab), horse ATG, etanercept, infliximab, and sirolimus and recently infusions of mesenchymal stem cells.\n\nMesenchymal stem cells (MSCs) are defined as self-renewing, multipotent progenitor cells with potential to differentiate into other cell types of mesodermal origin, such as adipocytes, osteocytes, and chondrocytes. Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy developed the minimal criteria for definition of MSCs which is as follows: first, adherence to plastic; Second, positivity for the cell-surface molecules CD105, CD73, and CD90 and negativity for CD45, CD34, CD14 or CD11b, CD79a or CD19, and human leukocyte antigen (HLA)-DR; and third, the ability to differentiate into osteoblasts, adipocytes, and chondroblasts under standard in vitro differentiation conditions. Since Le Blanc and colleagues first reported successful treatment of a patient with severe acute GVHD using third-party haploidentical MSCs in 2004, many clinical trials worldwide have described the benefits of MSC therapy in GVHD.\n\nThe proposed project is a phase I/II clinical trial of single group, open label, interventional study design. The objective is to observe the safety and efficacy of intravenous injection of ex-vivo expanded bone marrow mesenchymal cells from a third party donor for treating refractory GVHD. The study will also document the type and frequency of any adverse event or side effects, if discovered."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Graft Versus Host Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "acute GVHD",
                                                      "chronic GVHD",
                                                      "steroid-refractory",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "The experimental arm is comprised of GVHD patients receiving allogenic bone marrow mesenchymal stem cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Allogenic Human Bone Marrow Mesenchymal Stem Cells (ex-vivo expanded in pooled human platelet lysate)",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Allogenic Bone Marrow MSCs"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Incidence of treatment-emergent adverse events and complications [Safety and Tolerability]",
                                                            "PrimaryOutcomeDescription": "Safety will be evaluated by reporting any incidence of adverse event, complication and toxicity related to administration of MSCs within 4 weeks of last infusion .",
                                                            "PrimaryOutcomeTimeFrame": "4 weeks"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Acute GVHD-restaging [Efficacy]",
                                                            "PrimaryOutcomeDescription": "Efficacy of ex-vivo expanded allogenic mesenchymal stem cell infusion will be determined by organ-specific re-staging and global grading of Acute GVHD as per consensus group criteria. Response will be measured as complete response (CR), partial response (PR), stable disease(SD) and progressive disease(PD). CR:acute GVHD symptoms and signs disappear; PR:aGVHD symptoms and signs improve; SD:aGVHD symptoms and signs remain (without improvement or deterioration);PD: aGVHD symptoms and signs deteriorate.",
                                                            "PrimaryOutcomeTimeFrame": "4 weeks"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Chronic GVHD-restaging [Efficacy]",
                                                            "PrimaryOutcomeDescription": "Organ-specific scoring and global scoring of chronic GVHD will be done as per NIH consensus criteria of 2014. Treatment response will be measured as complete response (CR), partial response (PR), stable disease(SD) and progressive disease(PD). CR:chronic GVHD symptoms and signs disappear; PR:cGVHD symptoms and signs improve; SD:cGVHD symptoms and signs remain (without improvement or deterioration);PD: cGVHD symptoms and signs deteriorate.",
                                                            "PrimaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Survival analysis at six months after MSC infusion",
                                                            "SecondaryOutcomeDescription": "Documenting patients' survival status after 6 months of receiving MSC infusion\n\nTo document relapse of hematological malignancies post-MSC infusion.\n\nEvaluation of late infectious complications or toxicities after MSC infusion.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence free survival at six months after MSC infusion",
                                                            "SecondaryOutcomeDescription": "To document rate of GVHD recurrence in patients after MSC infusion.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMust fill Informed consent.\nPatient who has undergone allogeneic HSCT and has steroid-refractory grade II-IV acute GVHD.\nPatients who did not respond to treatment options including methylprednisolone, and or cyclosporine A or ATG.\nPatients who despite above mentioned treatment have unresponsive GVHD after 5 days or progressive acute GVHD for more than 72 hours.\nPatients who have received any other treatment and had discontinued for non-responsiveness.\n\nExclusion Criteria:\n\nPoor performance status, not expected to survive 5 days.\nPatients with hypersensitivity to penicillin and/or gentamycin.\nPoor compliance.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "1 Year",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Parvez Ahmed, FCPS, MCPS",
                                                            "OverallOfficialAffiliation": "Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Armed Forces Bone Marrow Transplant Centre",
                                                            "LocationCity": "Rawalpindi",
                                                            "LocationState": "Punjab",
                                                            "LocationZip": "46000",
                                                            "LocationCountry": "Pakistan"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000006086",
                                                            "ConditionMeshTerm": "Graft vs Host Disease"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M8341",
                                                            "ConditionBrowseLeafName": "Graft vs Host Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T2832",
                                                            "ConditionBrowseLeafName": "Homologous Wasting Disease",
                                                            "ConditionBrowseLeafAsFound": "Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T1303",
                                                            "ConditionBrowseLeafName": "Chronic Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T170",
                                                            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 35,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01946048",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "12276102D-Cardiac Disease"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Hebei Medical University",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Ischemic Cardiomyopathy",
                                          "OfficialTitle": "Safety and Efficacy Investigation of Patients With Ischemic Cardiomyopathy by Transplantation of Umbilical Cord Derived Mesenchymal Stem Cells"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "October 2013",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "October 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "October 2013",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2014",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 12, 2013",
                                          "StudyFirstSubmitQCDate": "September 16, 2013",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 19, 2013",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 5, 2013",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 8, 2013",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Quanhai Li",
                                                "ResponsiblePartyInvestigatorTitle": "Director of Cell Thearpy Center, the First Hospital of HeibeiMU",
                                                "ResponsiblePartyInvestigatorAffiliation": "Hebei Medical University"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Hebei Medical University",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy .",
                                          "DetailedDescription": "Coronary artery disease (CAD) is a common disorder that can lead to heart failure. Not all people with CAD are eligible for today's standard treatments. One new treatment approach uses umbilical cord blood derived mesenchymal stem cells-specialized cells capable of developing into other types of cells-to stimulate growth of new blood vessels for the heart. The aim of the present study is to investigate safety and efficacy of intramyocardial implantation of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy ."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Ischemic Cardiomyopathy"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "10",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Stem cells implantation Patients with severe coronary artery disease with ischemic cardiomyopathy managed with intramyocardial administration of allogeneic mesenchymal stem cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cells",
                                                            "InterventionDescription": "Procedure: Selected patients were randomly divided into a cell therapy group and a control group.\n\nUmbilical Cord Blood Derived Mesenchymal Stem Cells at a dose of 150-250 million.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The examination of heart function",
                                                            "PrimaryOutcomeDescription": "Left ventricular ejection fraction\uff1a Change in left ventricular ejection fraction assessed with echocardiography after intramyocardial implantation of allogeneic mesenchymal stem cells.",
                                                            "PrimaryOutcomeTimeFrame": "Post cell transplantation: 1, 3, 6 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "all-cause mortality",
                                                            "SecondaryOutcomeTimeFrame": "Post cell transplantation: one year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "all-cause morbidity",
                                                            "SecondaryOutcomeTimeFrame": "Post cell transplantation: one year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "major adverse cardiac and cerebrovascular events",
                                                            "SecondaryOutcomeTimeFrame": "Post cell transplantation: one year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAge from 30 to 80 years\nischemic cardiomyopathy\nLeft ventricular infarction area seriously low movement to no movement\nThe low whole left ventricular systolic function (LVEF 45% or less)\nHave line or quasi coronary interventional treatment\nWilling to accept patients with follow-up evaluation\nHave signed informed consent form approved by the ethics committee\n\nExclusion Criteria:\n\nNon elevation between S-wave and T-wave in patients with acute myocardial infarction\nNo function damage in patients with acute myocardial infarction\nAcute myocardial infarction complicated with left ventricular aneurysm intends to do surgery\nComplications of acute myocardial infarction with other machines (including: ventricular septal perforation, papillary muscle rupture, etc.)\nAcute infectious diseases\nBlood system diseases, such as thrombocytopenia, severe anemia, leukemia, etc\nSevere renal disease, creatinine clearance < 36 ml/min, serum creatinine > 265 umol/L\nLaboratory tests suggest abnormal liver function, glutamate-pyruvate transaminase (ALT) > 4 times the upper limit of normal\nUnstable cerebral lesions\nmalignant tumor\nCognitive dysfunction and dementia patients, patients with severe mental illness\nPatients with severe physical disabilities can't regular follow-up\nOther serious uncontrolled system disease\nTo prepare or have the pregnancy women patients\nHave a percutaneous coronary intervention contraindications: high-risk patients, such as the digestive tract, and intracranial hemorrhage or contrast allergy\nCannot use the test dose atorvastatin\nIs not completed in accordance with the requirements for test the timing of the magnetic resonance imaging (MRI), PET, SPECT, follow-up testing (e.g., patients with implanted pacemakers or artificial joint)\nPatients unable or unwilling to sign a consent form",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "30 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Baoyong Yan, Doctor",
                                                            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Gang Liu, Doctor",
                                                            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Guoping Ma, Master",
                                                            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Jun Zhang, Master",
                                                            "OverallOfficialAffiliation": "The First Hospital of Hebei Medical University",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "the First Hospital of Hebei Medical University",
                                                            "LocationCity": "Shijiazhuang",
                                                            "LocationState": "Hebei",
                                                            "LocationZip": "050000",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009202",
                                                            "ConditionMeshTerm": "Cardiomyopathies"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000007511",
                                                            "ConditionMeshTerm": "Ischemia"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006331",
                                                            "ConditionAncestorTerm": "Heart Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002318",
                                                            "ConditionAncestorTerm": "Cardiovascular Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9695",
                                                            "ConditionBrowseLeafName": "Ischemia",
                                                            "ConditionBrowseLeafAsFound": "Ischemic",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11306",
                                                            "ConditionBrowseLeafName": "Cardiomyopathies",
                                                            "ConditionBrowseLeafAsFound": "Cardiomyopathy",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8571",
                                                            "ConditionBrowseLeafName": "Heart Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC14",
                                                            "ConditionBrowseBranchName": "Heart and Blood Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 36,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03683953",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Guangdong W CH"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Guangdong Women and Children Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells",
                                          "OfficialTitle": "The Treatment of Bronchopulmonary Dysplasia by Intratracheal Instillation of Mesenchymal Stem Cells"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2018",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 29, 2018",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "August 1, 2019",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "July 1, 2020",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 24, 2018",
                                          "StudyFirstSubmitQCDate": "September 24, 2018",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 25, 2018",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 24, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 25, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "yangjie",
                                                "ResponsiblePartyInvestigatorTitle": "Professor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Guangdong Women and Children Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Guangdong Women and Children Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "To study the effect and saftey of intratracheal instillation of mesenchymal stem cells for treatment BPD",
                                          "DetailedDescription": "This is a Phase 1 clinical trial that constitues two points cohorts with 100 participants per cohort who will receive instillation dose of mesenchymal stem cells-25 million cells/kg,with ventilation after 14 days.And the placebol will be 0.9% sodium choride. The investigator will proceed the groups during the same period.\n\nDeographic Data and Baseline charateristics of the studied groups were collected:\n\nGestational age (weeks) Birth weight (g) gender Cesarean section delivery Antenatal steroids Prolonged rupture of membrane Multiple pregnancies APGAR score at 5 minutes\n\nmesenchymal stem cels dose is 25 million cells/kg\nAssessment the incidence of BPD after instillation of Mesenchymal stem cells\nthe adverse after instillation of Mesenchymal stem cells"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Safety Issues",
                                                      "Effect of Drugs"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "mesenchymal stem cells",
                                                      "safety",
                                                      "effect",
                                                      "BPD"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "200",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Placebo",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "0.9% sodium chloride intratracheal instillate on 14 days after birth",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: 0.9% sodium chloride"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "mesenchymal stem cells intratracheal instillate on 14 days after birth ,dose is 25 million cells/kg",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: mesenchymal stem cells therapy"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "mesenchymal stem cells therapy",
                                                            "InterventionDescription": "mesenchymal stem cells treatement of BPD for safety and effect evaluation0.9% sodium chloride incontrol group",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "0.9% sodium chloride",
                                                            "InterventionDescription": "0.9% sodium chloride in control group",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Placebo"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "number of patients with BPD after instillation mesenchymal stem cells",
                                                            "PrimaryOutcomeDescription": "incidence of BPD",
                                                            "PrimaryOutcomeTimeFrame": "up to 28 days after birth"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\ntwenty-eight weeks to thirty-seven weeks prematures who need ventilaton for 14 days after birth, and the oxygen concentration is more than 30%\n\nExclusion Criteria:\n\nPreterm infants with major congenital malformations, chromosomal anomalies, inborn errors of metabolism and clinical or laboratory evidence of a congenital infection",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "28 Weeks",
                                          "MaximumAge": "37 Weeks",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Zhuxiao Ren, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+8613538984634",
                                                            "CentralContactPhoneExt": "+86",
                                                            "CentralContactEMail": "renzhx1990@163.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Jie Yang, PHD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "39151777",
                                                            "CentralContactPhoneExt": "020",
                                                            "CentralContactEMail": "jieyang0830@163.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Jie Yang, PHD",
                                                            "OverallOfficialAffiliation": "Guangzhou, Guangdong,China\uff0c511442",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "26051681",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Mezey \u00c9, Nemeth K. Mesenchymal stem cells and infectious diseases: Smarter than drugs. Immunol Lett. 2015 Dec;168(2):208-14. doi: 10.1016/j.imlet.2015.05.020. Epub 2015 Jun 4. Review."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000001997",
                                                            "ConditionMeshTerm": "Bronchopulmonary Dysplasia"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000055397",
                                                            "ConditionAncestorTerm": "Ventilator-Induced Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000055370",
                                                            "ConditionAncestorTerm": "Lung Injury"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007235",
                                                            "ConditionAncestorTerm": "Infant, Premature, Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007232",
                                                            "ConditionAncestorTerm": "Infant, Newborn, Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M4425",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27296",
                                                            "ConditionBrowseLeafName": "Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27305",
                                                            "ConditionBrowseLeafName": "Ventilator-Induced Lung Injury",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M25022",
                                                            "ConditionBrowseLeafName": "Premature Birth",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9431",
                                                            "ConditionBrowseLeafName": "Infant, Premature, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9428",
                                                            "ConditionBrowseLeafName": "Infant, Newborn, Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T874",
                                                            "ConditionBrowseLeafName": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafAsFound": "Bronchopulmonary Dysplasia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 37,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01429012",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "TJT1101"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Liege",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting",
                                          "OfficialTitle": "Treatment of Atrophic Nonunion Fractures by Autologous Mesenchymal Stem Cell Percutaneous Grafting. A Randomized, Double-blind, Controlled Study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "May 2021",
                                          "OverallStatus": "Withdrawn",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "November 2012",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2016",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "November 2016",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 1, 2011",
                                          "StudyFirstSubmitQCDate": "September 2, 2011",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 5, 2011",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "May 11, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "May 12, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Yves Beguin",
                                                "ResponsiblePartyInvestigatorTitle": "MD, PhD",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Liege"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Liege",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Bone fractures heal most of the time particularly well and without complications. The solidification takes rarely more than two to three months. The wound healing depends greatly on a good blood supply and needs several steps. These processes culminate in a new mass of heterogeneous tissue which is known as the fracture callus. Unfortunately, 2%-5% bone fractures cannot achieve a proper solidification and between the ununited fragments a scar tissue appears. This incorrect healing induces pain and even infections. When this situation persists more than 6 months, it is referred to as nonunion fracture, which will require some form of intervention to stimulate the natural healing process of the body. First of all, good surgical techniques with stable immobilization should be applied and local infection should be excluded. Then stimulation of the callus is required. Cell therapy with bone marrow cells has emerged as a promising new approach for bone regeneration. Animal studies as well as preliminary human studies have shown that Mesenchymal Stem Cells, a particular kind of stem cells isolated from the bone marrow, could induce callus formation when injected in the nonunion site of a broken bone.\n\nIn this study the investigators aim at determining whether Mesenchymal Stem Cells (MSC) isolated from the patient's bone marrow and injected in the nonunion site could be a safe and effective treatment for nonunion fractures. Patients will be randomized in two groups; one injected with Mesenchymal Stem Cell and the other injected with placebo. The investigators seek also to know how long it takes to develop the callus formation and whether there is a partial or a complete callus formation."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Nonunion Fracture"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "bone",
                                                      "nonunion fracture",
                                                      "atrophic nonunion fracture",
                                                      "callus",
                                                      "mesenchymal stem cells",
                                                      "cell therapy",
                                                      "autologous",
                                                      "indium",
                                                      "Pet-scan"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Quadruple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator",
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "0",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal Stem Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "2 ml with 40 X 10E6 Mesenchymal Stem Cells (MSC) will be injected in the nonunion space of the bone fracture.\n\nMSC will be injected even if the number of available cells is lower than 40 X 10E6.\n\nThe injection of MSC in the nonunion space will be performed percutaneously using a 3-mm trephine needle under fluoroscopic control and loco-regional or general anesthesia, as deemed appropriate by the anesthetist.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Culture medium without MSC.",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Culture medium used to resuspend the Mesenchymal Stem Cells.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Other: Culture medium without MSC."
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Mesenchymal Stem Cells. Dose= 40 X 10E6 in 2 ml. Frequency = one injection. If no evidence of a callus after 6 months a second injection can be proposed.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal Stem Cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Other",
                                                            "InterventionName": "Culture medium without MSC.",
                                                            "InterventionDescription": "2 ml of culture medium.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Culture medium without MSC."
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Safety of Mesenchymal Stem Cells injection in nonunion fractures.",
                                                            "PrimaryOutcomeDescription": "Follow-up for revealing any significant immediate or late adverse effects.",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Proportion of patients receiving Mesenchymal Stem Cells that develop a partial or complete callus at 6 and 12 months, compared to patients receiving placebo.",
                                                            "PrimaryOutcomeDescription": "Radiological evaluation of the callus by standard X-rays and computed tomography (CT).",
                                                            "PrimaryOutcomeTimeFrame": "6 and 12 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Proportion of patients receiving Mensechymal Stem Cells that develop a partial or complete callus at 2, 3, 4, 8 and 10 months, compared to patients receiving placebo",
                                                            "SecondaryOutcomeDescription": "Radiological evaluation of the callus by standard X-rays and computed tomography (CT).",
                                                            "SecondaryOutcomeTimeFrame": "2, 3, 4, 8 and 10 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Timing of development of a partial or complete callus in the 2 groups.",
                                                            "SecondaryOutcomeDescription": "Time necessary for a partial or a complete callus formation. Radiological evaluation of the callus by standard X-rays and computed tomography (CT).",
                                                            "SecondaryOutcomeTimeFrame": "12 months for one injection or 18 months when a second injection is needed"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Patient evaluation of pain and global satisfaction.",
                                                            "SecondaryOutcomeDescription": "This evaluation will be measured through a 100-mm Visual Analogue Scale at 2, 3, 4, 6, 8, 10 and 12 months in the 2 groups.",
                                                            "SecondaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Proportion of patients achieving different degrees of functional success.",
                                                            "SecondaryOutcomeDescription": "The functional assessment will be evaluated in Mesenchymal Stem Cells treated and untreated patients by an orthopaedic surgeon and will include a 4-points scale:\n\n0 = only passive motion allowed\n1 = only active mobilization without any opposition allowed\n2 = active mobilization with some opposition and partial weight-bearing allowed\n3 = weight-bearing and full active mobilization allowed",
                                                            "SecondaryOutcomeTimeFrame": "2, 3, 4, 6, 8, 10 and 12 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Incidence of adverse events and severe adverse events in the 2 groups.",
                                                            "SecondaryOutcomeDescription": "Adverse events and serious adverse events will be continuously monitored .",
                                                            "SecondaryOutcomeTimeFrame": "12 months for one injection and 18 months when a second injection is performed"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Evaluation of early homing of Mesenchymal Stem Cells.",
                                                            "SecondaryOutcomeDescription": "Indium radiolabeled Mesenchymal Stem Cells (MSC) will be visualized with a Siemens e-CAM dual head gamma camera: 10% of the total amount of MSC will be incubated with 200 \u00b5Ci In-111-oxine. The radiolabelled cells will be mixed with the unlabelled ones. Twenty-four hours after injecting the cells into the target bone lesion, static images centered over the injection site and whole-body images will be acquired during 20 minutes. This will be performed with a Siemens e-CAM dual head gamma camera.",
                                                            "SecondaryOutcomeTimeFrame": "24 hours"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Value of [18F]-NaF PET scans for early prediction of the onset of the bone healing process.",
                                                            "SecondaryOutcomeDescription": "PET Fluor kinetics could identify early and perhaps quantify the increase of bone forming in the treated area. Four [18F]-NaF PET scan studies will be performed: at baseline, as well as around days 7-9 (1 week), 27-33 (one month) and 83-97 (three months).",
                                                            "SecondaryOutcomeTimeFrame": "3 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nMale or female; female patients must use a reliable contraception method\nAge \u2265 18 years\nFracture having no radiological callus after 6 months and absence of any hypertrophic bone reaction.\nNo sepsis\nGood skin covering\nBe able and willing to participate in the study\nWritten informed consent\n\nExclusion Criteria:\n\nEvidence of malignancy (except non-melanoma skin cancer) in the past five years\nPregnancy or breastfeeding\nPatient positive by serology or PCR for HIV, hepatitis B or C infection\nInsufficient reduction of the fracture with displaced fragments\nEvidence of local sepsis by clinical signs, biological parameters (CRP) and/or positive isotopic scan using Indium-labelled leucocytes",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Jean Philippe Hauzeur, MD, PhD",
                                                            "OverallOfficialAffiliation": "University of Liege",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Yves Beguin, Prof, MD, PhD",
                                                            "OverallOfficialAffiliation": "University of Liege",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Li\u00e8ge University Hospital",
                                                            "LocationCity": "Li\u00e8ge",
                                                            "LocationZip": "4000",
                                                            "LocationCountry": "Belgium"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000001284",
                                                            "ConditionMeshTerm": "Atrophy"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000050723",
                                                            "ConditionMeshTerm": "Fractures, Bone"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000005599",
                                                            "ConditionMeshTerm": "Fractures, Ununited"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000014947",
                                                            "ConditionAncestorTerm": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020763",
                                                            "ConditionAncestorTerm": "Pathological Conditions, Anatomical"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M25523",
                                                            "ConditionBrowseLeafName": "Fractures, Bone",
                                                            "ConditionBrowseLeafAsFound": "Fracture",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3741",
                                                            "ConditionBrowseLeafName": "Atrophy",
                                                            "ConditionBrowseLeafAsFound": "Atrophic",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7872",
                                                            "ConditionBrowseLeafName": "Fractures, Ununited",
                                                            "ConditionBrowseLeafAsFound": "Nonunion Fracture",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4559",
                                                            "ConditionBrowseLeafName": "Callosities",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21672",
                                                            "ConditionBrowseLeafName": "Pathological Conditions, Anatomical",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M3259",
                                                            "InterventionBrowseLeafName": "Anesthetics",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "CNSDep",
                                                            "InterventionBrowseBranchName": "Central Nervous System Depressants"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 38,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT03068988",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2016/05/25/09"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Hospital Znojmo",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Clinical Study on Mesenchymal Stem Cells Used in the Reconstruction Surgery of the Supraspinatus Muscle Lesions",
                                          "OfficialTitle": "Mesenchymal Stem Cells in the Reconstruction Surgery of the Supraspinatus Muscle Lesions"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2017",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Active, not recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 1, 2012",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 31, 2014",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 31, 2021",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "February 20, 2017",
                                          "StudyFirstSubmitQCDate": "February 25, 2017",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "March 3, 2017",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "September 3, 2017",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 7, 2017",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "MUDr. Petr \u0160m\u00edd",
                                                "ResponsiblePartyInvestigatorTitle": "Prinicpal investigator, Doctor",
                                                "ResponsiblePartyInvestigatorAffiliation": "Hospital Znojmo"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Hospital Znojmo",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No",
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No",
                                          "IsUSExport": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The prospective randomized clinical study investigating the effect of mesenchymal stem cells on tendon healing. The objective of the study is to demonstrate the effect of concentrated bone marrow stem cells ( MSCs ) to the healing of sutured tendon of the supraspinatus muscle in comparison to the same procedure performed without MSCs. We have postulated the hypothesis that MSCs enhance the healing of the sutured supraspinatus tendon to its humeral footprint.",
                                          "DetailedDescription": "The prospective randomized study is carried out at orthopaedic and traumatology, haematology and radiology departments. 50 patients were included in the study. Of the 25 patients in both groups, Group I (received the concentrate of marrow MSCs into the tendon- bone contact point at the site of the suture during surgery ) consisted of 7 women and 18 men ( mean age 51,2 years ), Group II ( without the use of MSCs ) consisted of 15 women and 10 men ( mean age 50,5 years ). Selection of patients into both groups was performed using permutation block randomization computer software Random Number Generator Software 7.0. All of radiographs/MRI/CT results were evaluated by an experienced radiologist specialized in musculoskeletal pathologies, that was blinded to the both groups of patients. Before entering the study, patients signed an informed consent created by the Ethical Committee of local hospital and were randomly assigned to one of the treatment possibilities with use of the Random Number Generator Software 7.0 by the method 1:1.\n\nBefore the surgical treatment, patients completed a questionnaire with VAS score, ASES score ( American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form ) and the Constant score. Further clinical control with completing these questionnaires is 6 months after surgery, 1 year after surgical treatment, 2, 5 and ten years postoperatively. Two years after the surgery MRI examination of the shoulder joint is performed. All of the outpatient clinical evaluations during the study were performed by the orthopaedic surgeon blinded to the both groups of patients.\n\nThe actual therapy was as follows: open surgery was preceded by a standard diagnostic arthroscopy, which was performed from the posterior portal for optics and anterior portal for arthroscopic instruments. The tendons of the rotator cuff were assessed from both sides - intraarticular and subacromial. To evaluate cuff tendon injury perioperatively and to measure the rupture width, a special arthroscopic hook calibrated in 1 mm was used. To evaluate the shape of the rupture, the classification of Ellman - Gartsman was used. Surgical treatment of injured tendons of the rotator cuff was performed in the beach chair position of the patient, by the deltoid muscle split approach. After evaluation of the extent and location of the cuff tendon lesion the aspiration of 10 ml of bone marrow blood was done ( from the humeral head through the same surgical approach ) into a 20 mL syringe prefilled with 0.5 ml of heparin with the Yamshidi needle. Aspiration of the bone marrow was performed by surgeon. From one bone puncture was aspirated maximally 3 ml of marrow blood. Centrifugation of the aspirate in 10 ml test-tube Monovette filled with citrate followed. Selected centrifugation regime consisted of gradient 15 minute centrifugation at 200 g RCF ( relative centrifugal force ). After such a centrifugation the tube contents is divided into three parts. The upper layer consists of the platelet-rich plasma (PRP), the middle layer of the buffy coat with the dominant proportion of leukocytes, and the lower layer is formed by sedimented erythrocytes. Using a sterile laboratory pipette, a collection of the buffy coat was performed. MSCs represented 0.01 to 0.02 % of all nuclear elements of the buffy coat, that is about 10 x 106 / l. The MSCs concentrate ( similar to synovial fluid in consistency and colour ) was impregnated into the collagen patch Hypro-Sorb F ( Otrokovice, Czech Republic ) of dimensions 1x2 cm. The collagen patch as a carrier of the MSCs concentrate was used to ensure its retention in desired place. This material was then inserted between the tendon and bone, into the place of re-fixing of the rotator cuff tendons ( footprint ) before tightening the threads of the anchors. Fixation of the tendon to the bone was made by a double row method with use of absorbable fixation anchors BioComposite Corkscrew ( Arthrex, Munich, Germany ). In all such treated cases the tendon was fixed in place of original attachment without any stress and without the need of abduction of the arm above 60 degrees. All patients underwent Neer acromioplasty for an increase of the subacromial space. This procedure was followed by the standard surgical wound closure in all anatomical layers, sterile dressing of the wound and by applying of the abduction orthosis. All patients were operated by the same orthopaedic surgeon with the same surgical technique. Open surgery instead of arthroscopy was chosen because of the safer fixation of the MSCs carrier under the re-inserted tendon and to reduce the risk of washout of the MSCs concentrate from the carrier during the arthroscopy.\n\nSurgical treatment of patients in Group II was identical as in Group I, except the aspiration of bone marrow from the humeral head and subsequent application of the scaffold saturated with MSCs into the tendon / bone interface.\n\nAbduction fixation lasted for 4 weeks. Passive motion over the horizontal line under the guidance of a physiotherapeutist was initiated the first postoperative day. After removing the fixation, an active rehabilitation began, that is a full range of motion exercises done actively 6 weeks after surgery. Full load was allowed 12 weeks after the surgery.\n\nOutpatient follow-up took place according to the schedule mentioned above. To check the integrity of the tendon at the point of insertion into the greater tuberosity of the humerus, MRI of the shoulder joint was performed 2 years postoperatively. Both, preoperative and postoperative MRI examinations were performed with a 1.5T high-field scanner, in sagittal, coronal, and axial planes, in T1- and T2-weighted fat-saturated sequences ( MRI arthrography using gadollinium as a contrast medium ). All of MRI results were evaluated by an experienced radiologist specialized in musculoskeletal pathologies. He evaluated tendon integrity, presence and localisation of complete retear, tendon and muscle borders, and presence of abnormal artifacts.\n\nThe primary hypothesis of this study is that the use of mesenchymal stem cells in the supraspinatus tendon reconstruction surgery will have a positive effect in the assessment of both subjective and objective scoring systems, and also in terms of reducing the number of tendon reruptures compared to the patients population in which mesenchymal stem cells were not used. All data were statistically analyzed with STATISTICA 9.0 programme. To compare the results of the of the VAS score, the Constant score, and the ASES score preoperatively and one year after the surgery Student\u00b4s t- test was used, to compare the incidence of reruptures between both groups of patients 2 years postoperatively Chi-square test was used. The significance level was determined at p <0.05. Patients were randomly assigned to one of the treatment possibilities with use of the Random Number Generator Software 7.0 by the method 1:1"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Rotator Cuff Tear"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "bone marrow stem cells",
                                                      "rotator cuff lesion"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "50",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "mesenchymal stem cells concentrate into the supraspinatus footprint during the surgery",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "without mesenchymal stem cells",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "rotator cuff surgery without mesenchymal stem cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Procedure: without mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cells",
                                                            "InterventionDescription": "mesenchymal stem cells concentrate into the supraspinatus footprint during the surgery",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Procedure",
                                                            "InterventionName": "without mesenchymal stem cells",
                                                            "InterventionDescription": "rotator cuff surgery without mesenchymal stem cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "without mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The supraspinatus tendon re-rupture rate",
                                                            "PrimaryOutcomeDescription": "presence of the supraspinatus tendon rupture on magnetic resonance imaging evaluated 2 years after the surgery, incidence of rerupture compared between group I- with the use of mesenchymal stem cells and group II- without the use of mesenchymal stem cells",
                                                            "PrimaryOutcomeTimeFrame": "2 years postoperatively"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "visual analogue scale",
                                                            "SecondaryOutcomeDescription": "patients subjectively rate the pain level at 6 grade scale from 0-5 where 0 represents no pain and 5 excruciating pain",
                                                            "SecondaryOutcomeTimeFrame": "1 day before the surgery, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively, 10 years postoperatively"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "ASES score- American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form",
                                                            "SecondaryOutcomeDescription": "Consists of two parts. The first part features a questionnaire filled in by the patients themselves, and included a visual analogue scale for pain and instability and assessment of ability to perform activities of daily living ( ADL ). The second part, which is completed by a doctor, represents an objective assessment of the conditions, and includes the evaluation of range of motion, specific physical characteristics, strength and stability. Score for the arm was then derived from the visual analogue scale for pain (50%) and the general score for ADL (50%).",
                                                            "SecondaryOutcomeTimeFrame": "1 day before the surgery, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively, 10 years postoperatively"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Constant score",
                                                            "SecondaryOutcomeDescription": "Two parts: first- subjective evaluation of ADL ( activities of daily living ) from the patient's perspective, the second part is an objective assessment of range of motion and muscle strength performed by the physician",
                                                            "SecondaryOutcomeTimeFrame": "1 day before the surgery, 6 months postoperatively, 1 year postoperatively, 2 years postoperatively, 5 years postoperatively, 10 years postoperatively"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nmen and women aged 18-60 years\nchronic supraspinatus tendon tear greater than 50% of its width\nno history of trauma to the examined shoulder girdle\nconfirmation by the clinical examination and preoperative imaging examination ( MRI arthrography )\nsigned informed consent\nminimum preoperative haemoglobin concentration in men 13.8 g / dl, in women 12.1 g / dl\n\nExclusion Criteria:\n\nprevious surgical treatment of the rotator cuff\ncuff tear arthropathy grade 3-5 according to Hamada\nfatty degeneration of the cuff muscle ( Goutallier 3 and 4 )\natrophy of the supraspinatus muscle according to the Thomazeau classification grade II and III\nretraction of the supraspinatus muscle tendon Patte III\npregnancy\nactive infection at the surgical site or elsewhere in the body\nosteomyelitis\nsepsis\nhistory of diabetes\nsteroids use\nchemotherapy\nuse of NSAIDs\nradiation\nhepatitis\nHIV\nhemato / oncological diseases\nalcohol abuse\ndrug abuse\ncigarettes\nmedical condition that affects the growth of bone or connective tissue (osteomalacia or other metabolic bone disease)\nvascular insufficiency\noperated extremity muscle atrophy\nneuromuscular disease",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Petr \u0160m\u00edd, Dr.",
                                                            "OverallOfficialAffiliation": "General Hospital Znojmo, Czech Republic",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Petr \u0160m\u00edd",
                                                            "LocationCity": "Znojmo",
                                                            "LocationState": "Czech Republic",
                                                            "LocationZip": "66902",
                                                            "LocationCountry": "Czechia"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "8020238",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Goutallier D, Postel JM, Bernageau J, Lavau L, Voisin MC. Fatty muscle degeneration in cuff ruptures. Pre- and postoperative evaluation by CT scan. Clin Orthop Relat Res. 1994 Jul;(304):78-83."
                                                      },
                                                      {
                                                            "ReferencePMID": "9372778",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Thomazeau H, Boukobza E, Morcet N, Chaperon J, Langlais F. Prediction of rotator cuff repair results by magnetic resonance imaging. Clin Orthop Relat Res. 1997 Nov;(344):275-83."
                                                      },
                                                      {
                                                            "ReferencePMID": "2323151",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Patte D. Classification of rotator cuff lesions. Clin Orthop Relat Res. 1990 May;(254):81-6."
                                                      },
                                                      {
                                                            "ReferencePMID": "22958838",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Richards RR, An KN, Bigliani LU, Friedman RJ, Gartsman GM, Gristina AG, Iannotti JP, Mow VC, Sidles JA, Zuckerman JD. A standardized method for the assessment of shoulder function. J Shoulder Elbow Surg. 1994 Nov;3(6):347-52. doi: 10.1016/S1058-2746(09)80019-0. Epub 2009 Feb 13."
                                                      },
                                                      {
                                                            "ReferencePMID": "3791738",
                                                            "ReferenceType": "result",
                                                            "ReferenceCitation": "Constant CR, Murley AH. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987 Jan;(214):160-4."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "No"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022",
                                          "RemovedCountryList": {
                                                "RemovedCountry": [
                                                      "Czech Republic"
                                                ]
                                          }
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000070636",
                                                            "ConditionMeshTerm": "Rotator Cuff Injuries"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000012421",
                                                            "ConditionAncestorTerm": "Rupture"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014947",
                                                            "ConditionAncestorTerm": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000070599",
                                                            "ConditionAncestorTerm": "Shoulder Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000013708",
                                                            "ConditionAncestorTerm": "Tendon Injuries"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M14393",
                                                            "ConditionBrowseLeafName": "Rupture",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21938",
                                                            "ConditionBrowseLeafName": "Lacerations",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M624",
                                                            "ConditionBrowseLeafName": "Rotator Cuff Injuries",
                                                            "ConditionBrowseLeafAsFound": "Rotator Cuff Tear",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M602",
                                                            "ConditionBrowseLeafName": "Shoulder Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15631",
                                                            "ConditionBrowseLeafName": "Tendon Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 39,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT01377870",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "Royn-nerve-001"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Royan Institute",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis",
                                          "OfficialTitle": "Effect and Side Effect of Mesenchymal Stem Cell in Multiple Sclerosis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "August 2010",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "December 2011"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "March 2014",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "April 2014",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 19, 2011",
                                          "StudyFirstSubmitQCDate": "June 20, 2011",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 21, 2011",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "March 6, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 7, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Royan Institute",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Multiple sclerosis is a multifocal inflammatory disease of the central nervous system which affects young individuals and causes paralysis of the limbs, sensation, visual and sphincter problems. The disease is caused by an autoimmune mechanism, ie the immune system produces antibodies and cells which attack the self myelin antigens, causing therefore demyelination. The disease is clinically evident with relapses of neurological disability due to the dysfunction of the areas (plaques of multiple sclerosis) in which damage of myelin occurs. Disability can accumulate with time and the disease enters a progressive phase due to damage of the axons and irreversible neurodegeneration. Although, effective immunotherapies exist which downregulate the autoimmune anti-myelin reactivity and reduce the rate of relapses of MS (like Copaxone and interferons), there is no effective means today to stop the progression of disability and induce rebuilding of the destroyed myelin.Adult bone marrow derived stromal cells (MSC) were shown to induce similar (to the neuronal stem cells) immunomodulatory and neuroregenerative effects and were shown in our laboratory to induce neuroprotection in the animal model of chronic experimental autoimmune encephalomyelitis (EAE). These bone marrow derived MSCs offer practical advantages for clinical therapeutic applications, since they can be obtained from the adult bone marrow and therefore the patient can be the donor for himself, without any danger for rejection of the cells. In addition, MSCs carry a safer profile and are less prone to malignant transformation.\n\nOur center will perform a clinical trial with intra venous transplantation of bone marrow derived mesenchymal stem cell.our purpose is to evaluate the safety and feasibility of cell transplantation after 1year following up.",
                                          "DetailedDescription": "In the clinical trial 30 patients with multiple sclerosis who are drug resistance will take apart.Based on inclusion and exclusion criteria patients are chosen.Bone marrow aspiration will be done for all of them under local anesthesia.Patients are randomly divided in 2 groups:case and control. Then mesenchymal stem cells which are separated and prepared will be transplanted by intravenous injection to the patients in case group and the cells which obtain from patients in control group are frozen and inject after 6 months. Patients will be followed by Evaluation of EDSS MSFC RAO Test brain and cervical MRI and quality of life questionnaire after 1th 3th 6th and 12th months after transplantation.all these tests will be done before transplantation as basic evaluation."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Multiple Sclerosis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "multiple sclerosis mesenchymal stem cell intravenous injection"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Double",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "22",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "cell free media",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "15 patients with relapsing remitting multiple sclerosis who receive cell free media",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: injection of cell free media"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cell reciepiants",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Patients with relapsing remitting multiple sclerosis who underwent intravenous injection of mesenchymal stem cells",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: intravenous injection of mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "intravenous injection of mesenchymal stem cells",
                                                            "InterventionDescription": "15 patients with relapsing remitting multiple sclerosis underwent intravenous injection of mesenchymal stem cell",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cell reciepiants"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "stem cell transplantation"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "injection of cell free media",
                                                            "InterventionDescription": "Patients who are in control group underwent media injection but after 6 months they will be transplanted by stem cell.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "cell free media"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "control group"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "MRI metrics changes",
                                                            "PrimaryOutcomeDescription": "evaluate the effect of mesenchymal stem cell transplantation on number of GD positive lesions.",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Brain atrophy",
                                                            "PrimaryOutcomeDescription": "evaluate the effect of mesenchymal stem cell transplantation to improve brain atrophy",
                                                            "PrimaryOutcomeTimeFrame": "12 months"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "number of sever relapses",
                                                            "PrimaryOutcomeDescription": "evaluation the effect of mesenchymal stem cell transplantation on number of sever relapses",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "EDSS",
                                                            "PrimaryOutcomeDescription": "Evaluation the effect of mesenchymal stem cells on progression of disease based on EDSS",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "MSFC",
                                                            "PrimaryOutcomeDescription": "Evaluation the effect of mesenchymal stem cells transplantation on MSFC",
                                                            "PrimaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "quality of life",
                                                            "SecondaryOutcomeDescription": "Evaluation the effect of mesenchymal stem cell transplantation on patients quality of life",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "RAO Test",
                                                            "SecondaryOutcomeDescription": "Evaluation the effect of mesenchymal stem cell transplantation on RAO Test.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "intravenous cell transplantation",
                                                            "SecondaryOutcomeDescription": "evaluation the side effect of intravenous transplantation of mesenchymal stem cell",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nBoth gender\nAge: 18-55years\nDuration of disease: 2-10 years\nRelapsing remitting with drug resistance\nEDSS: 3-6.5\n\nResistance to immunomodulatory and cytotoxic drugs:\n\nAt least 1-2 sever relapse during 1 year drug treatment\nAt least increase 1 point of EDSS during 1 year drug treatment\nSecondary progressive or relapsing multiple sclerosis\nPrimary progressive MS with relapse or GAD positive enhancement\nSecondary progressive MS with relapse\nSecondary progressive MS without relapse:progression of disease with 1 point increase of EDSS during last 18 months\n\nExclusion Criteria:\n\nPregnancy positive test\nUnder treatment with cytotoxic drugs at the same time or during last 3 months\nUnder treatment with immunomodulatory drugs at the same time or during last month\nRelapse of disease 30 days or less than 30 days before transplantation\nPrimary progressive MS with out relapse or GAD positive enhancement",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "55 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Hamid Gourabi, PhD",
                                                            "OverallOfficialAffiliation": "head of Royan Institute",
                                                            "OverallOfficialRole": "Study Chair"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Nasser Aghdami, MD,PhD",
                                                            "OverallOfficialAffiliation": "Head of cell therapy center of Royan Institute",
                                                            "OverallOfficialRole": "Study Director"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Masoud Nabavi, MD",
                                                            "OverallOfficialAffiliation": "scientist and clinician",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Leila Arab, MD",
                                                            "OverallOfficialAffiliation": "Department of regenerative medicine,Royan Institute",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Royan Institute",
                                                            "LocationCity": "Tehran",
                                                            "LocationCountry": "Iran, Islamic Republic of"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "SeeAlsoLinkList": {
                                                "SeeAlsoLink": [
                                                      {
                                                            "SeeAlsoLinkLabel": "Related Info",
                                                            "SeeAlsoLinkURL": "http://Royaninstitute.org"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009103",
                                                            "ConditionMeshTerm": "Multiple Sclerosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012598",
                                                            "ConditionMeshTerm": "Sclerosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020278",
                                                            "ConditionAncestorTerm": "Demyelinating Autoimmune Diseases, CNS"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020274",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases of the Nervous System"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003711",
                                                            "ConditionAncestorTerm": "Demyelinating Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M11212",
                                                            "ConditionBrowseLeafName": "Multiple Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Multiple Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14567",
                                                            "ConditionBrowseLeafName": "Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21251",
                                                            "ConditionBrowseLeafName": "Demyelinating Autoimmune Diseases, CNS",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21247",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases of the Nervous System",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6061",
                                                            "ConditionBrowseLeafName": "Demyelinating Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 40,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02482194",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "AFBMTC-SCI-2013"
                                          },
                                          "Organization": {
                                                "OrgFullName": "National Institute of Blood and Marrow Transplant (NIBMT), Pakistan",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Autologous Mesenchymal Stem Cells Transplantation for Spinal Cord Injury- A Phase I Clinical Study",
                                          "OfficialTitle": "Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells in Patients of Spinal Cord Injury-Phase I Clinical Trial"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "June 2016",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 2016",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "March 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 18, 2015",
                                          "StudyFirstSubmitQCDate": "June 25, 2015",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 26, 2015",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "June 28, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "June 29, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "National Institute of Blood and Marrow Transplant (NIBMT), Pakistan",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Armed Forces Institute of Regenerative Medicine",
                                                            "CollaboratorClass": "FED"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The conventional treatment of spinal cord injury (SCI) includes physical therapy and rehabilitation and in some cases may require surgical intervention. Although improved emergency care and aggressive treatment can help in preventing further damage and even restore minimal sensory functions, still a large proportion of patients suffer with prolonged disabilities. It led neurologists to search out for new treatment options for this otherwise debilitating disorder. Recent advances in research have developed a better understanding of stem cell biology especially their role in tissue repair and regeneration. Encouraging results in pre-clinical phase and limited human trials have proved that stem cells can be safely and effectively delivered to the injured site for regeneration of damaged tissue. Although a variety of cell types have been tried for their role in repair of spinal cord injury, majority of clinical trials employed stem cells taken from bone marrow especially mesenchymal stromal cells (MSC). Bone marrow MSCs are a good choice for regenerative therapies owing to advantages like ease of collection and ex-vivo culturing, immune tolerance and their ability to differentiate into a variety of cell types including neuronal lineage cells. Intravenous application or direct injection of MSCs into cerebrospinal fluid (CSF) via lumber puncture in animal models of SCI and brain trauma had shown that MSCs can migrate towards and integrate into injured spinal tissue and reduce cyst size and increase functional recovery. The literature indicates that acute, sub-acute and chronic injury can be a therapeutic target for MSC grafting. The mechanism of action may however vary among these conditions. In acute phase, MSC administration play anti-inflammatory role, while in sub-acute/chronic setting it may be used as neurostimulator and for cell bridging effect and possibly glial or neuronal cell replacement. The investigators propose a non-randomized, single group, open label, phase-I, interventional study to evaluate the safety and efficacy of intrathecal delivery of patient's own (autologous) bone marrow mesenchymal stem cells for treatment of spinal cord injury. This will include determination of functional recovery (neuro-muscular control and sensation) in the affected area and overall improvement in quality of life of the patients and also take into account any side effects, if observed.",
                                          "DetailedDescription": "The role of regenerative therapies has gained more importance due to increased number of SCI in the wake of recent anti-terrorism operations by the armed forces and non-availability of any curative treatment for this category of patients. The promising results of preliminary clinical trials have proved that adult stem cells especially multipotent mesenchymal stromal cells can be safely injected and well tolerated and have shown functional improvement in SCI patients. The successful treatment in these patients will not only improve functional status of these otherwise debilitating patients, but can also reduce the burden on health care facilities. Mesenchymal stem cells have been shown to promote anatomical and functional recovery in animal models of SCI by promoting tissue sparing, axonal regeneration, and remyelination. Therapeutic effects of MSCs are primarily due to the secretion of soluble factors and the provision of extracellular matrix that provide protection and support repair. MSC are attractive candidates for transplantation into human patients because they can be easily harvested, expanded and banked, or derived directly from the patient allowing for autologous transplantation, obviating the need for immune suppression. In this study patients suffering from sub-acute and chronic phase of spinal cord injury shall be included. Patients will undergo detailed screening through MRI and motor and sensory assessment by ASIA score. Further evaluation will include electromyography (EMG) and tests for electroneurophysiological assessment like nerve conduction velocity (NCV) will also be done. Bone marrow aspiration will be done from iliac crest of the patients, followed by mononuclear cells (MNCs) separation by density gradient centrifugation. MNCs will be washed and cultured in tissue culture flasks. After 48 hours non-adherent cells will be removed from culture. Medium will be changed twice weekly till MSCs reach 70-80 % confluence. At that point MSCs will be harvested and after microbiological and other quality control testing the cellular preparation will be diluted to final concentration and infused by intrathecal injection.\n\nPrimary outcome measure is safety which will be determined by clinical evaluation by two independent neurologists during one month of hospital stay after receiving treatment course.\n\nSecondary outcome measures will include American Spinal Injury Association (ASIA) impairment scale and NCV/EMG."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Spinal Cord Injury"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Spinal cord injury",
                                                      "mesenchymal stem cells",
                                                      "transplantation"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "9",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Autologous mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "use of mesenchymal stem cells as therapeutic intervention for spinal cord injury patients by autologous transplantation",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cells",
                                                            "InterventionDescription": "autologous transplantation of mesenchymal stem cells in spinal cord injury patients",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Autologous mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Number of adverse events",
                                                            "PrimaryOutcomeDescription": "Number of adverse events occurring in given time frame shall be reported to evaluate overall safety of the procedure",
                                                            "PrimaryOutcomeTimeFrame": "1 month"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Sensory and motor strength",
                                                            "SecondaryOutcomeDescription": "Improvement in sensitivity and motor strength will be measured through change in American Spinal Injury Association (ASIA) score from baseline",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Functional Independence",
                                                            "SecondaryOutcomeDescription": "Functional Independence will be measured by FIM scoring",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Muscle strength assessment",
                                                            "SecondaryOutcomeDescription": "Shall be done using Frankel scale",
                                                            "SecondaryOutcomeTimeFrame": "1 year"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients suffering from sub-acute and chronic phase of spinal cord injury\nTraumatic spinal cord injury at the thoracic level\nAmerican Spinal Injury Association (ASIA) impairment scale \"A\"\nConfirmation by MRI of injury level\nTime between injury and enrollment greater than 2 weeks\nAbility to provide informed consent\n\nExclusion Criteria:\n\nAxonic brain injury\nInability to provide consent\nOpen injuries\nActive infectious diseases\nTerminal patients\nNeurodegenerative diseases\nEvidence of meningitis\nCerebral palsy\nPrimary haematologic diseases\nCoagulopathies\nPregnancy\nOther medical complications that contra-indicate surgery, including major respiratory complications\nUse of metal implants close to vascular structures (such as cardiac pacemaker or prosthesis) that contraindicate MRI.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "50 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Parvez Ahmed",
                                                            "OverallOfficialAffiliation": "Commandant Armed Forces Bone Marrow Transplant Center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Armed Forces Bone Marrow Transplant Centre",
                                                            "LocationCity": "Rawalpindi",
                                                            "LocationZip": "46000",
                                                            "LocationCountry": "Pakistan"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "11922856",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Legos JJ, Gopez JJ, Young WF. Non-surgical management of spinal cord injury. Expert Opin Investig Drugs. 2002 Apr;11(4):469-82. Review. Erratum in: Expert Opin Investig Drugs 2002 Nov;11(11):1693."
                                                      },
                                                      {
                                                            "ReferencePMID": "19394407",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Zhang HT, Cheng HY, Cai YQ, Ma X, Liu WP, Yan ZJ, Jiang XD, Xu RX. Comparison of adult neurospheres derived from different origins for treatment of rat spinal cord injury. Neurosci Lett. 2009 Jul 24;458(3):116-21. doi: 10.1016/j.neulet.2009.04.045. Epub 2009 Apr 24."
                                                      },
                                                      {
                                                            "ReferencePMID": "20832402",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Mackay-Sim A, St John JA. Olfactory ensheathing cells from the nose: clinical application in human spinal cord injuries. Exp Neurol. 2011 May;229(1):174-80. doi: 10.1016/j.expneurol.2010.08.025. Epub 2010 Sep 9. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "21476980",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Hern\u00e1ndez J, Torres-Esp\u00edn A, Navarro X. Adult stem cell transplants for spinal cord injury repair: current state in preclinical research. Curr Stem Cell Res Ther. 2011 Sep;6(3):273-87. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "20146557",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Tetzlaff W, Okon EB, Karimi-Abdolrezaee S, Hill CE, Sparling JS, Plemel JR, Plunet WT, Tsai EC, Baptiste D, Smithson LJ, Kawaja MD, Fehlings MG, Kwon BK. A systematic review of cellular transplantation therapies for spinal cord injury. J Neurotrauma. 2011 Aug;28(8):1611-82. doi: 10.1089/neu.2009.1177. Epub 2010 Apr 20. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "22464434",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Karamouzian S, Nematollahi-Mahani SN, Nakhaee N, Eskandary H. Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients. Clin Neurol Neurosurg. 2012 Sep;114(7):935-9. doi: 10.1016/j.clineuro.2012.02.003. Epub 2012 Mar 30."
                                                      },
                                                      {
                                                            "ReferencePMID": "24772239",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Dasari VR, Veeravalli KK, Dinh DH. Mesenchymal stem cells in the treatment of spinal cord injuries: A review. World J Stem Cells. 2014 Apr 26;6(2):120-33. doi: 10.4252/wjsc.v6.i2.120. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "25635918",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "All AH, Gharibani P, Gupta S, Bazley FA, Pashai N, Chou BK, Shah S, Resar LM, Cheng L, Gearhart JD, Kerr CL. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors. PLoS One. 2015 Jan 30;10(1):e0116933. doi: 10.1371/journal.pone.0116933. eCollection 2015."
                                                      },
                                                      {
                                                            "ReferencePMID": "26971680",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Satti HS, Waheed A, Ahmed P, Ahmed K, Akram Z, Aziz T, Satti TM, Shahbaz N, Khan MA, Malik SA. Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study. Cytotherapy. 2016 Apr;18(4):518-22. doi: 10.1016/j.jcyt.2016.01.004."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000013119",
                                                            "ConditionMeshTerm": "Spinal Cord Injuries"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000014947",
                                                            "ConditionMeshTerm": "Wounds and Injuries"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000013118",
                                                            "ConditionAncestorTerm": "Spinal Cord Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002493",
                                                            "ConditionAncestorTerm": "Central Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020196",
                                                            "ConditionAncestorTerm": "Trauma, Nervous System"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15068",
                                                            "ConditionBrowseLeafName": "Spinal Cord Injuries",
                                                            "ConditionBrowseLeafAsFound": "Spinal Cord Injury",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafAsFound": "Injury",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15067",
                                                            "ConditionBrowseLeafName": "Spinal Cord Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4894",
                                                            "ConditionBrowseLeafName": "Central Nervous System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21176",
                                                            "ConditionBrowseLeafName": "Trauma, Nervous System",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 41,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02755922",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "2010-1301-27"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Instituto Mexicano del Seguro Social",
                                                "OrgClass": "OTHER_GOV"
                                          },
                                          "BriefTitle": "Bone Regeneration With Mesenchymal Stem Cells",
                                          "OfficialTitle": "Bone Regeneration in Mandibular Fractures After the Application of Autologous Mesenchymal Stem Cells. Randomized Clinical Trial."
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "April 2016",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 2010"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "September 2010",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2010",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "April 20, 2016",
                                          "StudyFirstSubmitQCDate": "April 26, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 29, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "April 26, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "April 29, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Alejandro Gonzalez-Ojeda",
                                                "ResponsiblePartyInvestigatorTitle": "M.D.,Ph.D., F.A.C.S.",
                                                "ResponsiblePartyInvestigatorAffiliation": "Instituto Mexicano del Seguro Social"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Instituto Mexicano del Seguro Social",
                                                "LeadSponsorClass": "OTHER_GOV"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Mandible fractures are a common cause of facial injury in adults. The autologous mesenchymal stem cell (AMSC) transplantation, is proposed as an alternative to the conventional graft treatment, improving bone neoformation.The objective was to evaluate the effectiveness of AMSCs application in mandibular fractures to reduce regeneration time and increase bone quality.",
                                          "DetailedDescription": "Single blinded controlled clinical trial in patients with mandibular angle fracture. The patients were divided into: Study Group (SG): fracture reduction plus application of AMSCs, Control Group (CG): Same procedure without AMSCs. AMSCs were obtained from adipose tissue , 24 hrs before the procedure. Intensity and density were evaluated in normal bone and fractured bone, at 4 and 12 weeks after surgery using panoramic radiography and computed tomography. (CT)\n\nA total of 20 patients, 10 in each group were included. SG with a mean age of 31.2 \u00b1 6.3 years and CG 29.7 \u00b1 7.2 years, all patients were male. Bone quality at week 4 SG 108.82 \u00b1 3.4 vs CG 93.92 \u00b1 2.6 (p = 0.000) by panoramic radiography, SG 123 \u00b1 4.53 vs CG 99.72 \u00b1 5.72 (p = 0.000) by CT. At week 12: SG 153.53\u00b11.83 vs CG 101.81\u00b14.83 (p= 0.000) by panoramic radiography, SG 165.4 \u00b1 4.2 vs CG 112.05\u00b12.1 (p= 0.000) by CT.\n\nThe application of AMSCs presented at week 4 similar ossification values compared with normal bone and a 36.48 % higher ossification rate at week 12."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Mandibular Fractures"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal Stem Cells",
                                                      "Treatment"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 3"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Single",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Outcomes Assessor"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Fractures with Mesenchymal Stem Cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "10 patients with mandibular fractures were managed by open reduction and internal fixation, with application of autologous mesenchymal stem cells on the fracture site.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Application of autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Fractures without Mesenchymal Stem Cells",
                                                            "ArmGroupType": "No Intervention",
                                                            "ArmGroupDescription": "10 patients with mandibular fractures were managed by open reduction and internal fixation, without application of autologous mesenchymal stem cells on the fracture site."
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Application of autologous mesenchymal stem cells",
                                                            "InterventionDescription": "within the surgical procedure, mesenchymal stem cells, were applied on the fracture site. Imaging by X-ray and CT and imaging analysis was done after fracture repair, at week 4 and week 12",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Fractures with Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change of bone quality",
                                                            "PrimaryOutcomeDescription": "After the procedure, imaging control by X-ray and analysis by software, was done after surgery at weeks 4 and 12. X- ray units: Voxels. Software analysis by Image Processing and Analysis ImageJ 1.43",
                                                            "PrimaryOutcomeTimeFrame": "from the moment of fracture diagnosis to week 4 and week 12 after surgery"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Change of bone quality",
                                                            "PrimaryOutcomeDescription": "After the procedure, imaging control by CT scan and analysis by software, was done after surgery at weeks 4 and 12. CT scan units: Hounsfiled . Software analysis by Image Processing and Analysis ImageJ 1.43",
                                                            "PrimaryOutcomeTimeFrame": "from the moment of fracture diagnosis to week 4 and week 12 after surgery"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of patients with infection ( increase of local temperature, tenderness, leukocyte count >10,000/ \u00b5L, confirmed by Gram stain and blood culture).",
                                                            "SecondaryOutcomeDescription": "Infection suggested by clinical diagnosis increase of leukocyte levels, and confirmed by Gram stain and blood culture of local sample.",
                                                            "SecondaryOutcomeTimeFrame": "from immediate postoperative period to three months after surgery"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of patients with bleeding after surgery (Persistent bleeding, ineffectiveness stopping bleeding using dressings)",
                                                            "SecondaryOutcomeDescription": "Persistent bleeding after surgery, that did not stop by dressings. If this complication developed, it had to be managed by surgical techniques.",
                                                            "SecondaryOutcomeTimeFrame": "from immediate postoperative period to 1 week after surgery"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Number of patients with surgical wound dehiscence (subcutaneous tissue , bone or osteosynthesis material exposed and seen through opened skin )",
                                                            "SecondaryOutcomeDescription": "Clinical signs of dehiscence on the surgical incision, surgical material or bone seen though the skin. This diagnosis is done by clinical findings. Does not need any laboratory or image test.",
                                                            "SecondaryOutcomeTimeFrame": "from immediate postoperative period to one month"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nEntitled patients to the Mexican Institute of Social Security\nPatients with mandibular condyle fractures associated or not to other initial fracture that required Open reduction and internal fixation\nAges from 17 to 59 years\nBoth female and male gender\nPatients who gave their consent to be part of this trial\n\nExclusion Criteria:\n\nPatients younger than 17 years and older than 59 years\nChronic-degenerative diseases, active smoking, collagen disorders\nPatients with signs of infection in the aimed area to treat and in whom the fracture occurred in a longer period than 10 days before their surgery.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "17 Years",
                                          "MaximumAge": "59 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Alejandro Gonzalez Ojeda, M.D., Ph.D.",
                                                            "OverallOfficialAffiliation": "Instituto Mexicano del Seguro Social",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Yes"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000008337",
                                                            "ConditionMeshTerm": "Mandibular Fractures"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000050723",
                                                            "ConditionAncestorTerm": "Fractures, Bone"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014947",
                                                            "ConditionAncestorTerm": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007572",
                                                            "ConditionAncestorTerm": "Jaw Fractures"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008446",
                                                            "ConditionAncestorTerm": "Maxillofacial Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005151",
                                                            "ConditionAncestorTerm": "Facial Injuries"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000006259",
                                                            "ConditionAncestorTerm": "Craniocerebral Trauma"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020196",
                                                            "ConditionAncestorTerm": "Trauma, Nervous System"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012887",
                                                            "ConditionAncestorTerm": "Skull Fractures"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M25523",
                                                            "ConditionBrowseLeafName": "Fractures, Bone",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10480",
                                                            "ConditionBrowseLeafName": "Mandibular Fractures",
                                                            "ConditionBrowseLeafAsFound": "Mandibular Fractures",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16837",
                                                            "ConditionBrowseLeafName": "Wounds and Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9754",
                                                            "ConditionBrowseLeafName": "Jaw Fractures",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10581",
                                                            "ConditionBrowseLeafName": "Maxillofacial Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M20242",
                                                            "ConditionBrowseLeafName": "Facies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7446",
                                                            "ConditionBrowseLeafName": "Facial Injuries",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8501",
                                                            "ConditionBrowseLeafName": "Craniocerebral Trauma",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21176",
                                                            "ConditionBrowseLeafName": "Trauma, Nervous System",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14842",
                                                            "ConditionBrowseLeafName": "Skull Fractures",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC26",
                                                            "ConditionBrowseBranchName": "Wounds and Injuries"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 42,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02945462",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "EDUJCTC"
                                          },
                                          "Organization": {
                                                "OrgFullName": "University of Jordan",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Bone Marrow Mesenchymal Stem Cells in Erectile Dysfunction (ED)",
                                          "OfficialTitle": "The Safety and Efficacy of Using Bone Marrow-derived Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction in Diabetic Patients"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "November 2016",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "September 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "November 2015",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "October 2016",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "October 17, 2016",
                                          "StudyFirstSubmitQCDate": "October 24, 2016",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "October 26, 2016",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "November 15, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "November 16, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Saddam Dmour",
                                                "ResponsiblePartyInvestigatorTitle": "Researcher",
                                                "ResponsiblePartyInvestigatorAffiliation": "University of Jordan"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "University of Jordan",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Recovery of erectile function using bone marrow mesenchymal stem cells (MSCs) after in vitro expansion under restricted culturing conditions.",
                                          "DetailedDescription": "Four diabetic male patients ranging from 25-65 years diagnosed with erectile dysfunction will be selected. This diagnosis is based on medical history, validated questionnaires, physical examinations, laboratory tests and specific diagnostic tests. Patients with any evidence of untreated hypogonadism, current urinary tract or bladder infection, clinically evident penile anatomical deformities, previous penile implant or penile vascular surgery, uncontrolled hypertension or hypotension, reported unstable Cardiovascular diseases, uncontrolled diabetes (HbA1c > 10%), or primary hyperlipidemia will be excluded. The investigators hypothesize that the intracavernous injection of stem cells will facilitate the recovery of erectile function resulting in satisfying clinical outcomes in patients.\n\nThis study was performed:\n\nTo test the safety of autologous intracavernous bone marrow mesenchymal stem cells.\nTo evaluate benefit for the patient concerning recovery of natural erection by performing detailed and specific diagnostic tests prior and post MSCs injection by a team from Jordan University Hospital and Cell Therapy Center in Jordan University.\nTo study the feasibility, indication criteria and application modalities of Bone marrow mesenchymal stem cells for further wider study."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Erectile Dysfunction"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "4",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "autologous mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intervention:\n\nAutologous bone marrow derived stem cells will be injected twice intracavernously to enrolled erectile dysfunction patients",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "autologous mesenchymal stem cells",
                                                            "InterventionDescription": "Patients will be injected with autologous mesenchymal stem cells, intracavernously",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]",
                                                            "PrimaryOutcomeDescription": "Observation of any relevant adverse side effect resulting from the injection. Assessing the safety of autologous Mesenchymal Stem Cells injection",
                                                            "PrimaryOutcomeTimeFrame": "six months"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Assessment the efficacy of intracavernous injection measured by SHIM/IIEF/EHS questionnaire",
                                                            "SecondaryOutcomeDescription": "Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells by Sexual Health Inventory for Men/ International Index for Erectile Function/ Erection Hardness Score (SHIM/IIEF/EHS) questionnaire.\n\nFor every patient tests would be performed at baseline and repeated at 1,3, 6,12, and 18 months post-injection.",
                                                            "SecondaryOutcomeTimeFrame": "18 months"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Evaluation the efficacy of intracavernous injection measured by Dynamic Infusion cavernosometry test.",
                                                            "SecondaryOutcomeDescription": "Assessing the therapeutic benefits of the injected Autologous Mesenchymal Stem Cells by Dynamic Infusion Cavernosometry test at baseline and repeated at 6 months post injection.",
                                                            "SecondaryOutcomeTimeFrame": "6 months"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAdult male patients ranging from 25 to 65 years.\nType 1 or type 2 diabetic patients with a personal history of diabetes \u2265 5 years.\nHistory of chronic erectile dysfunction for at least six months.\nHbA1c \u2264 10%.\nBaseline International Index of Erectile Function (IIEF) score of < 26.\nNot interested or able to use Phosphodiesterase type 5 inhibitor (PDE-5i) drug therapy and willing to forgo these treatments for the first 6 month period following study treatment.\nBody mass index between 20 -30.\nWilling to provide written informed consent, complete questionnaire, and to be available for all baseline treatment and follow up examinations required by protocol.\n\nExclusion Criteria:\n\nUntreated hypogonadism or low serum total testosterone < 200 ng/dl.\nCurrent urinary tract or bladder infection.\nAny medical evidence of any infectious disease.\nClinically evident penile anatomical deformities (e.g., Peyronie's disease) or history of priapism.\nSkin irritation, infection, wound, sore or disruption in the immediate areas of skin entry for penile injection.\nCurrent or previous malignancy.\nPatients with primary hyperlipidemia.\nUse of any non study treatment for erectile dysfunction within 4 weeks of study treatment.\nLack of willingness to continue through 6 months after study treatment.\nAny previous penile implant or penile vascular surgery.\nUncontrolled hypertension or hypotension (systolic blood pressure > 170 or < 90 mm Hg, and diastolic blood pressure > 100 or < 50 mm Hg).\nReported unstable cardiovascular disease (e.g., unstable angina, myocardial infarction within past 6 months, cardiac failure or life-threatening arrhythmia, congestive heart failure) or symptomatic postural hypotension within 6 months before screening.\nBleeding or clotting disorder, use of anticoagulant therapy.\nLab values for complete blood count, prothrombin time/ partial thromboplastin time/international randomized ratio (PT/PTT/INR), Aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatinine falling outside the normal lab values.\nSystemic autoimmune disorder.\nSignificant active systemic or localized infection.\nReceiving immunosuppressant medications.\nHbA1c > 10%.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "Male",
                                          "MinimumAge": "25 Years",
                                          "MaximumAge": "65 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided"
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000007172",
                                                            "ConditionMeshTerm": "Erectile Dysfunction"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000012735",
                                                            "ConditionAncestorTerm": "Sexual Dysfunction, Physiological"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020018",
                                                            "ConditionAncestorTerm": "Sexual Dysfunctions, Psychological"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001523",
                                                            "ConditionAncestorTerm": "Mental Disorders"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M9369",
                                                            "ConditionBrowseLeafName": "Erectile Dysfunction",
                                                            "ConditionBrowseLeafAsFound": "Erectile Dysfunction",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14698",
                                                            "ConditionBrowseLeafName": "Sexual Dysfunction, Physiological",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21026",
                                                            "ConditionBrowseLeafName": "Sexual Dysfunctions, Psychological",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3967",
                                                            "ConditionBrowseLeafName": "Mental Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13625",
                                                            "ConditionBrowseLeafName": "Psychotic Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXS",
                                                            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BXM",
                                                            "ConditionBrowseBranchName": "Behaviors and Mental Disorders"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 43,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02172885",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "EudraCT Number:2012-002553-38"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "Health Department of Spain",
                                                            "SecondaryIdType": "Other Grant/Funding Number",
                                                            "SecondaryIdDomain": "EC10-219"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Hospital de Cruces",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta",
                                          "OfficialTitle": "Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta",
                                          "Acronym": "TERCELOI"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "March 2019",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 2014"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2018",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2018",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "June 12, 2014",
                                          "StudyFirstSubmitQCDate": "June 23, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 24, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "March 22, 2019",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "March 26, 2019",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Clara I. Rodr\u00edguez",
                                                "ResponsiblePartyInvestigatorTitle": "PI Stem Cell Laboratory",
                                                "ResponsiblePartyInvestigatorAffiliation": "Hospital de Cruces"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Hospital de Cruces",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Hospital Universitario Getafe",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Hospital Infantil Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The purpose of this study is to determine the safety and effectiveness of five infusions of characterized HLA-identical MSC in non immunosuppressed children with Osteogenesis Imperfecta (OI).",
                                          "DetailedDescription": "The principal aim of this trial is to assess the safety of non-mutated HLA-identical Mesenchymal stem cell (MSC) transplantation for OI pediatric patients irrespective of treatment with biphosphonates. Since MSC are inherently non-immunogenic and do not elicit proliferation of allogeneic lymphocytes (in co-culture experiments), a cell therapy based on HLA-identical or histocompatible (at least 5 shared out of 6 HLA antigens) allogenic MSC may be accomplished without subjecting the patients to immunosuppressor treatment. Adverse secondary effects due to immunosuppressor treatment will be avoided using this strategy thus patients may benefit from two cellular infusions. The patients will be followed for 2 years post their fifth and last MSC infusion."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Osteogenesis Imperfecta"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Mesenchymal stem cell based therapy",
                                                      "cell infusion"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "2",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Five Mesenchymal Stem Cell infusions",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Mesenchymal Stem Cells",
                                                            "InterventionDescription": "Mesenchymal Stem Cell Infusions",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Adverse Events as a Measure of Safety",
                                                            "PrimaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "bone mineral density",
                                                            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "fracture rate",
                                                            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "growth velocity",
                                                            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "change from baseline in degree of functionality",
                                                            "SecondaryOutcomeDescription": "9 question survey using a Bleck functional scale",
                                                            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "change from baseline in well-being",
                                                            "SecondaryOutcomeDescription": "A 20 item questionnaire designed to evaluate the well-being will be used",
                                                            "SecondaryOutcomeTimeFrame": "up to 2 years post last MSCs infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatient age: older than 6 months and younger than 12 years old.\nPatients with molecular confirmation of mutation in either COL1A1 or COL1A2 genes associated with OI (type III).\nPatients with HLA identical (that shared at least 5/6 antigens) siblings willing to donate bone marrow-MSCs.\nAll patients that fulfil the inclusion criteria regardless of whether or not they are undergoing biphosphonate treatment.\nPatients whose parents or the legal guardians are willing to sign the consent forms to participate in this clinical trial.\n\nExclusion Criteria:\n\nPatient age: older than 12 years old\nPatients lacking confirmation of mutation in either COL1A1 or COL1A2 genes associated with severe deforming OI (type III).\nOther pathological subtypes of OI.\nPatients lacking of HLA identical (that shared at least 5/6 antigens) siblings willing to donate bone marrow-MSCs.\nImmunodeficiencies and any other malignancies.\nParticipation in other clinical trial.\nAny medical or psychiatric condition that in the researcher\u00b4s opinion could affect the patient\u00b4s ability to complete the trial or hamper the participation in the trial.\nPatients whose parents or the legal guardians do not sign the consent forms",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "6 Months",
                                          "MaximumAge": "12 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Clara I. Rodr\u00edguez, Ph. D.",
                                                            "OverallOfficialAffiliation": "BioCruces Health Research Institute/Cruces University Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Hospital Universitario Cruces",
                                                            "LocationCity": "Barakaldo",
                                                            "LocationState": "Bizkaia",
                                                            "LocationZip": "48903",
                                                            "LocationCountry": "Spain"
                                                      },
                                                      {
                                                            "LocationFacility": "Hospital Universitario Getafe",
                                                            "LocationCity": "Getafe",
                                                            "LocationState": "Madrid",
                                                            "LocationCountry": "Spain"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010013",
                                                            "ConditionMeshTerm": "Osteogenesis Imperfecta"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010009",
                                                            "ConditionAncestorTerm": "Osteochondrodysplasias"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001848",
                                                            "ConditionAncestorTerm": "Bone Diseases, Developmental"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001847",
                                                            "ConditionAncestorTerm": "Bone Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000030342",
                                                            "ConditionAncestorTerm": "Genetic Diseases, Inborn"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003095",
                                                            "ConditionAncestorTerm": "Collagen Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M12088",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12084",
                                                            "ConditionBrowseLeafName": "Osteochondrodysplasias",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11195",
                                                            "ConditionBrowseLeafName": "Mucopolysaccharidosis IV",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4278",
                                                            "ConditionBrowseLeafName": "Bone Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4279",
                                                            "ConditionBrowseLeafName": "Bone Diseases, Developmental",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M22839",
                                                            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4306",
                                                            "ConditionBrowseLeafName": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafAsFound": "Osteogenesis Imperfecta",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3909",
                                                            "ConditionBrowseLeafName": "Mucopolysaccharidosis Type IV",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC16",
                                                            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 44,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02116634",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "rokhsareh"
                                          },
                                          "SecondaryIdInfoList": {
                                                "SecondaryIdInfo": [
                                                      {
                                                            "SecondaryId": "stem cell injection in ALS",
                                                            "SecondaryIdType": "Other Identifier",
                                                            "SecondaryIdDomain": "iran national science foundation"
                                                      }
                                                ]
                                          },
                                          "Organization": {
                                                "OrgFullName": "Alzahra Hospital, Iran",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis",
                                          "OfficialTitle": "Phase 1, 2 Study of Mesenchymal Stem Cells Injection in ALS (Amyotrophic Lateral Sclerosis) Patients"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "January 2016",
                                          "OverallStatus": "Withdrawn",
                                          "WhyStopped": "Because economic problems",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "May 2015"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "May 2017",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "May 2017",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "April 6, 2014",
                                          "StudyFirstSubmitQCDate": "April 16, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "April 17, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "January 13, 2016",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "January 14, 2016",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "rokhsareh meamar",
                                                "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorAffiliation": "Alzahra Hospital, Iran"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Alzahra Hospital, Iran",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Whether the mesenchymal injection on ALS patients is effective or not?",
                                          "DetailedDescription": "After and before transplantation, all of the patients will visit by experience neurologist and evaluate with EMG (electromyography) and spirometry procedure and clinical progression of disease."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Amyotrophic Lateral Sclerosis"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "0",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "mesenchymal stem cell",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "intra spinal injection of 1 \u00d710(8) mesenchymal stem cells +10cc normal saline",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cell",
                                                            "InterventionDescription": "intra spinal injection of 1 \u00d710(8) mesenchymal stem cells +10cc normal saline",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "mesenchymal stem cell"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Effect of Intrathecal injection of autologous mesenchymal stem cells in improving the symptoms of ALS",
                                                            "PrimaryOutcomeTimeFrame": "every 6 months up 2 years after transplantation"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "ALS-FRS(functional rating scale) score and EMG scale",
                                                            "SecondaryOutcomeTimeFrame": "before transplatation and at 6 months, 12months, 18 months and 24 months after transplantation"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "FVC (forced vital capacity)and DWSE\u00b1QoL score",
                                                            "SecondaryOutcomeTimeFrame": "before transplantation and every 6 months up 2 years after transplantation"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nsporadic ALS according to escorial criteria\nonset of disease with spinal cord involvement, Less than 3 years of disease onset with disease progression at 6 past months\nmild to moderate spinal and bulbar disability,at least having score3 in swallowing, 2 in chewing and waking in ALS-FRS and FVC(functional vital capacity) equal or more than 50% of prediction amount\nnormal polysomnography\nSigned consent form\n\nExclusion Criteria:\n\npregnancy or lactation,\nvascular disease,diabetes, systemic disease as cancer, autoimmune , liver or hematologic disease\nHospitalization due to serious illness in the last two months\nsurvival time less than two years\nHypersensitivity to any component used in the cell culture",
                                          "HealthyVolunteers": "Accepts Healthy Volunteers",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "60 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "keivan basiri, MD",
                                                            "OverallOfficialAffiliation": "Isfahan neurosciences research center",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Neurosciences Research Center",
                                                            "LocationCity": "Isfahan",
                                                            "LocationZip": "0098311",
                                                            "LocationCountry": "Iran, Islamic Republic of"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000016472",
                                                            "ConditionMeshTerm": "Motor Neuron Disease"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000000690",
                                                            "ConditionMeshTerm": "Amyotrophic Lateral Sclerosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000012598",
                                                            "ConditionMeshTerm": "Sclerosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000019636",
                                                            "ConditionAncestorTerm": "Neurodegenerative Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009468",
                                                            "ConditionAncestorTerm": "Neuromuscular Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000013118",
                                                            "ConditionAncestorTerm": "Spinal Cord Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000002493",
                                                            "ConditionAncestorTerm": "Central Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000057177",
                                                            "ConditionAncestorTerm": "TDP-43 Proteinopathies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000057165",
                                                            "ConditionAncestorTerm": "Proteostasis Deficiencies"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M14567",
                                                            "ConditionBrowseLeafName": "Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M18031",
                                                            "ConditionBrowseLeafName": "Motor Neuron Disease",
                                                            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3176",
                                                            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M20711",
                                                            "ConditionBrowseLeafName": "Neurodegenerative Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11563",
                                                            "ConditionBrowseLeafName": "Neuromuscular Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M15067",
                                                            "ConditionBrowseLeafName": "Spinal Cord Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4894",
                                                            "ConditionBrowseLeafName": "Central Nervous System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27912",
                                                            "ConditionBrowseLeafName": "TDP-43 Proteinopathies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27900",
                                                            "ConditionBrowseLeafName": "Proteostasis Deficiencies",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T349",
                                                            "ConditionBrowseLeafName": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Amyotrophic Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4699",
                                                            "ConditionBrowseLeafName": "Primary Lateral Sclerosis",
                                                            "ConditionBrowseLeafAsFound": "Lateral Sclerosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 45,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT05160831",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "SCforKneeOA"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Southwest Hospital, China",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis",
                                          "OfficialTitle": "Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "December 2021",
                                          "OverallStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 20, 2022",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "January 20, 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "January 20, 2024",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "December 6, 2021",
                                          "StudyFirstSubmitQCDate": "December 6, 2021",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "December 16, 2021",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "December 6, 2021",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "December 16, 2021",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Liu Yang, MD",
                                                "ResponsiblePartyInvestigatorTitle": "Professor of Center for Joint Surgery",
                                                "ResponsiblePartyInvestigatorAffiliation": "Southwest Hospital, China"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Southwest Hospital, China",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study aims to investigate the effectiveness and safety of human umbilical cord mesenchymal stem cell injection in the articular cavity to treat moderate to severe knee osteoarthritis (OA), and whether it can achieve articular cartilage regeneration, reduction of joint pain, and restoration of joint function.",
                                          "DetailedDescription": "There are more than 100 types of arthritis, and the most common ones are rheumatoid arthritis (RA) and osteoarthritis (OA). The main cause of its pathogenesis is the compensatory hyperplasia of the articular cartilage caused by the body's degenerative changes, which will eventually cause the joint to partially or completely lose its function.\n\nIn the past few decades, continuous efforts have been made to treat OA. The treatment of OA changes with the development of the patient's condition. At present, there are many diagnosis and treatment options for knee OA, including conservative treatment and surgical treatment. There is an urgent need for an effective treatment to postpone or terminate the course of OA.\n\nCell therapy for OA has developed rapidly in recent years and has received widespread attention. Mesenchymal stem cells (MSCs) are pluripotent stem cells with potential of self-renewal, proliferation and differentiation. Stem cells are extracted from the patient's body and then implanted back. Their ability of regeneration and reproduction can fill the damaged cartilage tissue, so as to achieve an effective treatment of the joint damage.\n\nThis study aims to investigate the effectiveness and safety of human umbilical cord mesenchymal stem cell injection in the articular cavity to treat moderate to severe knee osteoarthritis (OA), and whether it can achieve articular cartilage regeneration, reduction of joint pain, and restoration of joint function."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Knee Osteoarthritis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "knee joint",
                                                      "osteoarthritis",
                                                      "human umbilical cord mesenchymal stem cells"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Not Applicable"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "50",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Human umbilical cord mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Human umbilical cord mesenchymal stem cells injection is applied for knee OA patients.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Human umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Human umbilical cord mesenchymal stem cells",
                                                            "InterventionDescription": "Human umbilical cord mesenchymal stem cell injection is applied for treating knee OA patients.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Human umbilical cord mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "VAS score",
                                                            "PrimaryOutcomeDescription": "Changes of Visual Analogue Scale (VAS) score after injection",
                                                            "PrimaryOutcomeTimeFrame": "1, 3, 6, 12 months after injection"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Kellgren-Lawrence score",
                                                            "SecondaryOutcomeDescription": "Changes of Kellgren-Lawrence Score",
                                                            "SecondaryOutcomeTimeFrame": "1, 3, 6, 12 months after injection"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Lequesne Index",
                                                            "OtherOutcomeDescription": "Changes of the Lequesne Index",
                                                            "OtherOutcomeTimeFrame": "1, 3, 6, 12 months after injection"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "WOMAC score",
                                                            "OtherOutcomeDescription": "Changes of the Western Ontario and McMaster Universities (WOMAC) Osteoarthritis Index",
                                                            "OtherOutcomeTimeFrame": "1, 3, 6, 12 months after injection"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Symptom Grading Scale",
                                                            "OtherOutcomeDescription": "Changes of Symptom Grading Scale",
                                                            "OtherOutcomeTimeFrame": "1, 3, 6, 12 months after injection"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "SF-12",
                                                            "OtherOutcomeDescription": "Changes of the 12-Item Short Form Survey (SF-12)",
                                                            "OtherOutcomeTimeFrame": "1, 3, 6, 12 months after injection"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nPatients who have no major organ dysfunction.\nDiagnosed as moderate to severe knee osteoarthritis according to internationally recognized criteria: a). Meets the criteria of the \"Guidelines for the Diagnosis and Treatment of Osteoarthritis (2018 Edition)\" revised by the Chinese Medical Association Rheumatology Branch in 2018; b). Meets the criteria of Grade 3 or more according to the American College of Rheumatology (ACR); c).Meets the criteria of Grade \u2162 or more according to Kellgren-Lawrence's OA radiology grading standard.\nThose who have the ability to move independently, except those who use wheelchairs, walkers or crutches, and who have no history of mental illness.\nThere is no obvious contraindication to articular cavity injection in hematology and biochemical testing.\nNo local or systemic infection.\nSubjects and their families understand the clinical trial protocol and agree to participate in the trial, and sign a written Informed Consent.\nPatients whose pain has lasted for more than half a year, and the routine clinical treatment of oral hormones, opioids and other drugs have been ineffective.\n\nExclusion Criteria:\n\nThose who are older than 70 years old or younger than 18 years old, or have no full capacity for civil conduct.\nHIV, hepatitis virus or syphilis virus infection or positive serological test.\nBody mass index (BMI) greater than 30 kg/m2.\nCongenital or acquired knee deformity; severe knee arthritis accompanied by severe varus deformity, with varus greater than 10\u00b0.\nPregnant or lactating women, or women of childbearing age who have a positive pregnancy test within 7 days before receiving treatment.\nComplicated with severe cardiovascular and cerebrovascular, liver, kidney, and endocrine, blood system diseases, malignant tumors, allergies, mental disorders, acute infections or local knee joint infections.\nPatients with immunodeficiency.\nPatients with a history of intra-articular injection within 3 months; patients being treated with immunosuppressive agents and glucocorticoids.\nPatients who are still participating in other clinical trials.\nSubjects who refuse to sign Informed Consent or refuse to participate in this clinical trial.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Fuyou Wang, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "86-23-68765290",
                                                            "CentralContactEMail": "arthro@126.com"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Liu Yang, MD",
                                                            "OverallOfficialAffiliation": "Center for Joint Surgery, Southwest Hospital, China",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      },
                                                      {
                                                            "OverallOfficialName": "Fuyou Wang, MD",
                                                            "OverallOfficialAffiliation": "Center for Joint Surgery, Southwest Hospital, China",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000010003",
                                                            "ConditionMeshTerm": "Osteoarthritis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000020370",
                                                            "ConditionMeshTerm": "Osteoarthritis, Knee"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000001168",
                                                            "ConditionAncestorTerm": "Arthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007592",
                                                            "ConditionAncestorTerm": "Joint Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012216",
                                                            "ConditionAncestorTerm": "Rheumatic Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M21321",
                                                            "ConditionBrowseLeafName": "Osteoarthritis, Knee",
                                                            "ConditionBrowseLeafAsFound": "Knee Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12078",
                                                            "ConditionBrowseLeafName": "Osteoarthritis",
                                                            "ConditionBrowseLeafAsFound": "Osteoarthritis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3628",
                                                            "ConditionBrowseLeafName": "Arthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9773",
                                                            "ConditionBrowseLeafName": "Joint Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 46,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02247973",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "MSC-alternative donor SCT-SAA"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Guangzhou General Hospital of Guangzhou Military Command",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.",
                                          "OfficialTitle": "Phase\u2161Trial of Co-transplantation With Bone Marrow Derived Mesenchymal Stem Cells From Related Donors in Alternative Donor Transplantation of Severe Aplastic Anemia."
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "September 2014",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Enrolling by invitation",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "February 2013"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "February 2017",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "February 2018",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "September 17, 2014",
                                          "StudyFirstSubmitQCDate": "September 19, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 25, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "September 19, 2014",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "September 25, 2014",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Yang Xiao",
                                                "ResponsiblePartyInvestigatorTitle": "Phase\u2161trial of co-transplantation with bone marrow derived mesenchymal stem cells from related donors in alternative donor transplantation of severe aplastic anemia.",
                                                "ResponsiblePartyInvestigatorAffiliation": "Guangzhou General Hospital of Guangzhou Military Command"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Guangzhou General Hospital of Guangzhou Military Command",
                                                "LeadSponsorClass": "OTHER"
                                          },
                                          "CollaboratorList": {
                                                "Collaborator": [
                                                      {
                                                            "CollaboratorName": "Guangzhou First People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Nanfang Hospital of Southern Medical University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Southern Medical University, China",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "First Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Second Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Third Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Fifth Affiliated Hospital, Sun Yat-Sen University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Guangdong Provincial People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "The Second People's Hospital of GuangDong Province",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "First Affiliated Hospital of Jinan University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "The First Affiliated Hospital of Guangzhou Medical University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Second Affiliated Hospital of Guangzhou Medical University",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Peking University Shenzhen Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      },
                                                      {
                                                            "CollaboratorName": "Shenzhen Second People's Hospital",
                                                            "CollaboratorClass": "OTHER"
                                                      }
                                                ]
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "The study is a phase II trial designed to evaluate the efficacy and safety of co-transplantation with bone marrow derived mesenchymal stem cells from related donors in alternative donor transplantation of severe aplastic anemia.",
                                          "DetailedDescription": "Aplastic anemia (AA) is an autoimmune hematologic stem cell disease mediated by activated T-lymphocytes that leads to bone marrow dysfunction. In the presence of an empty marrow, pancytopenia, and transfusion dependence, the severity of the disease is based on neutrophil (PMN) count: nonsevere AA (nSAA; PMN > 0.5 \u00d7 109/L), severe AA (SAA;PMN 0.2- 0.5 \u00d7 109/L), and very severe AA (vSAA; PMN< 0.2 \u00d7 109/L).\n\nAllogeneic BMT from an HLA-identical sibling donor or matched-alternative donor is the treatment of choice for patients with aplastic anaemia.Transplantation for patients with severe aplastic anaemia from an HLA identical sibling donor is now very successful with a 75-90% chance of long term cure and with overall survival of between 65% and 73% at 5 years for matched-alternative donor transplantation. However, these two approachs are limited by the availability of HLA-matched donors.\n\nPatients without HLA-identical sibling donor or matched-alternative donor can be offered immunosuppressive treatment (IST) involving injections of Anti-thymocyte globulin (ATG) in combination with cyclosporine (CsA). The treatment response with ATG is at best between 60-80%, 30%-40% patients relapse following an initial response to treatment. Moreover, a recent study has shown that on multivariate analysis of response at 6 months, only younger age, absolute reticulocyte count (ARC) and absolute lymphocyte count (ALC), correlate with response to ATG. Patients with SAA or vSAA, with much lower ARC and ALC, were poor response to IST and have high risks of dying of infection and bleeding.\n\nNowadays, with advances in transplant technology, HLA-mismatched related donors and unrelated donors transplantation has achieved good clinical results. Data from the XJ Huang indicated that patients with HLA-mismatched related donors achieved 100% donor myeloid engraftment and have a survival rate of 64.6\u00b112.4%. Retrospectively analyzed results for 154 patients with acquired SAA who received BMT from unrelated donors identified through the Japan Marrow Donor Program showed the probability of OS at 5 years was 56% (95% confidence interval, 34%-78%).\n\nCompared with malignant disease, mismatched related donor or unrelated donor HSCT for SAA involves distinct challenges mainly associated with high graft failure and high GVHD. So, if we can find a way to promote implantation meanwhile prevent or reduce GVHD , the efficacy of HLA-mismatched related donors transplantation can improve.\n\nMesenchymal stem cells (MSCs) are multi-potent non-hematopoietic progenitors mainly found in BM, cord blood, and adipose tissue. MSCs are attractive because of the ease with which they can be isolated and expanded ex vivo, their ability to undergo multilineage differentiation, and their lack of immunogenicity. These cells were shown to provide support for the growth and differentiation of hematopoietic progenitor cells in BM micro-environments. In additon, preliminary studies have shown clinical effectiveness of allogeneic MSC in the treatment of refractory graft-versus-host disease and an improvement in or resolution of severe aGVHD when co-transplantation with MSCs. Due to these properties, MSCs have become an interesting candidate for use in cellular therapy and are considered \"theoretically perfect cells\" for potential clinical use against AA mismatched related donors transplantation."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Severe Aplastic Anemia"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "100",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Mesenchymal stem cells",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Intravenous bone marrow derived mesenchymal stem cells infusion from related donor to patients with severe aplastic anemia.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cells",
                                                            "InterventionDescription": "Intravenous administration of up to 1~2x10^6 MSCs per kg,for 2 times,d0 and d14",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "Multipotent Mesenchymal Stromal Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "mesenchymal stem cells",
                                                            "InterventionDescription": "bone marrow derived mesenchymal stem cells from related donors.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "survival rate",
                                                            "PrimaryOutcomeDescription": "The 2-year disease-free survival and overall survival.",
                                                            "PrimaryOutcomeTimeFrame": "up to 2 years after HSCT"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "acute GVHD",
                                                            "SecondaryOutcomeDescription": "The incidence of acute GVHD after HSCT.",
                                                            "SecondaryOutcomeTimeFrame": "UP to 3 months after HSCT"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "chronic GVHD",
                                                            "SecondaryOutcomeDescription": "The incidence of chronic GVHD after HSCT.",
                                                            "SecondaryOutcomeTimeFrame": "UP to 2 years after HSCT"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Transplant-related mortality",
                                                            "SecondaryOutcomeTimeFrame": "UP to 1 months after HSCT"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Rates of relapse",
                                                            "SecondaryOutcomeTimeFrame": "UP to 2 years after HSCT"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The implantation",
                                                            "SecondaryOutcomeDescription": "The implantation rate and implantation time.",
                                                            "SecondaryOutcomeTimeFrame": "Up to 4 weeks after HSCT"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nIn line with the 2009 Edition (United Kingdom) aplastic anemia diagnostic criteria for SAA or VSAA;\nAge less than 50 years old,willing to transplant\uff1b\nNo HLA-identical sibling donor\uff1b\nHave HLA-mismatched related donors or unrelated donors ( \u22655/10 HLA matched loci in related donors; \u22658/10 HLA matched loci in unrelated donors )\nNo serious infection or acute hemorrhage;\nCardiac ultrasound examination showed left ventricular ejection fraction is greater than 50%;\nBoth transaminase and serum creatinine level are no more than twice times the upper limit of normal value (ULN);\nNo acute infectious disease;\nAbility to understand and the willingness to sign a written informed consent document.\nECOG score of 0-2 points.\n\nExclusion Criteria:\n\nPatients with severe infection or active bleeding;\nWith severe cardiac insufficiency, left ventricular ejection fraction <50%;\nWith severe liver dysfunction, liver function (ALT and the TBIL) is higher than the ULN 3 times;\nWith severe renal insufficiency, renal function (Cr) is twice higher than the ULN; or 24-hour urine creatinine clearance rate (Ccr) lower than 50ml/min;\nActive tuberculosis, severe acute hepatitis and other infectious diseases in active period;\nECOG score more than 3 points;\nAccompanied by malignant tumors and other clonal disease;\nPoor compliance and the researchers considered unsuitable for MSC infusion.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "14 Years",
                                          "MaximumAge": "50 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Yang Xiao, MD",
                                                            "OverallOfficialAffiliation": "Guangzhou General Hospital of Guangzhou Military Command",
                                                            "OverallOfficialRole": "Study Chair"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Guangzhou General Hospital of Guangzhou Military Command",
                                                            "LocationCity": "Guangzhou",
                                                            "LocationState": "Guangdong",
                                                            "LocationZip": "510010",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "19673883",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, Keidan J, Laurie A, Martin A, Mercieca J, Killick SB, Stewart R, Yin JA; British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol. 2009 Oct;147(1):43-70. doi: 10.1111/j.1365-2141.2009.07842.x. Epub 2009 Aug 10. Review."
                                                      },
                                                      {
                                                            "ReferencePMID": "16205733",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Bacigalupo A, Locatelli F, Lanino E, Marsh J, Soci\u00e9 G, Maury S, Prete A, Locasciulli A, Cesaro S, Passweg J; Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant. 2005 Dec;36(11):947-50."
                                                      },
                                                      {
                                                            "ReferencePMID": "16684959",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA, Territo MC, Collins RH, McSweeney PA, Copelan EA, Khan SP, Woolfrey A, Storer B. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood. 2006 Sep 1;108(5):1485-91. Epub 2006 May 9."
                                                      },
                                                      {
                                                            "ReferencePMID": "20201693",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "George B, Mathews V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients. Pediatr Hematol Oncol. 2010 Mar;27(2):122-31. doi: 10.3109/08880010903540542."
                                                      },
                                                      {
                                                            "ReferencePMID": "12130489",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A, Sakamaki H, Ikuta K, Tsuchida M, Hoshi Y, Morishima Y, Kodera Y. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002 Aug 1;100(3):799-803."
                                                      },
                                                      {
                                                            "ReferencePMID": "12160838",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Noort WA, Kruisselbrink AB, in't Anker PS, Kruger M, van Bezooijen RL, de Paus RA, Heemskerk MH, L\u00f6wik CW, Falkenburg JH, Willemze R, Fibbe WE. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002 Aug;30(8):870-8."
                                                      },
                                                      {
                                                            "ReferencePMID": "15121408",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Le Blanc K, Rasmusson I, Sundberg B, G\u00f6therstr\u00f6m C, Hassan M, Uzunel M, Ringd\u00e9n O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004 May 1;363(9419):1439-41."
                                                      },
                                                      {
                                                            "ReferencePMID": "16732175",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ringd\u00e9n O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, L\u00f6nnies H, Marschall HU, Dlugosz A, Szakos A, Hassan Z, Omazic B, Aschan J, Barkholt L, Le Blanc K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006 May 27;81(10):1390-7."
                                                      },
                                                      {
                                                            "ReferencePMID": "18468541",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringd\u00e9n O; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008 May 10;371(9624):1579-86. doi: 10.1016/S0140-6736(08)60690-X."
                                                      },
                                                      {
                                                            "ReferencePMID": "17638847",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, Locatelli F, Fibbe WE. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007 Oct 1;110(7):2764-7. Epub 2007 Jul 16."
                                                      },
                                                      {
                                                            "ReferencePMID": "18673358",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Fang B, Li N, Song Y, Li J, Zhao RC, Ma Y. Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia. Pediatr Transplant. 2009 Jun;13(4):499-502. doi: 10.1111/j.1399-3046.2008.01002.x. Epub 2008 Jul 30."
                                                      },
                                                      {
                                                            "ReferencePMID": "20380540",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Wang H, Wang Z, Xue M, Liu J, Yan H, Guo Z. Co-transfusion of haplo-identical hematopoietic and mesenchymal stromal cells to treat a patient with severe aplastic. Cytotherapy. 2010 Jul;12(4):563-5. doi: 10.3109/14653241003695059."
                                                      },
                                                      {
                                                            "ReferencePMID": "20724985",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Jaganathan BG, Tisato V, Vulliamy T, Dokal I, Marsh J, Dazzi F, Bonnet D. Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation. Leukemia. 2010 Oct;24(10):1791-5. doi: 10.1038/leu.2010.164. Epub 2010 Aug 19."
                                                      },
                                                      {
                                                            "ReferencePMID": "18769919",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Fang B, Song Y, Li N, Li J, Han Q, Zhao RC. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Ann Hematol. 2009 Mar;88(3):261-6. doi: 10.1007/s00277-008-0599-0. Epub 2008 Sep 4."
                                                      },
                                                      {
                                                            "ReferencePMID": "23731760",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Xiao Y, Jiang ZJ, Pang Y, Li L, Gao Y, Xiao HW, Li YH, Zhang H, Liu Q. Efficacy and safety of mesenchymal stromal cell treatment from related donors for patients with refractory aplastic anemia. Cytotherapy. 2013 Jul;15(7):760-6. doi: 10.1016/j.jcyt.2013.03.007."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000000740",
                                                            "ConditionMeshTerm": "Anemia"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000000741",
                                                            "ConditionMeshTerm": "Anemia, Aplastic"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000006402",
                                                            "ConditionAncestorTerm": "Hematologic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000080983",
                                                            "ConditionAncestorTerm": "Bone Marrow Failure Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001855",
                                                            "ConditionAncestorTerm": "Bone Marrow Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M3222",
                                                            "ConditionBrowseLeafName": "Anemia",
                                                            "ConditionBrowseLeafAsFound": "Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3223",
                                                            "ConditionBrowseLeafName": "Anemia, Aplastic",
                                                            "ConditionBrowseLeafAsFound": "Aplastic Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M8642",
                                                            "ConditionBrowseLeafName": "Hematologic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M12270",
                                                            "ConditionBrowseLeafName": "Pancytopenia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M2241",
                                                            "ConditionBrowseLeafName": "Bone Marrow Failure Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M4286",
                                                            "ConditionBrowseLeafName": "Bone Marrow Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T460",
                                                            "ConditionBrowseLeafName": "Aplastic Anemia",
                                                            "ConditionBrowseLeafAsFound": "Aplastic Anemia",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC15",
                                                            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 47,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT05468502",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "SHLF-MSC-101"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Shanghai Life Science & Technology",
                                                "OrgClass": "INDUSTRY"
                                          },
                                          "BriefTitle": "Phase I/IIa Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)",
                                          "OfficialTitle": "An Open Clinical Study to Explore the Safety, Tolerance and Preliminary Efficacy of Human Umbilical Cord Mesenchymal Stem Cell Injection in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "July 2022",
                                          "OverallStatus": "Not yet recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "August 2022",
                                                "StartDateType": "Anticipated"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "August 2023",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "August 2025",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "July 12, 2022",
                                          "StudyFirstSubmitQCDate": "July 19, 2022",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "July 21, 2022",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "July 29, 2022",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "August 1, 2022",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Shanghai Life Science & Technology",
                                                "LeadSponsorClass": "INDUSTRY"
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Main purpose\n\n-To explore the safety and tolerance of human umbilical cord mesenchymal stem cells in the treatment of idiopathic pulmonary fibrosis (IPF).\n\nSecondary purpose\n\nTo explore the preliminary efficacy of human umbilical cord mesenchymal stem cells in the treatment of idiopathic pulmonary fibrosis (IPF), and to recommend the appropriate dose of cell therapy for subsequent clinical studies.\nTo explore the immunogenicity of human umbilical cord mesenchymal stem cell injection in the treatment of idiopathic pulmonary fibrosis (IPF).\n\nThis study adopts a clinical research design of multi center, single dose and increasing dose.\n\n18 qualified IPF subjects will be included in this study."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Idiopathic Pulmonary Fibrosis"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Idiopathic pulmonary fibrosis",
                                                      "IPF"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "N/A",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "18",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Dose escalation",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Four different doses were set, and three subjects in each dose plan received human umbilical cord mesenchymal stem cell injection successively. Each subject received a single dose of 6.0*10^6, 3.0*10^7, 6.0*10^7, and 9.0*10^7 cells / person.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Drug: Human umbilical cord mesenchymal stem cell injection"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Drug",
                                                            "InterventionName": "Human umbilical cord mesenchymal stem cell injection",
                                                            "InterventionDescription": "Different doses of human umbilical cord mesenchymal stem cell injection were infused to the focus of patients with idiopathic pulmonary fibrosis through bronchoscope, and the tolerance of subjects to different doses of human umbilical cord mesenchymal stem cell injection was observed, and the curative effect was preliminarily observed.",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Dose escalation"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Tolerance of patients with idiopathic fibrosis to human umbilical cord mesenchymal stem cell injection",
                                                            "PrimaryOutcomeDescription": "Incidence and severity of adverse events according to CTCAE5.0",
                                                            "PrimaryOutcomeTimeFrame": "From the first administration to 4 weeks after administration"
                                                      },
                                                      {
                                                            "PrimaryOutcomeMeasure": "Dose exploration of patients with idiopathic fibrosis to human umbilical cord mesenchymal stem cell injection",
                                                            "PrimaryOutcomeDescription": "The maximum tolerable dose (MTD) of a single administration depends on whether dose limiting toxicity (DLT) occurs within 4 weeks after the first administration, for example (1) Hematological toxicity of grade 3 and above caused by the treatment of human umbilical cord mesenchymal stem cell injection,\n\n\uff082\uff09 There are grade 3 and above non hematological toxic reactions caused by the treatment of human umbilical cord mesenchymal stem cell injection, except for the following cases, (3) Any other toxicity related to cell therapy that is higher than the baseline level is judged as clinically significant and / or unacceptable by the investigator and the sponsor, (4) There are acute exacerbations and serious adverse events (SAE) of IPF related to the treatment of human umbilical cord mesenchymal stem cell injection (which may be related, likely to be related and definitely related)",
                                                            "PrimaryOutcomeTimeFrame": "From the first administration to 4 weeks after administration"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Preliminary efficacy evaluation",
                                                            "SecondaryOutcomeDescription": "Changes from baseline in St. George's respiratory questionnaire SGRQ, dyspnea score, cough score and 6-minute walk test (grade and distance)in the treatment of idiopathic pulmonary fibrosis (IPF), and to recommend the appropriate dose of cell therapy for subsequent clinical studies",
                                                            "SecondaryOutcomeTimeFrame": "The 4th, 12th, 24th and 48th week after administration"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Preliminary efficacy evaluation",
                                                            "SecondaryOutcomeDescription": "Changes in lung function (FVC, DLCO sb) compared with baseline",
                                                            "SecondaryOutcomeTimeFrame": "The 4th, 12th, 24th and 48th week after administration"
                                                      }
                                                ]
                                          },
                                          "OtherOutcomeList": {
                                                "OtherOutcome": [
                                                      {
                                                            "OtherOutcomeMeasure": "Preliminary efficacy evaluation",
                                                            "OtherOutcomeDescription": "Changes in abnormal values of routine safety tests (blood routine, urine routine, blood biochemistry, 12 lead ECG, etc.) compared with baseline",
                                                            "OtherOutcomeTimeFrame": "The 4th, 12th, 24th and 48th week after administration"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Preliminary efficacy evaluation",
                                                            "OtherOutcomeDescription": "Changes in chest HRCT scores from baseline",
                                                            "OtherOutcomeTimeFrame": "The 12th, 24th and 48th week after administration"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Preliminary efficacy evaluation",
                                                            "OtherOutcomeDescription": "Changes of lung tumor markers from baseline",
                                                            "OtherOutcomeTimeFrame": "The 12th, 24th and 48th week after administration"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Preliminary efficacy evaluation",
                                                            "OtherOutcomeDescription": "Frequency and severity of acute exacerbations of IPF",
                                                            "OtherOutcomeTimeFrame": "Within 48 weeks after administration"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Immunogenicity of human umbilical cord mesenchymal stem cells",
                                                            "OtherOutcomeDescription": "Changes of specific immunoglobulin G (IgG) from baseline",
                                                            "OtherOutcomeTimeFrame": "The 1st and 4th weeks after administration"
                                                      },
                                                      {
                                                            "OtherOutcomeMeasure": "Immunogenicity of human umbilical cord mesenchymal stem cells",
                                                            "OtherOutcomeDescription": "Cytokines (TNF- \u03b1\u3001 IFN- \u03b3\u3001 Changes of IL-2, IL-4, IL-5 and IL-6) from baseline",
                                                            "OtherOutcomeTimeFrame": "The 1st and 4th weeks after administration"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\n(1) Age 50~75 years old (including the threshold), regardless of gender;\n\n(2) IPF was diagnosed according to the diagnostic guidelines for idiopathic pulmonary fibrosis jointly issued by the American Thoracic Society (ATS), the European Respiratory Society (ERs), the Japanese Respiratory Society (JRS) and the Latin American Thoracic Association (ALAT) in 2018;\n\n(3) Subjects with typical imaging manifestations of IPF (honeycomb, stretch bronchiectasis or bronchiectasis (mainly in ground glass shadow and fine mesh shadow) on HRCT within 12 months before screening;\n\n(4) Within 3 months before administration, the researcher determined that the disease was stable. The pulmonary carbon monoxide diffusion volume (DLCO) was 30% - 79% of the predicted value (corrected by HB value), or FVC was 50% - 80% of the predicted value;\n\n(5) Blood biochemical examination should meet the following standards: alanine aminotransferase (ALT) \u2264 1.5uln, aspartate aminotransferase (AST) \u2264 1.5uln, total bilirubin (TBIL) \u2264 1.5uln, direct bilirubin (DBIL) \u2264 1.5uln, blood creatinine (CR) \u2264 1.5uln;\n\n(6) Expected survival \u2265 12 months;\n\n(7) Subjects who have good compliance, can understand and cooperate with the completion of pulmonary function examination, are willing to take drugs according to the requirements of the protocol and receive follow-up examination on time;\n\n(8) Subjects who voluntarily participated in the trial, understood and signed the informed consent form.\n\nExclusion Criteria:\n\n(1) Have previously received stem cell therapy, or are intolerant to cell therapy, or have taken drugs that may cause or aggravate pulmonary fibrosis (such as amiodarone, bleomycin or methotrexate);\n\n(2) Suffering from interstitial lung disease (ILD) other than IPF, including but not limited to: any other type of interstitial pneumonia; Lung disease related to exposure to fibroblasts or other environmental toxins or drugs; Other types of occupational lung disease; Granulomatous pulmonary disease; Pulmonary vascular disease; Systemic diseases, including vasculitis, infectious diseases (i.e. tuberculosis) and connective tissue diseases;\n\n(3) Those who need oxygen therapy at present (oxygen therapy time 15h/d);\n\n(4) Those who used or planned to use nidanib during the study 1 month before screening;\n\n(5) Subjects with a history of mechanical ventilation or complicated with infectious pneumonia and asthma within 1 month before screening;\n\n(6) Patients with malignant tumors within 5 years before screening;\n\n(7) Those who have been hospitalized for 3 times or more due to acute exacerbation of IPF or other respiratory diseases within 1 year before screening;\n\n(8) There is evidence that the subjects currently have digestive, urinary, cardiovascular, cerebrovascular, hematological, nervous, mental and metabolic diseases that may affect safety, such as type 2 diabetes with poor blood glucose control (fasting blood glucose \u2265 10.0mmol/l or HbA1c \u2265 8.0%), hypertension with poor blood pressure control (\u2265 160/100mmhg), etc;\n\n(9) Have a history of psychotropic drug abuse and drug abuse;\n\n(10) People with known history of immune system (such as thymus disease and systemic lupus erythematosus);\n\n(11) Patients with positive serum Virology (HBsAg, HCV antibody, HIV antibody, Treponema pallidum antibody), including hepatitis B virus carriers, patients with stable hepatitis B after drug treatment (DNA titer \u2264 500iu/ml or copy number < 1000copies/ml) and cured patients with hepatitis C (HCV RNA test negative) can be enrolled after being judged to be qualified by the researcher;\n\n(12) People who are allergic to human albumin, narcotic drugs or their ingredients;\n\n(13) Subjects who participated in any other clinical trials within the first 3 months of screening;\n\n(14) Subjects who cannot tolerate bronchoscopy (including but not limited to the following conditions: active massive hemoptysis; severe hypertension and arrhythmia; myocardial infarction or history of unstable angina pectoris within 4-6 weeks before screening; severe cardiopulmonary dysfunction; uncorrectable bleeding tendency (platelet count < 60 \u00d7 109/l), such as severe coagulation dysfunction, uremia and severe pulmonary hypertension; Severe superior vena cava obstruction syndrome; Suspected aortic aneurysm; Multiple pulmonary bullae; General condition (extreme failure);\n\n(15) The researchers judged that the risk of general anesthesia / local anesthesia was higher;\n\n(16) Human chorionic gonadotrophin in pregnancy or lactation, or screening \u03b2 \uff08 \u03b2- HCG) positive, or unable and unwilling to take effective non drug contraceptives during the study period and 6 months after the end of the study;\n\n(17) Other circumstances that the researcher believes are not suitable for entering this test.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "50 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Baowen Chen, CEO",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "086-13701662450",
                                                            "CentralContactEMail": "glu@shlifestemcell.com"
                                                      },
                                                      {
                                                            "CentralContactName": "Wang Kai, PM",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "086-17601600819",
                                                            "CentralContactEMail": "kwang@shlifestemcell.com"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Shanghai Sixth People's Hospital",
                                                            "LocationCity": "Shanghai",
                                                            "LocationState": "Shanghai",
                                                            "LocationZip": "200233",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "Ren Tao, Doctor of Medicine",
                                                                              "LocationContactRole": "Contact",
                                                                              "LocationContactPhone": "021-64369181",
                                                                              "LocationContactEMail": "rentao305@163.com"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Song Yuanlin, Doctor of Medicine",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        },
                                                                        {
                                                                              "LocationContactName": "Li Feng, Doctor of Medicine",
                                                                              "LocationContactRole": "Principal Investigator"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "27890713",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, Shafazand S, Khan A, Pujol MV, LaRussa VF, Lancaster LH, Rosen GD, Fishman J, Mageto YN, Mendizabal A, Hare JM. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial. Chest. 2017 May;151(5):971-981. doi: 10.1016/j.chest.2016.10.061. Epub 2016 Nov 24."
                                                      },
                                                      {
                                                            "ReferencePMID": "23855653",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Tzouvelekis A, Paspaliaris V, Koliakos G, Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N, Dardzinski B, Gritzalis D, Antoniadis A, Froudarakis M, Kolios G, Bouros D. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. J Transl Med. 2013 Jul 15;11:171. doi: 10.1186/1479-5876-11-171."
                                                      },
                                                      {
                                                            "ReferencePMID": "25039426",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM, Hopkins PM. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology. 2014 Oct;19(7):1013-8. doi: 10.1111/resp.12343. Epub 2014 Jul 9."
                                                      },
                                                      {
                                                            "ReferencePMID": "19497992",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol. 2009 Jul;175(1):303-13. doi: 10.2353/ajpath.2009.080629. Epub 2009 Jun 4."
                                                      },
                                                      {
                                                            "ReferencePMID": "21569606",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Hass R, Kasper C, B\u00f6hm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011 May 14;9:12. doi: 10.1186/1478-811X-9-12."
                                                      },
                                                      {
                                                            "ReferencePMID": "21471066",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, M\u00fcller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Sch\u00fcnemann HJ; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL."
                                                      }
                                                ]
                                          }
                                    },
                                    "IPDSharingStatementModule": {
                                          "IPDSharing": "Undecided",
                                          "IPDSharingDescription": "Undecided: It is not yet known if there will be a plan to make IPD available."
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000011658",
                                                            "ConditionMeshTerm": "Pulmonary Fibrosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000054990",
                                                            "ConditionMeshTerm": "Idiopathic Pulmonary Fibrosis"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000005355",
                                                            "ConditionMeshTerm": "Fibrosis"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008171",
                                                            "ConditionAncestorTerm": "Lung Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012140",
                                                            "ConditionAncestorTerm": "Respiratory Tract Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M7637",
                                                            "ConditionBrowseLeafName": "Fibrosis",
                                                            "ConditionBrowseLeafAsFound": "Fibrosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M13664",
                                                            "ConditionBrowseLeafName": "Pulmonary Fibrosis",
                                                            "ConditionBrowseLeafAsFound": "Pulmonary Fibrosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M27142",
                                                            "ConditionBrowseLeafName": "Idiopathic Pulmonary Fibrosis",
                                                            "ConditionBrowseLeafAsFound": "Idiopathic Pulmonary Fibrosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10320",
                                                            "ConditionBrowseLeafName": "Lung Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14129",
                                                            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3003",
                                                            "ConditionBrowseLeafName": "Idiopathic Pulmonary Fibrosis",
                                                            "ConditionBrowseLeafAsFound": "Idiopathic Pulmonary Fibrosis",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC08",
                                                            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 48,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT02249676",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "IRB2013-055-02"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Tianjin Medical University General Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Autologous Mesenchymal Stem Cells for the Treatment of Neuromyelitis Optica Spectrum Disorders",
                                          "OfficialTitle": "Autologous Mesenchymal Stem Cells for the Treatment of Progressive and Refractory Neuromyelitis Optica Spectrum Disorders: an Open-label Phase 2a Proof-of-concept Study"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "October 2018",
                                          "OverallStatus": "Completed",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "January 2013",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 31, 2014",
                                                "PrimaryCompletionDateType": "Actual"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 31, 2014",
                                                "CompletionDateType": "Actual"
                                          },
                                          "StudyFirstSubmitDate": "September 15, 2014",
                                          "StudyFirstSubmitQCDate": "September 22, 2014",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "September 25, 2014",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "October 15, 2018",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "October 17, 2018",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Principal Investigator",
                                                "ResponsiblePartyInvestigatorFullName": "Fu-Dong Shi",
                                                "ResponsiblePartyInvestigatorTitle": "Head of Neurology Department",
                                                "ResponsiblePartyInvestigatorAffiliation": "Tianjin Medical University General Hospital"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Tianjin Medical University General Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "Neuromyelitis optica (NMO) is a demyelinating and degenerative disorder of the central nervous system affecting vision and brain and spinal cord function which leads to accumulating disability with a 5 year-mortality of approximately 30%. Survivors are typically left with severe morbidity secondary to blindness, quadriparesis and respiratory failure. No agent has been found to be highly effective in halting disease activity.Based on recent outcomes of Multipotent mesenchymal stromal cells in autoimmune diseases including multiple sclerosis, and based on the mechanisms of neuromyelitis optica, the investigators anticipate that mesenchymal stem cells transplantation may provide lasting disease stability for neuromyelitis optica patients.",
                                          "DetailedDescription": "Primary objective was to assess feasibility and safety; the investigators compared adverse events from up to 3months before treatment until up to 12 months after the infusion.\n\nAs a secondary objective, the investigators chose efficacy outcomes to assess the Expanded Disability Status (EDSS)\u3001annual relapse rate (ARR) and time to next relapse after transplant.\n\nThird objective anterior visual pathway and pyramidal tract as a model of wider disease. Masked endpoint analyses was used for electrophysiological and selected imaging outcomes."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Devic's Syndrome",
                                                      "Devic's Neuromyelitis Optica",
                                                      "Devic Syndrome",
                                                      "Devic's Disease",
                                                      "Devic Disease"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Autologous mesenchymal stem cells",
                                                      "neuromyelitis optica",
                                                      "treatment"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "15",
                                                "EnrollmentType": "Actual"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "Autologous mesenchymal stem cells group",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "Generated clinical-grade MSC 10 mg chlorpheniramine Po.;100 mg hydrocortisone iv.;10 mg metoclopramide im.;30 min before administration of the cells .\n\nMSC a day-case 2\u00b70\u00d7106 cells/kg i.v. 15min Infused normal saline 500 Ml over 4 h i.v.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "Control group",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "Patients with progressive and refractory NMO treated with regular methods",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Autologous mesenchymal stem cells"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Autologous mesenchymal stem cells",
                                                            "InterventionDescription": "Autologous mesenchymal stem cells",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "Autologous mesenchymal stem cells group",
                                                                        "Control group"
                                                                  ]
                                                            },
                                                            "InterventionOtherNameList": {
                                                                  "InterventionOtherName": [
                                                                        "MSC"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "EDSS",
                                                            "PrimaryOutcomeDescription": "Compare EDSS change before and one year after mesenchymal stem cells (MSC) infusion",
                                                            "PrimaryOutcomeTimeFrame": "change from baseline to one year"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Annual relapse rate",
                                                            "SecondaryOutcomeDescription": "Compare annual relapse rate before and one year after MSC infusion",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Lesion load",
                                                            "SecondaryOutcomeDescription": "Compared lesion load before and one year after MSC infusion",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Retinal nerve fiber layer (RNFL)",
                                                            "SecondaryOutcomeDescription": "Compared RNFL before and one year after MSC infusion",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Cognition",
                                                            "SecondaryOutcomeDescription": "Compare cognition questionnaire scale before and one year after MSC infusion",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Immunological assessments",
                                                            "SecondaryOutcomeDescription": "Compare anti-aquaporin4-ab before and one year after MSC infusion.",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Immunological assessments",
                                                            "SecondaryOutcomeDescription": "Compare immune cell subpopulation before and one year after MSC infusion.",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Immunological assessments",
                                                            "SecondaryOutcomeDescription": "Compare cytokine kinetics before and one year after MSC infusion.",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "cerebral volume",
                                                            "SecondaryOutcomeDescription": "Compare cerebral volume before and one year after MSC infusion",
                                                            "SecondaryOutcomeTimeFrame": "1 year after infusion"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nClinically definite neuromyelitis optica or neuromyelitis optica spectrum disorder\nAge > 18 year\nEDSS > 3\n\nProgression continued relapses or worsening MRI after at least a year of attempted therapy as evidenced by one or more of the following:\n\nIncrease of 1 EDSS point (if baseline EDSS<5.0) or 0.5 EDSS points (if baseline EDSS >5.5)\nModerate-severe relapses in past 18 months\nGadolinium enhancing lesions (double or triple dose Gd)\n1 new T2 lesion\n\nEvidence of recent inflammatory disease, as evidenced by any one of the following:\n\n1 moderate-severe relapses in past 18 months\n1 Gd-enhancing lesions (single, double or triple dose Gd)\n1 new T2 lesion\n\nExclusion Criteria:\n\nReceived Immune inhibitors immunomodulator during the three months before the trial\nSignificant cardiac, renal, or hepatic failure or any other disease that may affect the results of the study\nAllergies\nPregnant or possibly pregnant\nCognitive decline to understand or sign the informed consent\nBrain tumor, HIV (+) tumor marker (+), blood pressure (BP): 200 /110 mmHg\nJudged not suitable by doctors",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "18 Years",
                                          "MaximumAge": "80 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Fu-Dong Shi, MD,PhD",
                                                            "OverallOfficialAffiliation": "Tianjin Medical University General Hospital",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Tianjin Medical University General Hospital",
                                                            "LocationCity": "Tianjin",
                                                            "LocationState": "Tianjin",
                                                            "LocationZip": "300052",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000009471",
                                                            "ConditionMeshTerm": "Neuromyelitis Optica"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009188",
                                                            "ConditionAncestorTerm": "Myelitis, Transverse"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020278",
                                                            "ConditionAncestorTerm": "Demyelinating Autoimmune Diseases, CNS"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000020274",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases of the Nervous System"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009422",
                                                            "ConditionAncestorTerm": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009902",
                                                            "ConditionAncestorTerm": "Optic Neuritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009901",
                                                            "ConditionAncestorTerm": "Optic Nerve Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003389",
                                                            "ConditionAncestorTerm": "Cranial Nerve Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003711",
                                                            "ConditionAncestorTerm": "Demyelinating Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005128",
                                                            "ConditionAncestorTerm": "Eye Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11566",
                                                            "ConditionBrowseLeafName": "Neuromyelitis Optica",
                                                            "ConditionBrowseLeafAsFound": "Neuromyelitis Optica",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11294",
                                                            "ConditionBrowseLeafName": "Myelitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11295",
                                                            "ConditionBrowseLeafName": "Myelitis, Transverse",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21251",
                                                            "ConditionBrowseLeafName": "Demyelinating Autoimmune Diseases, CNS",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M21247",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases of the Nervous System",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11539",
                                                            "ConditionBrowseLeafName": "Neuritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11985",
                                                            "ConditionBrowseLeafName": "Optic Neuritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11984",
                                                            "ConditionBrowseLeafName": "Optic Nerve Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5757",
                                                            "ConditionBrowseLeafName": "Cranial Nerve Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6061",
                                                            "ConditionBrowseLeafName": "Demyelinating Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7423",
                                                            "ConditionBrowseLeafName": "Eye Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4103",
                                                            "ConditionBrowseLeafName": "Neuromyelitis Optica Spectrum Disorder",
                                                            "ConditionBrowseLeafAsFound": "Neuromyelitis Optica",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T3988",
                                                            "ConditionBrowseLeafName": "Myelitis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "T4263",
                                                            "ConditionBrowseLeafName": "Optic Neuritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC10",
                                                            "ConditionBrowseBranchName": "Nervous System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC11",
                                                            "ConditionBrowseBranchName": "Eye Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC01",
                                                            "ConditionBrowseBranchName": "Infections"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC04",
                                                            "ConditionBrowseBranchName": "Neoplasms"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "Rare",
                                                            "ConditionBrowseBranchName": "Rare Diseases"
                                                      }
                                                ]
                                          }
                                    },
                                    "InterventionBrowseModule": {
                                          "InterventionBrowseLeafList": {
                                                "InterventionBrowseLeaf": [
                                                      {
                                                            "InterventionBrowseLeafId": "M10912",
                                                            "InterventionBrowseLeafName": "Metoclopramide",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M9064",
                                                            "InterventionBrowseLeafName": "Hydrocortisone",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M155022",
                                                            "InterventionBrowseLeafName": "Hydrocortisone 17-butyrate 21-propionate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M228602",
                                                            "InterventionBrowseLeafName": "Hydrocortisone acetate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M263157",
                                                            "InterventionBrowseLeafName": "Hydrocortisone hemisuccinate",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "InterventionBrowseLeafId": "M5137",
                                                            "InterventionBrowseLeafName": "Chlorpheniramine",
                                                            "InterventionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "InterventionBrowseBranchList": {
                                                "InterventionBrowseBranch": [
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AnEm",
                                                            "InterventionBrowseBranchName": "Antiemetics"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Gast",
                                                            "InterventionBrowseBranchName": "Gastrointestinal Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "All",
                                                            "InterventionBrowseBranchName": "All Drugs and Chemicals"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Infl",
                                                            "InterventionBrowseBranchName": "Anti-Inflammatory Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "AAll",
                                                            "InterventionBrowseBranchName": "Anti-Allergic Agents"
                                                      },
                                                      {
                                                            "InterventionBrowseBranchAbbrev": "Derm",
                                                            "InterventionBrowseBranchName": "Dermatologic Agents"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 49,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT04441658",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "DFSC-2020(CR)-02"
                                          },
                                          "Organization": {
                                                "OrgFullName": "Shanghai East Hospital",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus",
                                          "OfficialTitle": "Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "June 2020",
                                          "OverallStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "April 10, 2020",
                                                "StartDateType": "Actual"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "July 2022",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2022",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "June 19, 2020",
                                          "StudyFirstSubmitQCDate": "June 19, 2020",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "June 22, 2020",
                                                "StudyFirstPostDateType": "Actual"
                                          },
                                          "LastUpdateSubmitDate": "June 19, 2020",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "June 22, 2020",
                                                "LastUpdatePostDateType": "Actual"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyType": "Sponsor"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "Shanghai East Hospital",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "IsFDARegulatedDrug": "No",
                                          "IsFDARegulatedDevice": "No"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study is a 24-week single-center, randomized, double-blind, placebo-controlled trial. The trial includes a 3-week early screening and lifestyle education period, 6-week treatment period, and 18-week follow-up period. Chinese type 2 diabetic subjects receiving traditional hypoglycemic treatment were randomly assigned to umbilical cord mesenchymal stem cell or placebo infusion therapy to observe the efficacy and safety of umbilical cord mesenchymal stem cell infusion therapy.",
                                          "DetailedDescription": "This study is a 24-week single-center, randomized, double-blind, placebo-controlled trial. The trial includes a 3-week early screening and lifestyle education period, 6-week treatment period, and 18-week follow-up period. Chinese type 2 diabetic subjects receiving traditional hypoglycemic treatment\uff08including insulin\uff09 were randomly assigned to umbilical cord mesenchymal stem cell or placebo infusion therapy to observe the efficacy and safety of umbilical cord mesenchymal stem cell infusion therapy."
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Type 2 Diabetes",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Umbilical Cord Mesenchymal Stem Cells",
                                                      "Type 2 Diabetes"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Randomized",
                                                "DesignInterventionModel": "Parallel Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "Triple",
                                                      "DesignWhoMaskedList": {
                                                            "DesignWhoMasked": [
                                                                  "Participant",
                                                                  "Care Provider",
                                                                  "Investigator"
                                                            ]
                                                      }
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "30",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "ArmGroupList": {
                                                "ArmGroup": [
                                                      {
                                                            "ArmGroupLabel": "experimental group",
                                                            "ArmGroupType": "Experimental",
                                                            "ArmGroupDescription": "The volunteers of the experimental group will be given peripheral intravenously a dose of 0.75*10^6/ kg human umbilical cord mesenchymal stem cells at 0,1,5,6 week.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: Umbilical Cord Mesenchymal Stem Cells"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "ArmGroupLabel": "control group",
                                                            "ArmGroupType": "Placebo Comparator",
                                                            "ArmGroupDescription": "The control group will be given the same dose of saline containing human albumin.",
                                                            "ArmGroupInterventionList": {
                                                                  "ArmGroupInterventionName": [
                                                                        "Biological: saline"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          },
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Umbilical Cord Mesenchymal Stem Cells",
                                                            "InterventionDescription": "human umbilical cord mesenchymal stem cells were peripheral intravenous infused to experimental group",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "experimental group"
                                                                  ]
                                                            }
                                                      },
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "saline",
                                                            "InterventionDescription": "saline containing human albumin will be infused to the control group",
                                                            "InterventionArmGroupLabelList": {
                                                                  "InterventionArmGroupLabel": [
                                                                        "control group"
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "The changes in HbA1C level",
                                                            "PrimaryOutcomeDescription": "The changes in HbA1C level after transplantation",
                                                            "PrimaryOutcomeTimeFrame": "24 weeks after treatment"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "Reduction of insulin requirement",
                                                            "SecondaryOutcomeDescription": "Reduction of insulin requirement after transplantation",
                                                            "SecondaryOutcomeTimeFrame": "24 weeks after treatment"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "The changes in blood glucose level",
                                                            "SecondaryOutcomeDescription": "The changes in blood glucose level after transplantation",
                                                            "SecondaryOutcomeTimeFrame": "24 weeks after treatment"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nType 2 diabetes\uff1b\nThe course of diabetes is 5-15 years;\n20kg/m2\u2264body mass index (BMI)\u226430 kg /m2\uff1b\n7.5% \u2264HbA1c\u226410%\uff1b\nInsulin dose and other oral antidiabetic drugs doses should be stable over the 3 months prior to randomization.\n\nExclusion Criteria:\n\nHeavy allergic constitution or an allergy to any component used in cell culture.\nBeing treated with drug (Glucocorticoids\uff0cTricyclic Antidepressive Agents,etc.) affect the metabolism of glucose in the past 1 month;\nother causes of diabetes;\nAll kinds of acute complications such as diabetic ketoacidosis and non-ketohyperosmotic syndrome were screened in the past 6 months;\nHaving evidence of ongoing or frequent/severe hypoglycemia in the past 6 months;\nSevere cardiovascular and cerebral events\uff1aoccurrence of heart failure NYHA Classification III or IV, myocardial infarction, cerebral infarction, cerebral hemorrhage within 6 months before the observation period;\nPatients with abnormal liver and kidney function: AST and ALT exceeding 2.5 times of the normal upper limit, and serum creatinine exceeding 1.5 mg/dl for men, exceeding 1.4 mg/dl for women;\nPositive results of HbsAg\u3001Anti-HCV\u3001HIV or syphilis;\nPatients suffering from other serious systemic diseases (such as malignancy, central nervous system,cardiovascular system, blood system, digestive system,endocrine system,respiratory system, genitourinary system, immune system and);\nOngoing pregnancy or absence of effective contraception in women with childbearing potential;\nPatients who had received other stem cell therapy before screening.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "30 Years",
                                          "MaximumAge": "75 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "wang congrong, doctor",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86-021-38804518",
                                                            "CentralContactEMail": "wcr601@163.com"
                                                      },
                                                      {
                                                            "CentralContactName": "liu zhongmin, doctor",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86-021-38804518",
                                                            "CentralContactEMail": "liu.zhongmin@tongji.edu.cn"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "wang congrong, doctor",
                                                            "OverallOfficialAffiliation": "Shanghai East Hospital. China.",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "Shanghai East Hospital, Shanghai Tongji University",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Shanghai",
                                                            "LocationState": "Shanghai",
                                                            "LocationZip": "200120",
                                                            "LocationCountry": "China",
                                                            "LocationContactList": {
                                                                  "LocationContact": [
                                                                        {
                                                                              "LocationContactName": "wang congrong, doctor",
                                                                              "LocationContactRole": "Contact"
                                                                        }
                                                                  ]
                                                            }
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000003920",
                                                            "ConditionMeshTerm": "Diabetes Mellitus"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000003924",
                                                            "ConditionMeshTerm": "Diabetes Mellitus, Type 2"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000044882",
                                                            "ConditionAncestorTerm": "Glucose Metabolism Disorders"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000008659",
                                                            "ConditionAncestorTerm": "Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000004700",
                                                            "ConditionAncestorTerm": "Endocrine System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M6267",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus",
                                                            "ConditionBrowseLeafAsFound": "Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M6271",
                                                            "ConditionBrowseLeafName": "Diabetes Mellitus, Type 2",
                                                            "ConditionBrowseLeafAsFound": "Type 2 Diabetes",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M10791",
                                                            "ConditionBrowseLeafName": "Metabolic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M24556",
                                                            "ConditionBrowseLeafName": "Glucose Metabolism Disorders",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7014",
                                                            "ConditionBrowseLeafName": "Endocrine System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC18",
                                                            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC19",
                                                            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  },
                  {
                        "Rank": 50,
                        "Study": {
                              "ProtocolSection": {
                                    "IdentificationModule": {
                                          "NCTId": "NCT00953485",
                                          "OrgStudyIdInfo": {
                                                "OrgStudyId": "NJGLYY002"
                                          },
                                          "Organization": {
                                                "OrgFullName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
                                                "OrgClass": "OTHER"
                                          },
                                          "BriefTitle": "Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sj\u00f6gren's Syndrome (pSS)",
                                          "OfficialTitle": "Clinical Trial of Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sj\u00f6gren's Syndrome - Phase \u2160/\u2161"
                                    },
                                    "StatusModule": {
                                          "StatusVerifiedDate": "August 2009",
                                          "OverallStatus": "Unknown status",
                                          "LastKnownStatus": "Recruiting",
                                          "ExpandedAccessInfo": {
                                                "HasExpandedAccess": "No"
                                          },
                                          "StartDateStruct": {
                                                "StartDate": "June 2009"
                                          },
                                          "PrimaryCompletionDateStruct": {
                                                "PrimaryCompletionDate": "December 2010",
                                                "PrimaryCompletionDateType": "Anticipated"
                                          },
                                          "CompletionDateStruct": {
                                                "CompletionDate": "December 2011",
                                                "CompletionDateType": "Anticipated"
                                          },
                                          "StudyFirstSubmitDate": "August 4, 2009",
                                          "StudyFirstSubmitQCDate": "August 4, 2009",
                                          "StudyFirstPostDateStruct": {
                                                "StudyFirstPostDate": "August 6, 2009",
                                                "StudyFirstPostDateType": "Estimate"
                                          },
                                          "LastUpdateSubmitDate": "August 19, 2009",
                                          "LastUpdatePostDateStruct": {
                                                "LastUpdatePostDate": "August 20, 2009",
                                                "LastUpdatePostDateType": "Estimate"
                                          }
                                    },
                                    "SponsorCollaboratorsModule": {
                                          "ResponsibleParty": {
                                                "ResponsiblePartyOldNameTitle": "the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
                                                "ResponsiblePartyOldOrganization": "the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School"
                                          },
                                          "LeadSponsor": {
                                                "LeadSponsorName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
                                                "LeadSponsorClass": "OTHER"
                                          }
                                    },
                                    "OversightModule": {
                                          "OversightHasDMC": "Yes"
                                    },
                                    "DescriptionModule": {
                                          "BriefSummary": "This study will explore safety and efficacy of allogeneic mesenchymal stem cells transplantation (MSCT) to treat patients with diagnosis of primary Sj\u00f6gren's Syndrome (pSS) who have been resistant to multiple standard treatments. The underlying hypothesis is that the pSS condition is caused by an abnormal immune homeostasis that can be restored by MSCT.",
                                          "DetailedDescription": "To test a new approach using allogeneic derived mesenchymal stem cell based therapy (MSCT) to treat refractory primary Sj\u00f6gren's Syndrome (pSS)\nTo determine the disease-free survival in pSS patients treated with MSCT in terms of disease activity index, pSS serology and salivary gland function\nTo assess adverse events of allogeneic MSC transplantation\nTo assess the association of disease activity index, pSS serology levels, and saliva flow rate at baseline with disease-free survival"
                                    },
                                    "ConditionsModule": {
                                          "ConditionList": {
                                                "Condition": [
                                                      "Sjogren's Syndrome",
                                                      "Mesenchymal Stem Cells"
                                                ]
                                          },
                                          "KeywordList": {
                                                "Keyword": [
                                                      "Sjogren's Syndrome",
                                                      "Mesenchymal Stem Cells",
                                                      "Transplantation"
                                                ]
                                          }
                                    },
                                    "DesignModule": {
                                          "StudyType": "Interventional",
                                          "PhaseList": {
                                                "Phase": [
                                                      "Phase 1",
                                                      "Phase 2"
                                                ]
                                          },
                                          "DesignInfo": {
                                                "DesignAllocation": "Non-Randomized",
                                                "DesignInterventionModel": "Single Group Assignment",
                                                "DesignPrimaryPurpose": "Treatment",
                                                "DesignMaskingInfo": {
                                                      "DesignMasking": "None (Open Label)"
                                                }
                                          },
                                          "EnrollmentInfo": {
                                                "EnrollmentCount": "20",
                                                "EnrollmentType": "Anticipated"
                                          }
                                    },
                                    "ArmsInterventionsModule": {
                                          "InterventionList": {
                                                "Intervention": [
                                                      {
                                                            "InterventionType": "Biological",
                                                            "InterventionName": "Allogeneic Mesenchymal Stem Cells (AlloMSC)",
                                                            "InterventionDescription": "Allogeneic mesenchymal stem cells will be infused intravenously (single dose, 10^6 cells/kg body weight)."
                                                      }
                                                ]
                                          }
                                    },
                                    "OutcomesModule": {
                                          "PrimaryOutcomeList": {
                                                "PrimaryOutcome": [
                                                      {
                                                            "PrimaryOutcomeMeasure": "Sj\u00f6gren's syndrome disease activity index",
                                                            "PrimaryOutcomeTimeFrame": "Monthly"
                                                      }
                                                ]
                                          },
                                          "SecondaryOutcomeList": {
                                                "SecondaryOutcome": [
                                                      {
                                                            "SecondaryOutcomeMeasure": "pSS Serology (ANA, dsDNA, SS-A, SS-B)",
                                                            "SecondaryOutcomeTimeFrame": "Monthly"
                                                      },
                                                      {
                                                            "SecondaryOutcomeMeasure": "Improvement of salivary gland function (measured as stimulated saliva flow rate)",
                                                            "SecondaryOutcomeTimeFrame": "Monthly"
                                                      }
                                                ]
                                          }
                                    },
                                    "EligibilityModule": {
                                          "EligibilityCriteria": "Inclusion Criteria:\n\nAll patients fulfilled the international classification criteria (2002) for primary Sj\u00f6gren's Syndrome, man or woman aged from 15 to 70 years old, Sj\u00f6gren's Syndrome Disease Activity Index (SSDAI)\u22658.\nStimulated whole saliva flow rate less than 1~6ml/6min.\nPatients must be informed of the investigational nature of this study and give written informed consent in accordance with the institutional and hospital guidelines.\nWomen of reproductive potential may not participate unless they have agreed to use an effective contraceptive method while on this trial and for 12 months following treatment. Women of child-bearing potential must have a pregnancy test performed within 72 hours prior to initiation of treatment.\n\nExclusion Criteria:\n\nEnd-stage renal failure.\nSevere cardiopulmonary compromise, or other system failure.\nActive, uncontrolled infections.\nPregnant or nursing women may not participate due to the possibility of fetal harm or harm to nursing infants from this treatment regimen.",
                                          "HealthyVolunteers": "No",
                                          "Gender": "All",
                                          "MinimumAge": "15 Years",
                                          "MaximumAge": "70 Years",
                                          "StdAgeList": {
                                                "StdAge": [
                                                      "Child",
                                                      "Adult",
                                                      "Older Adult"
                                                ]
                                          }
                                    },
                                    "ContactsLocationsModule": {
                                          "CentralContactList": {
                                                "CentralContact": [
                                                      {
                                                            "CentralContactName": "Lingyun Sun, MD",
                                                            "CentralContactRole": "Contact",
                                                            "CentralContactPhone": "+86-25-83105219",
                                                            "CentralContactEMail": "lingyunsun2001@yahoo.com.cn"
                                                      }
                                                ]
                                          },
                                          "OverallOfficialList": {
                                                "OverallOfficial": [
                                                      {
                                                            "OverallOfficialName": "Lingyun Sun, MD",
                                                            "OverallOfficialAffiliation": "the Affiliated Drum Tower Hospital of Nanjing University Medical School",
                                                            "OverallOfficialRole": "Principal Investigator"
                                                      }
                                                ]
                                          },
                                          "LocationList": {
                                                "Location": [
                                                      {
                                                            "LocationFacility": "the Affiliated Drum Tower Hospital of Nanjing University Medical School",
                                                            "LocationStatus": "Recruiting",
                                                            "LocationCity": "Nanjing",
                                                            "LocationState": "Jiangsu",
                                                            "LocationZip": "210008",
                                                            "LocationCountry": "China"
                                                      }
                                                ]
                                          }
                                    },
                                    "ReferencesModule": {
                                          "ReferenceList": {
                                                "Reference": [
                                                      {
                                                            "ReferencePMID": "19489103",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, Xu T, Le A, Shi S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells. 2009 Jun;27(6):1421-32. doi: 10.1002/stem.68."
                                                      },
                                                      {
                                                            "ReferencePMID": "19389752",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L. Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler. 2009 May;15(5):644-6. doi: 10.1177/1352458509104590."
                                                      },
                                                      {
                                                            "ReferencePMID": "19118507",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Zhou K, Zhang H, Jin O, Feng X, Yao G, Hou Y, Sun L. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol Immunol. 2008 Dec;5(6):417-24. doi: 10.1038/cmi.2008.52."
                                                      },
                                                      {
                                                            "ReferencePMID": "17402368",
                                                            "ReferenceType": "background",
                                                            "ReferenceCitation": "Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2007;16(2):121-8."
                                                      },
                                                      {
                                                            "ReferencePMID": "22927248",
                                                            "ReferenceType": "derived",
                                                            "ReferenceCitation": "Xu J, Wang D, Liu D, Fan Z, Zhang H, Liu O, Ding G, Gao R, Zhang C, Ding Y, Bromberg JS, Chen W, Sun L, Wang S. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sj\u00f6gren syndrome. Blood. 2012 Oct 11;120(15):3142-51. doi: 10.1182/blood-2011-11-391144. Epub 2012 Aug 27."
                                                      }
                                                ]
                                          }
                                    }
                              },
                              "DerivedSection": {
                                    "MiscInfoModule": {
                                          "VersionHolder": "September 29, 2022"
                                    },
                                    "ConditionBrowseModule": {
                                          "ConditionMeshList": {
                                                "ConditionMesh": [
                                                      {
                                                            "ConditionMeshId": "D000012859",
                                                            "ConditionMeshTerm": "Sjogren's Syndrome"
                                                      },
                                                      {
                                                            "ConditionMeshId": "D000013577",
                                                            "ConditionMeshTerm": "Syndrome"
                                                      }
                                                ]
                                          },
                                          "ConditionAncestorList": {
                                                "ConditionAncestor": [
                                                      {
                                                            "ConditionAncestorId": "D000004194",
                                                            "ConditionAncestorTerm": "Disease"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000010335",
                                                            "ConditionAncestorTerm": "Pathologic Processes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001172",
                                                            "ConditionAncestorTerm": "Arthritis, Rheumatoid"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001168",
                                                            "ConditionAncestorTerm": "Arthritis"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007592",
                                                            "ConditionAncestorTerm": "Joint Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009140",
                                                            "ConditionAncestorTerm": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012216",
                                                            "ConditionAncestorTerm": "Rheumatic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000014987",
                                                            "ConditionAncestorTerm": "Xerostomia"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000012466",
                                                            "ConditionAncestorTerm": "Salivary Gland Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009059",
                                                            "ConditionAncestorTerm": "Mouth Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000009057",
                                                            "ConditionAncestorTerm": "Stomatognathic Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000015352",
                                                            "ConditionAncestorTerm": "Dry Eye Syndromes"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007766",
                                                            "ConditionAncestorTerm": "Lacrimal Apparatus Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000005128",
                                                            "ConditionAncestorTerm": "Eye Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000003240",
                                                            "ConditionAncestorTerm": "Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000001327",
                                                            "ConditionAncestorTerm": "Autoimmune Diseases"
                                                      },
                                                      {
                                                            "ConditionAncestorId": "D000007154",
                                                            "ConditionAncestorTerm": "Immune System Diseases"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseLeafList": {
                                                "ConditionBrowseLeaf": [
                                                      {
                                                            "ConditionBrowseLeafId": "M15507",
                                                            "ConditionBrowseLeafName": "Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14816",
                                                            "ConditionBrowseLeafName": "Sjogren's Syndrome",
                                                            "ConditionBrowseLeafAsFound": "Sjogren's Syndrome",
                                                            "ConditionBrowseLeafRelevance": "high"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3628",
                                                            "ConditionBrowseLeafName": "Arthritis",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3632",
                                                            "ConditionBrowseLeafName": "Arthritis, Rheumatoid",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9773",
                                                            "ConditionBrowseLeafName": "Joint Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11249",
                                                            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14197",
                                                            "ConditionBrowseLeafName": "Rheumatic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5475",
                                                            "ConditionBrowseLeafName": "Collagen Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M16876",
                                                            "ConditionBrowseLeafName": "Xerostomia",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M14437",
                                                            "ConditionBrowseLeafName": "Salivary Gland Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11171",
                                                            "ConditionBrowseLeafName": "Mouth Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M11169",
                                                            "ConditionBrowseLeafName": "Stomatognathic Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M17192",
                                                            "ConditionBrowseLeafName": "Dry Eye Syndromes",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9816",
                                                            "ConditionBrowseLeafName": "Keratoconjunctivitis Sicca",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9938",
                                                            "ConditionBrowseLeafName": "Lacrimal Apparatus Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M7423",
                                                            "ConditionBrowseLeafName": "Eye Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M5616",
                                                            "ConditionBrowseLeafName": "Connective Tissue Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M3781",
                                                            "ConditionBrowseLeafName": "Autoimmune Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      },
                                                      {
                                                            "ConditionBrowseLeafId": "M9352",
                                                            "ConditionBrowseLeafName": "Immune System Diseases",
                                                            "ConditionBrowseLeafRelevance": "low"
                                                      }
                                                ]
                                          },
                                          "ConditionBrowseBranchList": {
                                                "ConditionBrowseBranch": [
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC23",
                                                            "ConditionBrowseBranchName": "Symptoms and General Pathology"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "All",
                                                            "ConditionBrowseBranchName": "All Conditions"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC05",
                                                            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC07",
                                                            "ConditionBrowseBranchName": "Mouth and Tooth Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC11",
                                                            "ConditionBrowseBranchName": "Eye Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC17",
                                                            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
                                                      },
                                                      {
                                                            "ConditionBrowseBranchAbbrev": "BC20",
                                                            "ConditionBrowseBranchName": "Immune System Diseases"
                                                      }
                                                ]
                                          }
                                    }
                              }
                        }
                  }
            ]
      }
}